Management of sepsis during Mars treatment in acute on chronic liver failure. Novelli G, Morabito V, Pugliese F, Ferretti G, Novelli S, Ianni S, Lai Q, Rossi M, Berloco PB.
Transplant Proc. 2011 May;43(4):1085-90.
2011 http://www.ncbi.nlm.nih.gov/pubmed/21620059
Proteomic Analysis of Polypeptides Captured from Blood during Extracorporeal Albumin Dialysis in Patients with Cholestasis and Resistant Pruritus Gay M, Pares A, Carrascal M, Bosch-I-Crespo P, Gorga M, Mas A, Abian J. PLoS One. 2011;6(7):e21850. Epub 2011 Jul 14 2011 http://www.ncbi.nlm.nih.gov/pubmed/21779339
Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in a children with acute liver failure Schaefer B, Schaefer F, Engelmann G, Meyburg J, Heckert KH, Zorn M, Schmitt CP. Nephrol Dial Transplant. 2011 Mar 18 2011 http://www.ncbi.nlm.nih.gov/pubmed/21421589
Renal replacement therapy in special settings: extracorporeal support devices in liver failure. Cerda J, Tolwani A, Gibney N, Tiranathanagul K Semin Dialysis 2011;24(2):197-202 2011 http://www.ncbi.nlm.nih.gov/pubmed/21517988
Acute-on-chronic liver failure: the heart and systemic hemodynamics.
Liu H, Lee SS Curr Opin Crit Care. 2011 Apr;17(2):190-4 2011 http://www.ncbi.nlm.nih.gov/pubmed/21326096
Bridging therapies and liver transplantation in acute liver failure, 10 years of MARS experience from Finland Kantola T, Ilmakunnas M, Koivusalo AM, Isoniemi H. Scand J Surg. 2011;100(1):8-13 2011 http://www.ncbi.nlm.nih.gov/pubmed/21482500
Intoxications amenable to extracorporeal removal Winchester JF, Harbord NB Adv Chronic Kidney Dis 2011;18(3):167-71 2011 http://www.ncbi.nlm.nih.gov/pubmed/21531322
Continuous renal replacement therapy (CRRT) and plasma adsorption prior to and following liver transplantation. Penkov RD, Vladov N 16th Int. Conf. on Continous Renal Replacement Therapies (CRRT), Feb. 22-25, 2011, San Diego, CA, USA 2011  
Effect of ELAD liver support on plasma HGF and TGF-beta 1 in acute liver failure Miwa Y, Ellis AJ, Hughes RD, Langley PG, Wendon JA, Williams R. Int J Artif Organs. 1996 Apr;19(4):240-4 1996 http://www.ncbi.nlm.nih.gov/pubmed/8786175
Effective bilirubin reduction by novel single-pass albumin dialysis with super-flux dialyser (SPAD-SF) compared with standard spad in liver failure Tiranathanagul K, Chancharoenthana W, Susantitaphong P, Katavetin P, Praditpornsilpa K, Eiam-Ong S WCN 2011, MO361/8-12 April 2011 2011  
Single-dose application of antithrombin III as alternative anticoagulation during extracorporeal therapy in critically ill patients with advanced liver cirrhosis: a retrospective data analysis Brunner R, Madl C, Druml W, Holzinger U
Crit Care 2011;15(suppl.1):S44-5/31st Int Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 22-25 March 2011 2011  
More data on the effect of haemoperfusion for acute poisoning is required.
Chau AM, Roberts DM. Blood Purif. 2011;31(1-3):41 2011 http://www.ncbi.nlm.nih.gov/pubmed/21135548
Indications for blood purification in critical care Hirasawa H. Contrib Nephrol. 2010;166:21-30. Epub 2010 May 7 2010 http://www.ncbi.nlm.nih.gov/pubmed/20472988
Treatment of hepatic encephalopathy by on-line hemodiafiltration: a case series study Arata S, Tanaka K, Takayama K, Moriwaki Y, Suzuki N, Sugiyama M, Aoyagi K. BMC Emerg Med. 2010 May 21;10:10 2010 http://www.ncbi.nlm.nih.gov/pubmed/20492684
Performance of the Hepatic Encephalopathy Scoring Algorithm in a Clinical Trial of Patients With Cirrhosis and Severe Hepatic Encephalopathy Hassanein T, Blei AT, Perry W, Hilsabeck R, Stange J, Larsen FS, Brown RS Jr, Caldwell S, McGuire B, Nevens F, Fontana R. Am J Gastroenterol. 2009 May 19 2009 http://www.ncbi.nlm.nih.gov/pubmed/19455117?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, Azoulay D, Ducot B, Chiche L. Ann Surg. 1995 Aug;222(2):109-19 1995 http://www.ncbi.nlm.nih.gov/pubmed/7639578
Artificial liver support: quo vadis? Rozga J, Malkowski P. Ann Transplant. 2010 Dec 22;15(4):92-101. 2010 http://www.ncbi.nlm.nih.gov/pubmed/21183883
Thromboelastography to monitor clotting/bleeding complications in patients treated with the molecular adsorbent recirculating system Bachli EB, Bšsiger J, BŽchir M, Stover JF, Stocker R, Maggiorini M, Renner EL, MŸllhaupt B, Schuepbach RA Crit Care Res Pract. 2011;2011:313854. Epub 2011 Mar 6 2011 http://www.ncbi.nlm.nih.gov/pubmed/21527982
Clinical features and treatment in patients with acute 2,4-dinitrophenol poisoning Lu YQ, Jiang JK, Huang WD J Zhejiang Univ Sci B. 2011 Mar;12(3):189-92. 2011 http://www.ncbi.nlm.nih.gov/pubmed/21370503
Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival Das V, Boelle PY, Galbois A, Guidet B, Maury E, Carbonell N, Moreau R, Offenstadt G.
Crit Care Med. 2010 Nov;38(11):2108-16.
2010 http://www.ncbi.nlm.nih.gov/pubmed/20802324
Early indicators of prognosis in fulminant hepatic failure O'Grady JG, Alexander GJ, Hayllar KM, Williams R.
Gastroenterology. 1989 Aug;97(2):439-45.
1989 http://www.ncbi.nlm.nih.gov/pubmed/2490426
Artificial liver support. Literature review Lafuente S, Bertran MJ, Escorsell A Med Clin (Barc). 2010 Apr 21 2010 http://www.ncbi.nlm.nih.gov/pubmed/20416900
Current management of acute liver failure. Craig DG, Lee A, Hayes PC, Simpson KJ. Aliment Pharmacol Ther.  2010 Feb 1;31(3):345-58 2010 http://www.ncbi.nlm.nih.gov/pubmed/19845566?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=4
Role of artificial liver support in hepatic encephalopathy Stadlbauer V, Wright GA, Jalan R. Metab Brain Dis. 2009; 24(1):15-26 2009 http://www.ncbi.nlm.nih.gov/pubmed/19101787?dopt=AbstractPlus
Acute liver failure: redefining the syndromes. O'Grady JG, Schalm SW, Williams R. Lancet. 1993 Jul 31;342(8866):273-5 1993 http://www.ncbi.nlm.nih.gov/pubmed/8101303
Intensive care unit management of fulminant hepatic failure.
Gagliardi G, Laccania G, Boscolo A, La Guardia P, Arrigoni M, Michielan F. Transplant Proc. 2006 Jun;38(5):1389-93. 2006 http://www.ncbi.nlm.nih.gov/pubmed/16797312
Regional citrate anticoagulation in critically ill patients with liver and kidney failure. Balogun RA, Turgut F, Caldwell S, Abdel-Rahman EM J Nephrol. 2011 May 23 2011 http://www.ncbi.nlm.nih.gov/pubmed/21607918
Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS). Mitzner SR. Ann Hepatol. 2011; Suppl 1:S21-8 2011 http://www.ncbi.nlm.nih.gov/pubmed/21566251
Molecular adsorbents recirculating system in patients with severe liver failure. Experience of a single Romanian centre Rusu EE, Voiculescu M, Zilisteanu DS, Ismail G J Gastrointestin Liver Dis. 2009 Sep;18(3):311-6 2009 http://www.ncbi.nlm.nih.gov/pubmed/19795025
 Influence of Albumin Dialysis on Pharmacokinetics of Amphotericin B Colloidal Dispersion and Amphotericin B Lipid Complex Weiler S, Helene V,
Joannidis M, Dunzendorfer S, Bellmann, R.
Artificial Organs 2011  
Teicoplanin Pharmacokinetics During Albumin Dialysis Weiler S, Falkensammer G,  Seger C,  Joannidis M,  Bellmann, R. Artificial Organs 2011  
Systematic review and meta-analysis of survival following extracorporeal liver support Saliba F. Br J Surg. 2011 May;98(5):632 2011 http://www.ncbi.nlm.nih.gov/pubmed/21462173
Systematic review and meta-analysis of survival following extracorporeal liver support. Stutchfield BM, Simpson K, Wigmore SJ. Br J Surg. 2011 May;98(5):623-31 2011 http://www.ncbi.nlm.nih.gov/pubmed/21462172
MARS: The ultimate warrior against pruritus of cholestasis? Chazouillres O. J Hepatol. 2010 Aug;53(2):228-9 2010 http://www.ncbi.nlm.nih.gov/pubmed/20494469
Extracellular brain ammonia levels in association with arterial ammonia, intracranial pressure and the use of albumin dialysis devices in pigs with acute liver failure Zwirner K, Thiel C, Thiel K, Morgalla MH, Kšnigsrainer A, Schenk M. Metab Brain Dis. 2010 Nov 18 2010 http://www.ncbi.nlm.nih.gov/pubmed/21086032
Japanese-style intensive medical care improves prognosis for acute liver failure and the perioperative management of liver transplantation Inoue K, Watanabe T, Maruoka N, Kuroki Y, Takahashi H, Yoshiba M. Transplant Proc. 2010 Dec;42(10):4109-12 2010 http://www.ncbi.nlm.nih.gov/pubmed/21168638
Long-term absence of porcine endogenous retrovirus infection in chronically immunosuppressed patients after treatment with the porcine cell-based Academic Medical Center bioartificial liver Di Nicuolo G, D'Alessandro A, Andria B, Scuderi V, Scognamiglio M, Tammaro A, Mancini A, Cozzolino S, Di Florio E, Bracco A, Calise F, Chamuleau RA. Xenotransplantation. 2010 Nov-Dec;17(6):431-9 2010 http://www.ncbi.nlm.nih.gov/pubmed/21158944
Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach Baweja S, Wiggins K, Lee D, Blair S, Fraenkel M, McMahon LP. J Artif Organs. 2011 Mar;14(1):9-22 2011 http://www.ncbi.nlm.nih.gov/pubmed/21153038
Effects of membrane molecular weight cutoff on performance of a novel bioartificial liver Shi XL, Zhang Y, Han B, Gu JY, Chu XH, Xiao JQ, Ren HZ, Tan JJ, Ding YT Artif Organs. 2011 Mar; 35(3):1525-1594 2011 http://www.ncbi.nlm.nih.gov/pubmed/21371057
Methotrexate Transmembrance Clearance During Albumin Based Continuous Venovenous Hemodialysis D.A. Pasko, M. Grio, S. Thomas, T. Mottes, P.D. Brophy Blood Purif 2005;23:165 2005 No Pubmed
Stabilizing mechanisms in commercial albumin preparations: octanoate and N-acetyl-L-tryptophanate protect human serum albumin against heat and oxidative stress Anraku Makoto; Tsurusaki Yasufumi; Watanabe Hiroshi; Maruyama Toru; Kragh-Hansen Ulrich; Otagiri Masaki Biochimica et biophysica acta 2004;1702(1):9-17 2004 http://www.ncbi.nlm.nih.gov/pubmed/15450846
The effect of Prometheus device on laboratory markers of inflammation and tissue regeneration in acute liver failure management Rocen M, Kieslichova E, Merta D, Uchytilova E, Pavlova Y, Cap J, Trunecka P. Transplant Proc. 2010 Nov;42(9):3606-11. 2010 http://www.ncbi.nlm.nih.gov/pubmed/21094824
Combined continuous haemodialysis with a single pass high cut off albumin dialysis in severe cholestatic jaundice associated to liver failure: a case report Atzeni D, Caravetta P, Castaldi P, Farris A, Loria P, Murru S
Crit Care Med 2010;38(12):912/Society of Critical Care Medicine 40th Critical Care Congress San Diego, CA, USA, Jan. 15-19, 2011 2010 No Pubmed
Liver support systems as perioperative care in liver transplantation-historical perspective and recent progress in Japan Inoue K, Watanabe T, Hirasawa H, Yoshiba M
Minerva Gastroenterol Dietol 2010;56(3):345-53 2010 http://www.ncbi.nlm.nih.gov/pubmed/21037550
Future of bioartificial liver support Chamuleau R World J Gastrointest Surg 2010;1(1):21-5 2009 http://www.ncbi.nlm.nih.gov/pubmed/21160791
Long-term absence of porcine endogenous retrovirus infection in chronically immunosuppressed patients after treatment with the porcine cell-based Academic Medical Center bioartificial liver Di Nicuolo G, D'Alessandro A, Andria B, Scuderi V, Scognamiglio M, Tammaro A, Mancini A, Cozzolino S, Di Florio E, Bracco A, Calise F, Chamuleau RA. Xenotransplantation. 2010 Nov-Dec;17(6):431-9 2010 http://www.ncbi.nlm.nih.gov/pubmed/21158944
Hepatic encephalopathy: An updated approach from pathogenesis to treatment Toris GT, Bikis CN, Tsourouflis GS, Theocharis SE. Med Sci Monit. 2011 Feb 1;17(2):RA53-63. 2011 http://www.ncbi.nlm.nih.gov/pubmed/21278704
Molecular adsorbent recycling system therapy in the treatment of acute valproic acid intoxication Dichtwald S, Dahan E, Adi N, Moses A, Sorkine P. Isr Med Assoc J. 2010 May;12(5):307-8 2010 http://www.ncbi.nlm.nih.gov/pubmed/20929088
Vasoactive mediators in patients with acute liver failure treated with albumin dialysis Kortgen A, Hetz H, Morgenthaler NG, Paxian G, Hitzler P, Krenn CG, Bauer M. Liver Int. 2010 Apr;30(4):634-6. 2010 http://www.ncbi.nlm.nih.gov/pubmed/19780957?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
A randomized controlled trial or the use of albumin dialysis (MARS) in fulminant hepatic failure due to paracetamol poisoning. Pollock KJ, Lee AC, Hayes PC. Gut 2004; 53(Suppl. III):
A13, Abstract 047.
2004  
Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome. Kalambokis GN, Tsianos EV. Hepatology.2008; 48(2): 686 2008 http://www.ncbi.nlm.nih.gov/pubmed/18666233?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Albumin Dialysis Without Anticoagulation in High-Risk Patients: An Observational Study Tan HK, Yang WS, Choong HL, Wong KS. Artif Organs. 2010;1525-1594 2010 http://www.ncbi.nlm.nih.gov/pubmed/21091517
Life support of artificial liver: development of a bioartificial liver to treat liver failure.
Kobayashi N. J Hepatobiliary Pancreat Surg. 2009; 16: 113-7 2009 http://www.ncbi.nlm.nih.gov/pubmed/19110648?dopt=AbstractPlus
Introduction of a Novel Prototype BAL Support System Utilizing Small Human Hepatocytes (SH) in Rotary Culture. Wurm M, Lubei V, Caronna M, Hermann M, Buttiglieri S, Bodamer O, Muehl A, Tetta C, Margreiter R, Hengster P. Tissue Eng Part A. 2009; 15(5): 1063-73  2009 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=18847359&itool=pubmed_DocSum
A novel design improves the efficiency of detoxification charcoal columns Weiping Ding, Rumana Ahmad, Robert Winrow, Dayong Gao,
Suhail Ahmad
Hemodial Int 2010;14(1):131/30th Annual Dialysis Conference, Seattle, WA, USA
March 7-9, 2010 2010  
Bioartificial liver support systems Pless G. Methods Mol Biol. 2010;640:511-23 2010 http://www.ncbi.nlm.nih.gov/pubmed/20645071
Blood purification in fulminant hepatic failure Shinozaki K, Oda S, Abe R, Tateishi Y, Yokoi T, Hirasawa H. Contrib Nephrol. 2010;166:64-72 2010 http://www.ncbi.nlm.nih.gov/pubmed/20472993
Extracorporeal removal techniques for the poisoned patient: a review for the intensivist Fertel BS, Nelson LS, Goldfarb DS J Intensive Care Med 2010;25(3):139-48 2010 http://www.ncbi.nlm.nih.gov/pubmed/20444738
Review article: the current management of acute liver failure Craig DG, Lee A, Hayes PC, Simpson KJ. Aliment Pharmacol Ther. 2010 Feb 1;31(3):345-58. 2010 http://www.ncbi.nlm.nih.gov/pubmed/19845566?ordinalpos=2&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Cholestasis and liver dysfunction in critical care patients Kredel M, Brederlau J, Roewer N, Wunder C. Anaesthesist. 2008, 57:1172-82. 2008 http://www.ncbi.nlm.nih.gov/pubmed/18989650?dopt=AbstractPlus
Hot topics in liver intensive care Bacher A, Zimpfer M Transplant Proc. 2008; 40(4): 1179-82 2008 http://www.ncbi.nlm.nih.gov/pubmed/18555143
What fires prometheus? The link between inflammation and regeneration following chronic liver injury. Viebahn CS, Yeoh GC Int J Biochem Cell Biol. 2008; 40(5): 855-73 2008 http://www.ncbi.nlm.nih.gov/pubmed/18207446?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Standardized intensive care unit management in an anhepatic pig model: new standards for analyzing liver support systems Thiel C, Thiel K, Etspueler A, Schenk T, Morgalla MH, Koenigsrainer A, Schenk M. Crit Care. 2010 Jul 22;14(4):R138 2010 http://www.ncbi.nlm.nih.gov/pubmed/20649958
Which patients benefit from hemodialysis therapy in hepatorenal syndrome? Witzke O, Baumann M, Patschan D, Patschan S, Mitchell A, Treichel U, Gerken G, Philipp T, Kribben A. J Gastroenterol Hepatol. 2004 Dec;19(12):1369-73 2004 http://www.ncbi.nlm.nih.gov/pubmed/15610310
Reversal of Experimental Posthepatectomy Liver Failure in Pigs: A New Application of Hepatocyte Bioreactors. Arkadopoulos N, Kostopanagiotou G, Nastos C, Papalois A, Papoutsidakis N, Kalimeris K, Defterevos G, Kanna T, Polyzois K, Kampouroglou G, Kypriotis D, Costopanagiotou C, Pafiti A, Tzanatos H, Smyrniotis V Artif Organs. 2010 Jul 6. [Epub ahead of print] 2010 http://www.ncbi.nlm.nih.gov/pubmed/20618230
Plasma adsorption using bilirubin-adsorbent materials as a treatment for patients with hepatic failure Morimoto T, Matsushima M, Sowa N, Ide K, Sawanishi K. Int J Artif Organs. 1989 Apr;13(5):447-52 1989 http://www.ncbi.nlm.nih.gov/pubmed/2803055?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=8
MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: A pilot study Roth GA, Faybik P, Hetz H, Ankersmit HJ, Hoetzenecker K, Bacher A, Thalhammer T, Krenn CG. Scand J Gastroenterol. 2009 Feb 44(6):745-51 2009 http://www.ncbi.nlm.nih.gov/pubmed/19247846?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Plasma exchange in combination with online-hemodiafiltration as a promising method for purifying the blood of fulminant hepatitis patients. Inoue K, Kourin A, Watanabe T, Yamada M, Yasuda H, Yoshiba M. Hepatol Res. 2008, 38(Suppl. 1): S46-S51 2008 http://www.ncbi.nlm.nih.gov/pubmed/19125952?ordinalpos=2&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure Hessel FP, Bramlage P, Wasem J, Mitzner SR. Eur J Gastroenterol Hepatol. 2010, 22:213-220 2010 http://www.ncbi.nlm.nih.gov/pubmed/19773666?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Artificial liver support system using large buffer volumes removes significant glutamine and is an ideal bridge to liver transplantation Inoue K, Kourin A, Watanabe T, Yamada M, Yoshiba M. Transplant Proc. 2009 Jan-Feb;41(1):259-61 2009 http://www.ncbi.nlm.nih.gov/pubmed/19249529?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Multiple organ failure caused by non-exertional heat stroke after bathing in a hot spring Lee CW, Perng CL, Huang YS, Luo JC, Hung CL, Lin HC. J Chin Med Assoc. 2010 Apr;73(4):212-5 2010 http://www.ncbi.nlm.nih.gov/pubmed/20457444
Efficacy of fractionated plasma separation and adsorption system (Prometheus) for treatment of liver failure due to mushroom poisoning. Vardar R, Gunsar F, Ersoz G, Akarca US, Karasu Z Hepatogastroenterology 2010;57(99-100):573-7 2010 http://www.ncbi.nlm.nih.gov/pubmed/20698230
Major coagulation disturbances during fractionated plasma separation and adsorption Meijers BK, Verhamme P, Nevens F, Hoylaerts MF, Bammens B, Wilmer A, Arnout J, Vanrenterghem Y, Evenepoel P. Am J Transplant. 2007 Sep;7(9):2195-9 2007 http://www.ncbi.nlm.nih.gov/pubmed/17640311
Coupled plasma filtration adsorption reduces serum bilirubine in a case of acute hypoxic hepatitis secondary to cardiogenic shock. Caroleo S, Rubino AS, Tropea F, Bruno O, Vuoto D, Amantea B, Renzulli A Int J Artif Organs. 2010 33(10):749-52 2010 http://www.ncbi.nlm.nih.gov/pubmed/21058270
Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system Faybik P, Hetz H, Mitterer G, Krenn CG, Schiefer J, Funk GC, Bacher A. Crit Care Med. 2010 Oct 21. [Epub ahead of print] 2010 http://www.ncbi.nlm.nih.gov/pubmed/20975551
The treatment of acute liver failure with fractionated plasma separation and adsorption system: Experience in 85 applications SentŸrk E, Esen F, Ozcan PE, Rifai K, Pinarbaşi B, Cakar N, Telci L. J Clin Apher. 2010 00;25(4):195-201 2010 http://www.ncbi.nlm.nih.gov/pubmed/20818714
Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients Oberkofler CE/Duttkowski P/Stocker R/Schuepbach R/Clavien PA/Bechir M Crit Care 2010;14(3):R117
2010 http://www.ncbi.nlm.nih.gov/pubmed/20550662
Mixed anticoagulation with low dose heparin and epoprostenol as preferred method for MARS circuits Seller-Perez G, Herrera-Gutierrez ME, Olalla-Sanchez R, Cabrera-Calandria A, Olea-Jimenez V, Narvaez de Linares A, Quesada-Garcia G Intensive Care Med 2009;35(suppl.1):S28 2009  
Effect of charcoal hemoperfusion for removal of plasma methotrexate in a patient with acute renal failure Nemoto T, Imai C, Kaneko U, Takachi T, Iwabuchi H, Tanaka A, Nakamura G, Ogose A, Uchiyama M Pediatr Hematol Oncol 2009;26(7):520-5
2009 http://www.ncbi.nlm.nih.gov/pubmed/19863208
Cell death in acute hepatic failure and MARS treatment Lubsczyk BA, Roth G, Pilz J, Faybik P, Hetz H, Bacher A, Krenn C Intensive Care Med 2009;35(suppl.1):S217 2009  
Molecular adsorbent recirculating system in patients with acute liver failure: prospective follow-up Tran-Zweifel D, Goubaux B, Bornard L, Dellamonica J, Carles M, Perus O, Raucoules M Crit Care Med 2010;14(suppl.1):S180 2010  
Molecular adsorbent recirulating system in hepatic failure patients with a ventricular assist device Cristinar M, Thiranos J, Kremer H, Chalumeau C, Mazzucotelli J
Crit Care Med 2010;14(suppl.1):S180/30th Int. Symposium on Intensive Care and Emergence Medicine, Brussels, Belgium, March 9-12, 2010
2010  
         
And the winner is: regional citrate anticoagulation Bouman CS. Crit Care Med. 2009 Feb;37(2):545-52. 2009 http://www.ncbi.nlm.nih.gov/pubmed/19325378
RIFLE criteria and hepatic function in the assessment of acute renal failure in liver transplantation. Tinti F, Umbro I, Mecule A, Rossi M, Merli M, Nofroni I, Ginanni Corradini S, Poli L, Pugliese F, Ruberto F, Berloco PB, Mitterhofer AP Transplant Proc 2010;42(4):1233-6 2010 http://www.ncbi.nlm.nih.gov/pubmed/20534269
Predictive parameters after molecular absorbent recirculating system treatment integrated with model for end stage liver disease model in patients with acute-on-chronic liver failure. Novelli G, Rossi M, Ferretti G, Pugliese F, Travaglia D, Guidi S, Novelli S, Lai Q, Morabito V, Berloco PB Transplant Proc 2010;42(4):1182-7 2010 http://www.ncbi.nlm.nih.gov/pubmed/20534256
Evaluation of extracorporeal liver support systems in the treatment of liver failure. A systematic review Atienza Merino G. Gastroenterol Hepatol. 2010 Apr 2, 33(5):352-62 2010 http://www.ncbi.nlm.nih.gov/pubmed/20363534
Comparison of the molecular adsorbent recirculating system and plasmapheresis for patients with graft dysfunction after liver transplantation Lee JY, Kim SB, Chang JW, Park SK, Kwon SW, Song KW, Hwang S, Lee SG. Transplant Proc. 2010 Sep;42(7):2625-30. 2010 http://www.ncbi.nlm.nih.gov/pubmed/20832557
Practical management of acute liver failure in the intensive care unit Trotter, JF Current Opinion in Critical Care 2009, 15:163-167 2009 http://www.ncbi.nlm.nih.gov/pubmed/19578326
Adverse events in therapeutic apheresis: a single center survey of various therapies Ishihara T, Inoue S, Takagi Y, Shimomura T, Sagami Y, Katayama S, Eguchi Y, Watase K, Miyamoto M, Minakata T Ther Apher Dial 2010, 14(6):589-95
2010 http://www.ncbi.nlm.nih.gov/pubmed/21118368
Management of Poisonings: Core Curriculum 2010 Winchester JF, Harbord NB, Rosen H. Am J Kidney Dis. 2010, Oct;56(4):788-800 2010 http://www.ncbi.nlm.nih.gov/pubmed/20692080
Clinical outcome of hemoperfusion in poisoned patients Gil HW, Kim SJ, Yang JO, Lee EY, Hong SY
Blood Purif 2010;30(2):84-88
2010 http://www.ncbi.nlm.nih.gov/pubmed/20628243
Enhanced Paracetamol Clearance with Molecular Adsorbents Recirculating System (MARS(R)) in Severe Autointoxication de Geus H, Math™t R, van der Hoven B, Tjoa M, Bakker J. Blood Purif. 2010 Aug 12;30(2):118-119 2010 http://www.ncbi.nlm.nih.gov/pubmed/20714142
Thyroid hormones in molecular adsorbent recirculating system-treated patients with Child C cirrhosis: a case series. Bodlaj G, Hubmann R, Pichler R, Saleh K, Stojakovic T, Biesenbach G, Berg J Liver Int. 2010, 30(6):927-8 2010 http://www.ncbi.nlm.nih.gov/pubmed/20345698
Treatment of resistant pruritus from cholestasis with albumin dialysis: Combined analysis of patients from three centers ParŽs A, Herrera M, AvilŽs J, Sanz M, Mas A. J Hepatol. 2010, 53(2):307-12 2010 http://www.ncbi.nlm.nih.gov/pubmed/20580987
Value of albumin dialysis therapy in severe liver insufficiency LahdenperŠ A, Koivusalo AM, Vakkuri A, Hšckerstedt K, Isoniemi H. Transpl Int, 2005, 17(11): 717-723 2005 http://www.ncbi.nlm.nih.gov/pubmed/15580335
Treatment with bioartificial liver improves lung injury in a swine model of partial hepatectomy and ischemia/reperfusion Arkadopoulos N, Kalimeris K, Papalois A, Nastos C, Papoutsidakis N, Defterevos G, Zarkadis IK, Mikrou A, Pafiti A, Andreadou I, Kostopanagiotou G, Smyrniotis V. Int J Artif Organs. 2010 Feb;33(2):105-13 2010 http://www.ncbi.nlm.nih.gov/pubmed/20306437985
Citrate anticoagulation for continuous venovenous hemofiltration Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF. Crit Care Med. 2009 Feb;37(2):545-52 2009 http://www.ncbi.nlm.nih.gov/pubmed/19114912
Significant decrease in dialysate albumin concentration during molecular adsorbent recirculating system (M.A.R.S.) therapy. Gong D, Ji D, Ren B, Tao J, Xu B, Ronco C, Li L. Int J Artif Organs. 2008 Apr;31(4):333-9 2008 http://www.ncbi.nlm.nih.gov/pubmed/18432590?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=27
Changes in plasma amino acids during extracorporeal liver support by fractionated plasma separation and adsorption. Rifai K, Das A, Rosenau J, Ernst T, Kretschmer U, Haller H, Fliser D, Manns MP Artif Organs. 2010 Feb;34(2):166-70. 2010 http://www.ncbi.nlm.nih.gov/pubmed/19817727
Levomethadone is poorly removed by the molecular adsorbents recirculating system Czock D, Keller F, Hameister J, Tiefenbach B, Mitzner S  J Clin Psychopharmacol 2009;29(6):622-4 2009 http://www.ncbi.nlm.nih.gov/pubmed/19910741
Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different? Agarwal B, Shaw S, Hari MS, Burroughs AK, Davenport A. J Hepatol. 2009 Sep;51(3):504-9. Epub 2009 Jun 24. 2009 http://www.ncbi.nlm.nih.gov/pubmed/19615775?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=10
Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase Vilay AM, Mueller BA, Haines H, Alten JA, Askenazi DJ. Pharmacotherapy. 2010 Jan;30(1):111. 2010 http://www.ncbi.nlm.nih.gov/pubmed/20030480?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1
Liver transplantation for acute liver failure: a Spanish perspective Mas A, Escorsell A, Fern‡ndez J. Transplant Proc. 2010 Mar;42(2):619-21. 2010 http://www.ncbi.nlm.nih.gov/pubmed/20304207
Rescue of a marginal liver graft by sequential treatment with molecular adsorbent recirculating system and transjugular intrahepatic portosystemic shunt: a case report. Darius T, Monbaliu D, Aerts R, Laleman W, Roskams T, Van Steenbergen W, Cassiman D, Verslype C, Maleux G, Nevens F, Pirenne J. Transplant Proc. 2009 Oct;41(8):3427-9 2009 http://www.ncbi.nlm.nih.gov/pubmed/19857762?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=6
Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies. Meltzer J, Brentjens TE  Curr Opin Anaesthesiol 2010;23(2):139-44 2010 http://www.ncbi.nlm.nih.gov/pubmed/20124895
Severe sepsis in cirrhosis. Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R. Hepatology. 2009 Dec;50(6):2022-33 2009 http://www.ncbi.nlm.nih.gov/pubmed/19885876?itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum&ordinalpos=1
Results of treatment of acute liver failure patients with use of the prometheus FPSA system. Grodzicki M, Kotulski M, Leonowicz D, Zieniewicz K, Krawczyk M. Transplant Proc. 2009 Oct;41(8):3079-81. 2009 http://www.ncbi.nlm.nih.gov/pubmed/19857681?itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum&ordinalpos=4
Nitric-oxide-lowering effect of terlipressin in decompensated cirrhosis: comparison to the molecular adsorbent recirculating system and correlation with clinical status Kurtovic J, Boyle M, Bihari D, Riordan SM  Eur J Gastroenterol Hepatol 2004;16(12):1335-8 2004 http://www.ncbi.nlm.nih.gov/pubmed/15618842
Hemodynamic effects of albumin dialysis in patients with liver failure: for better or for worse?
Laleman W. Ther Apher Dial. 2009 Oct;13(5):384-92 2009 http://www.ncbi.nlm.nih.gov/pubmed/19788454
Nucleosome serum levels in acute hepatic failure and MARS treatment. Roth GA, Lubsczyk BA, Pilz J, Faybik P, Hetz H, Krenn CG. Transplant Proc. 2009 Dec;41(10):4207-10. 2009 http://www.ncbi.nlm.nih.gov/pubmed/20005370?itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum&ordinalpos=1
Comparison of molecular adsorbents recirculating system (MARS) dialysis with combined plasma exchange and hemodialysis (PE/HD) in children with acute liver failure (ALF) Schaefer B, Schaefer F, Heckert KH, Schmitt CP
J Am Soc Nephrol 2009;20:465A/Renal Week 2009, San Diego, CA, USA, Oct.27 - Nov.1, 2009  2009  
Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly Alison MR, Islam S, Lim S J Pathol 2008;217(2):282-98 2008 http://www.ncbi.nlm.nih.gov/pubmed/18991329
The use of the molecular adsorbent recirculating system (MARS) albumin dialysis for the treatment of liver failure: a nursing perpective. McCready R  Dynamics 2009;20(3):18-22 2009 http://www.ncbi.nlm.nih.gov/pubmed/19953756?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1
Reduced cholestatic pruritus with molecular adsorbents recirculating system (MARS) dialysis in children with chronic liver disease Schaefer B, Schmitt CP, Engelmann G, Wittmer D, Schaefer F J Am Soc Nephrol 2009;20:906A/Renal Week 2009, San Diego, CA, USA, Oct.27 - Nov.1, 2009 2009  
A modeling study of bilirubin kinetics during Molecular Adsorbent Recirculating System sessions Magosso E, Ursino M, Col“ L, Baraldi O, Bolondi L, Stefoni S. Artif Organs. 2006 Apr;30(4):285-300. 2006 http://www.ncbi.nlm.nih.gov/pubmed/16643387?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=63
Renal dysfunction in chronic liver disease Slack A, Yeoman A, Wendon J
Crit Care 2010;14(2):214  2010 http://www.ncbi.nlm.nih.gov/pubmed/20236458
Removal of asymmetric dimethylarginine during artificial liver support using fractionated plasma separation and adsorption. Rifai K, Bode-Boeger SM, Martens-Lobenhoffer J, Ernst T, Kretschmer U, Hafer C, Fliser D, Manns MP, Kielstein JT. Scand J Gastroenterol. 2010 Sep;45(9):1110-5 2010 http://www.ncbi.nlm.nih.gov/pubmed/20441555
Treatment of thyrotoxic crisis with plasmapheresis and single pass albumin dialysis: a case report Koball S, Hickstein H, Gloger M, Hinz M, Henschel J, Stange J, Mitzner S. Artif Organs. 2010 Feb;34(2):E55-8. 2010 http://www.ncbi.nlm.nih.gov/pubmed/20420590
Contamination of commercial albumin with octanoate is a limiting factor for the efficacy of albumin dialysis in liver support Stange J, Strube S, Koball S, Klammt S, Hickstein H, Hentschel J  Blood Purif 2009;27(3):289 2009  
Characterization of peptides and proteins in commercial human serum albumin solutions. Gay M, Carrascal M, Gorga M, ParŽs A, Abian J Proteomics. 2010 Jan;10(2):172-81 2010 http://www.ncbi.nlm.nih.gov/pubmed/19882658?itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum&ordinalpos=3
Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit? Ekser B, Gridelli B, Tector AJ, Cooper DK. Transplantation. 2009 Nov 15;88(9):1041-9 2009 http://www.ncbi.nlm.nih.gov/pubmed/19898198?itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum&ordinalpos=1
Management of hepatic encephalopathy in children. Arya R, Gulati S, Deopujari S. Postgrad Med J. 2010 Jan;86(1011):34-41 2010 http://www.ncbi.nlm.nih.gov/pubmed/20065339?itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum&ordinalpos=1
Acute liver failure. Pathikonda M, Munoz SJ. Ann Hepatol. 2010 Jan-Mar;9(1):7-14 2010 http://www.ncbi.nlm.nih.gov/pubmed/20308717
Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in cirrhotic patients with ascites who have failed vasoconstrictor therapy Wong F, Raina N, Richardson R Gut. 2010; 59:381-386 2010 http://www.ncbi.nlm.nih.gov/pubmed/19710033?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure. Kantola T, MŠklin S, Koivusalo AM, RŠsŠnen P, Rissanen A, Roine R, Sintonen H, Hšckerstedt K, Isoniemi H. World J Gastroenterol. 2010 May 14;16(18):2227-34 2010 http://www.ncbi.nlm.nih.gov/pubmed/20458759
Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy Camus C, LavouŽ S, Gacouin A, Compagnon P, BoudjŽma K, Jacquelinet C, Thomas R, Le Tulzo Y. Ther Apher Dial. 2009 Dec;13(6):549-55 2009 http://www.ncbi.nlm.nih.gov/pubmed/19954480?itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum&ordinalpos=3
Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells FrŸhauf JH, Mertsching H, Giri S, FrŸhauf NR, Bader A. Liver Int. 2009 Nov;29(10):1553-61 2009 http://www.ncbi.nlm.nih.gov/pubmed/19686312?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Cytokine level modifications: molecular adsorbent recirculating system versus standard medical therapy Novelli G, Annesini MC, Morabito V, Cinti P, Pugliese F, Novelli S, Piemonte V, Turchetti L, Rossi M, Berloco PB Transplant Proc. 2009 May;41(4):1243-8 2009 http://www.ncbi.nlm.nih.gov/pubmed/19460529?ordinalpos=2&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Fractionated plasma separation and adsorption significantly decreases intracranial pressure in acute liver failure: experimental study Ryska M, Laszikova E, Pantoflicek T, Ryska O, Prazak J, Koblihova E Eur Surg Res. 2009;42(4):230-5.  2009 http://www.ncbi.nlm.nih.gov/pubmed/19279388?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Current trends in the treatment of hepatic encephalopathy Al Sibae MR, McGuire BM. Ther Clin Risk Manag. 2009 Jun;5(3):617-26. 2009 http://www.ncbi.nlm.nih.gov/pubmed/19707277?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Effective bilirubin reduction by single-pass albumin dialysis in liver failure Boonsrirat U, Tiranathanagul K, Srisawat N, Susantitaphong P, Komolmit P, Praditpornsilpa K, Tungsanga K, Eiam-Ong S. Artif Organs. 2009, 33(8):648-53. 2009 http://www.ncbi.nlm.nih.gov/pubmed/19624591?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Albumin dialysis MARS: knowledge from 10 years of clinical investigation Mitzner SR, Stange J, Klammt S, Koball S, Hickstein H, Reisinger EC ASAIO J. 2009 Sep-Oct;55(5):498-502 2009 http://www.ncbi.nlm.nih.gov/pubmed/19730006?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Efficacy and Safety of Anticoagulation With Heparin Versus Heparin Plus Epoprostenol in Patients Undergoing Extracorporeal Liver Support With Prometheus. Krisper P, Tiran B, Fliser D, Haditsch B, Stadlbauer V, Otto R, Ernst T, Kretschmer U, Stauber RE, Haller H, Holzer H, Manns MP, Rifai K. Artif Organs. 2009; 34(1):84-8 2009 http://www.ncbi.nlm.nih.gov/pubmed/19663866?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Proteomic Analysis of Proteins Bound to Adsorption Units of Extracorporeal Liver Support System under Clinical Conditions. Mares J, Thongboonkerd V, Tuma Z, Moravec J, Karvunidis T, Matejovic M. J Proteome Res. 2009 Apr;8(4):1756-64 2009 http://www.ncbi.nlm.nih.gov/pubmed/19265403?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
A Case-Control Study of Single-Pass Albumin Dialysis for Acetaminophen-Induced Acute Liver Failure. Karvellas CJ, Bagshaw SM, McDermid RC, Stollery DE, Bain VG, Gibney RT Blood Purif. 2009 Jul 4;28(3):151-158 2009 http://www.ncbi.nlm.nih.gov/pubmed/19590182?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Extracorporeal albumin dialysis Rifai K. Hepatol Res. 2008 Nov;38(s1The 6 Japan Society of Hepatology Single Topic Conference: Liver Failure: Recent Progress and Pathogenesis to Management. 28-29 September 2007, Iwate, Japan):S41-S45 2008 http://www.ncbi.nlm.nih.gov/pubmed/19125951?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Acute liver failure related to hepatitis B virus. Lee HC Hepatol Res. 2008 Nov;38(s1The 6 Japan Society of Hepatology Single Topic Conference: Liver Failure: Recent Progress and Pathogenesis to Management. 28-29 September 2007, Iwate, Japan):S9-S13 2008 http://www.ncbi.nlm.nih.gov/pubmed/19125959?ordinalpos=2&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Incidence and prognosis of early hepatic dysfunction in critically ill patients--a prospective multicenter study. Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG; Austrian Epidemiologic Study on Intensive Care, ASDI Study Group. Crit Care Med. 2007 Apr;35(4):1099-104 2007 http://www.ncbi.nlm.nih.gov/pubmed/17334250?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2
Increase of octanoate concentrations during extracorporeal albumin dialysis treatments Klammt S, Koball S, Hickstein H, Gloger M, Henschel J, Mitzner S, Stange J, Reisinger EC. Ther Apher Dial. 2009 Oct;13(5):437-43 2009 http://www.ncbi.nlm.nih.gov/pubmed/19788462?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Effect of extracorporeal liver support by molecular adsorbents recirculating system and prometheus on redox state of albumin in acute-on-chronic liver failure Oettl K, Stadlbauer V, Krisper P, Stauber RE Ther Apher Dial. 2009 Oct;13(5):431-6 2009 http://www.ncbi.nlm.nih.gov/pubmed/19788461?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Extracorporeal liver support therapy with prometheus in patients with liver failure in the intensive care unit Oppert M, Rademacher S, Petrasch K, Jšrres A. Ther Apher Dial. 2009 Oct;13(5):426-30 2009 http://www.ncbi.nlm.nih.gov/pubmed/19788460?ordinalpos=2&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis--a retrospective analysis Kortgen A, Rauchfuss F, Gštz M, Settmacher U, Bauer M, Sponholz C. Ther Apher Dial. 2009 Oct;13(5):419-25 2009 http://www.ncbi.nlm.nih.gov/pubmed/19788459?ordinalpos=2&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Is it possible to gain extra waiting time to liver transplantation in acute liver failure patients using albumin dialysis? Koivusalo AM, Kantola T, Arola J, Hšckerstedt K, Kairaluoma P, Isoniemi H Ther Apher Dial. 2009 Oct;13(5):413-8 2009 http://www.ncbi.nlm.nih.gov/pubmed/19788458?ordinalpos=3&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system Novelli G, Rossi M, Ferretti G, Pugliese F, Ruberto F, Lai Q, Novelli S, Piemonte V, Turchetti L, Morabito V, Annesini MC, Berloco PB. Ther Apher Dial. 2009 Oct;13(5):404-12 2009 http://www.ncbi.nlm.nih.gov/pubmed/19788457?ordinalpos=4&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Early molecular adsorbents recirculating system treatment of Amanita mushroom poisoning. Kantola T, Koivusalo AM, Hšckerstedt K, Isoniemi H. Ther Apher Dial. 2009 Oct;13(5):399-403. 2009 http://www.ncbi.nlm.nih.gov/pubmed/19788456?ordinalpos=5&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Albumin dialysis molecular adsorbents recirculating system: impact of dialysate albumin concentration on detoxification efficacy Drexler K, Baustian C, Richter G, Ludwig J, Ramlow W, Mitzner S Ther Apher Dial. 2009 Oct;13(5):393-8 2009 http://www.ncbi.nlm.nih.gov/pubmed/19788455?ordinalpos=6&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Liver support 2009: time for another revolution? Mitzner SR, Kaplan AA Ther Apher Dial. 2009 Oct;13(5):381-3 2009 http://www.ncbi.nlm.nih.gov/pubmed/19788453?ordinalpos=3&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Artificial liver support system in acute liver failure patients waiting liver transplantation. Montejo Gonz‡lez JC, Catal‡n Gonz‡lez M, Meneu D’az JC, Moreno Elola-Olaso A, De la Cruz J, Moreno Gonz‡lez E Hepatogastroenterology. 2009 Mar-Apr;56(90):456-61 2009 http://www.ncbi.nlm.nih.gov/pubmed/19579620?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Extracorporeal treatment of acute liver failure Brophy CM, Nyberg SL. Hepatol Res. 2008 Nov;38:S34-S40 2008 http://www.ncbi.nlm.nih.gov/pubmed/19125950?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials Mookerjee RP, Jalan R. Crit Care. 2008;12(2):119. Epub 2008 Mar 19. 2008 http://www.ncbi.nlm.nih.gov/pubmed/18394181?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Liver support therapy with molecular adsorbents recirculating system in liver failure: a summary of 252 cases from 14 centers in China Wang MM, Chen SJ, Ye QF, Yang YJ, Chen SB, Zhou XM, Guo LM, Zhang YX, Ding XQ, Hu XB, Luo HT, Liu YH, Wang WY. Chin Med J (Engl). 2008 Nov 5;121(21):2197-201. 2008 http://www.ncbi.nlm.nih.gov/pubmed/19080184?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation Annicchiarico BE, Avolio AW, Siciliano M, Passalacqua S, Caracciolo G, Gasbarrini A, Agnes S, Castagneto M. Transplant Proc. 2008 Jul-Aug;40(6):1929-31 2008 http://www.ncbi.nlm.nih.gov/pubmed/18675092?ordinalpos=8&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Prometheus: from legend to the real liver support therapy Rifai K, Tetta C, Ronco C Int J Artif Organs. 2007 30(10):858-63 2007 http://www.ncbi.nlm.nih.gov/pubmed/17992646?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation Sgroi A, Serre-Beinier V, Morel P, BŸhler L. Transplantation. 2009 Feb 27;87(4):457-66 2009 http://www.ncbi.nlm.nih.gov/pubmed/19307780?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Transplantation of Monocyte-Derived Hepatocyte-Like Cells (NeoHeps) Improves Survival in a Model of Acute Liver Failure. Glanemann M, Gaebelein G, Nussler N, Hao L, Kronbach Z, Shi B, Neuhaus P, Nussler AK. Ann Surg. 2009 Jan;249(1):149-154. 2009 http://www.ncbi.nlm.nih.gov/pubmed/19106691?dopt=AbstractPlus
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs Gaspari R, Cavaliere F, Sollazzi L, Perilli V, Melchionda I, Agnes S, Gasbarrini A, Avolio AW. Transplant Proc. 2009 Jan-Feb;41(1):253-8 2009 http://www.ncbi.nlm.nih.gov/pubmed/19249528?ordinalpos=2&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: A pilot study Roth GA, Faybik P, Hetz H, Ankersmit HJ, Hoetzenecker K, Bacher A, Thalhammer T, Krenn CG. Scand J Gastroenterol. 2009, 44(6):745-51 2009 http://www.ncbi.nlm.nih.gov/pubmed/19247846?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure Yokoi T, Oda S, Shiga H, Matsuda KI, Sadahiro T, Nakamura M, Hirasawa H. Transfus Apher Sci. 2008, 40(1):61-70 2008 http://www.ncbi.nlm.nih.gov/pubmed/19117803?dopt=AbstractPlus
Vasopressin insufficiency and intradialytic hypotension Perazella MA, Rho M, Brewster UC. Am J Kidney Dis. 2008 Aug;52(2):294-304.  2008 http://www.ncbi.nlm.nih.gov/pubmed/19026359?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Clinical epidemiology of fulminant hepatitis in Japan Takikawa Y, Suzuki K. Hepatol Res. 2008 Nov; 38, S14-S18 2008 http://www.ncbi.nlm.nih.gov/pubmed/19125945?ordinalpos=5&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
A 15-Year-Old Girl with Severe Hemolytic Wilson's Crisis Recovered without Transplantation after Extracorporeal Circulation with the Prometheus(R) System Aagaard NK, Thomsen KL, Holland-Fischer P, J¿rgensen SP, Ott P Blood Purif. 2009 May 11;28(2):102-107 2009 http://www.ncbi.nlm.nih.gov/pubmed/19439930?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Hepatic assist devices: will they ever be successful? Sussman NL, McGuire BM, Kelly JH. Curr Gastroenterol Rep. 2009 Feb;11(1):64-8. 2009 http://www.ncbi.nlm.nih.gov/pubmed/19166661?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
The management of hepatorenal syndrome. Carl DE, Sanyal A. Minerva Gastroenterol Dietol. 2009 Jun;55(2):207-26 2009 http://www.ncbi.nlm.nih.gov/pubmed/19305378?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure. Pares A, Deulofeu R, Cisneros L, Escorsell A, Salmeron JM, Caballeria J, Mas A. Crit Care. 2009 Jan 28;13(1):R8. 2009 http://www.ncbi.nlm.nih.gov/pubmed/19175915?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum
Albumin liver dialysis as pregnancy-saving procedure in cholestatic liver disease and intractable pruritus Lemoine M, Revaux A, Francoz C, Ducarme G, Brechignac S, Jacquemin E, Uzan M, Ganne-Carrie N. World J Gastroenterol. 2008 Nov 14;14(42):6572-4 2008 http://www.ncbi.nlm.nih.gov/pubmed/19030215?dopt=AbstractPlus
Emerging Therapies for Extracorporeal Support. Bouchard J, Khosla N, Mehta RL Nephron Physiol. 2008;109(4): 85-91. 2008 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=18802380&itool=pubmed_DocSum
A bioartificial liver that combines plasma dialysis and whole liver perfusion. Umehara M, Totsuka E, Ishizawa Y, Nara M, Hakamada K, Umehara Y, Sasaki M Hepatogastroenterology. 2008; 55(85):1216-21. 2008 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=18795660&itool=pubmed_DocSum
Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease Stewart CA, Malinchoc M, Kim WR, Kamath PS Liver Transpl. 2007; 13(10): 1364-5 2007 http://www.ncbi.nlm.nih.gov/pubmed/17520742?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Thermodynamic considerations in solid adsorption of bound solutes for patient support in liver failure Patzer JF 2nd Artif Organs. 2008; 32(7): 499-508 2008 http://www.ncbi.nlm.nih.gov/pubmed/18638303?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Hepatic encephalopathy C—rdoba J, M’nguez B. Semin Liver Dis. 2008; 28(1): 70-80 2008 http://www.ncbi.nlm.nih.gov/pubmed/18293278?ordinalpos=10&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Mars and prometheus: our clinical experience in acute chronic liver failure Faenza S, Baraldi O, Bernardi M, Bolondi L, Coli L, Cucchetti A, Donati G, Gozzetti F, Lauro A et al. Transplant Proc. 2008; 40(4): 1169-71 2008 http://www.ncbi.nlm.nih.gov/pubmed/18555140?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Bioartificial liver systems: why, what, whither? Gerlach JC, Zeilinger K, Patzer Ii JF Regen Med. 2008; 3(4): 575-95 2008 http://www.ncbi.nlm.nih.gov/pubmed/18588477?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Hepatology: a Personal Story. Williams R. Clin Med. 2008; 8(1): 25-8 2008 http://www.ncbi.nlm.nih.gov/pubmed/18335663?ordinalpos=13&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients Kantola T, Koivusalo AM, Hšckerstedt K, Isoniemi H Transpl Int. 2008; 21(9):857-66. 2008 http://www.ncbi.nlm.nih.gov/pubmed/18510596?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Fulminant hepatitis requiring MARS and liver transplantation in a patient with Still's disease. Taccone FS, Lucidi V, Donckier V, Bourgeois N, Decaux G, Vandergheynst F. Eur J Intern Med. 2008 Oct;19(6):e26-8. 2008 http://www.ncbi.nlm.nih.gov/pubmed/18848162?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Successful Treatment of Fosinopril-Induced Severe Cholestatic Jaundice with Plasma Exchange (December). Chou JW, Yu CJ, Chuang PH, Lai HC, Hsu CH, Cheng KS, Peng CY, Chiang IP. Ann Pharmacother. 2008 Dec;42(12):1887-92 2008 http://www.ncbi.nlm.nih.gov/pubmed/19017832?dopt=AbstractPlus
Liver transplantation for fulminant Wilson's disease in children Markiewicz-Kijewska M, Szymczak M, Ismail H, Prokurat S, Teisseyre J, Socha P, Jankowska I, Chyżyńska A, Kaliciński P, Migdał M Ann Transplant.2008; 13(2): 28-31 2008 http://www.ncbi.nlm.nih.gov/pubmed/18566556?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Acetaminophen-induced acute liver failure treated with single-pass albumin dialysis: report of a case. Karvellas CJ, Bagshaw SM, McDermid RC, Stollery DE, Gibney RT. Int J Artif Organs.2008; 31(5): 450-5 2008 http://www.ncbi.nlm.nih.gov/pubmed/18609519?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Acute renal and hepatic failure associated with allopurinol treatment Fagugli RM, Gentile G, Ferrara G, Brugnano R. Clin Nephrol. 2008 Dec;70(6):523-6 2008 http://www.ncbi.nlm.nih.gov/pubmed/19049711?dopt=AbstractPlus
Liver Support Systems Phua J, Lee KH. Curr Opin Crit Care.2008; 14(2): 208-15 2008 http://www.ncbi.nlm.nih.gov/pubmed/18388685?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Albumin dialysis in critically ill patients: use versus omission of intradialytic heparin. Yang WS, Tan HK, Lui HF, Chow PK, Choong HL, Wong KS. Artif Organs.2008; 32(5): 411-6 2008 http://www.ncbi.nlm.nih.gov/pubmed/18471171?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Pathogenesis and treatment of hepatorenal syndrome Arroyo V, Fernandez J, Gins P. Semin Liver Dis.2008; 28(1): 81-95 2008 http://www.ncbi.nlm.nih.gov/pubmed/18293279?ordinalpos=18&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Use of the molecular adsorbents recirculating system as a treatment for acute decompensated wilson disease. Chiu A, Tsoi NS, Fan ST. Liver Transpl. 2008, 14(10):1512-6 2008 http://www.ncbi.nlm.nih.gov/pubmed/18825711?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Which is the best way to analyze the efficacy of albumin dialysis in hepatic encephalopathy? Ba–ares R, Albillos A, Catalina MV. Hepatology.2008; 48(2): 686-7 2008 http://www.ncbi.nlm.nih.gov/pubmed/18666248?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients. Pugliese F, Novelli G, Poli L, Levi Sandri GB, Di Folco G, Ferretti S, Morabito V, Ruberto F, Berloco PB. Transplant Proc.2008; 40(6): 1925-8 2008 http://www.ncbi.nlm.nih.gov/pubmed/18675091?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Pediatric acute liver failure with molecular adsorbent recirculating system treatment. Novelli G, Rossi M, Morabito V, Pugliese F, Ruberto F, Perrella SM, Novelli S, Spoletini G, Ferretti G, Mennini G, Berloco PB. Transplant Proc.2008; 40(6): 1921-4 2008 http://www.ncbi.nlm.nih.gov/pubmed/18675090?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Primary nonfunction: timing retransplantation versus hemodynamic parameters and kidney function. Novelli G, Rossi M, Poli L, Morabito V, Bussotti A, Pugliese F, Ruberto F, Novelli S, Mennini G, Berloco PB. Transplant Proc.2008; 40(6): 1854-7 2008 http://www.ncbi.nlm.nih.gov/pubmed/18675069?ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Management of hepatorenal syndrome. McCormick PA, Donnelly C. Pharmacol Ther.2008; 119(1): 1-6 2008 http://www.ncbi.nlm.nih.gov/pubmed/18539334?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Artificial and Bioartificial Liver Support McKenzie TJ, Lillegard JB, Nyberg SL. Semin Liver Dis.2008; 28(2): 210-7 2008 http://www.ncbi.nlm.nih.gov/pubmed/18452120?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy Koivusalo AM, Teikari T, Hšckerstedt K, Isoniemi H. Metab Brain Dis. 2008 Dec;23(4):387-98 2008 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=18773287&itool=pubmed_DocSum
Acute liver failure due to a treatment by nimesulide: Another case and review Page M, Christin F, Hayi-Slayman D, Baillon JJ, Ber CE, Delafosse B, Dumortier J, RimmelŽ T. Ann Fr Anesth Reanim. 2008 Sep;27(9):742-6 2008 http://www.ncbi.nlm.nih.gov/pubmed/18760563?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Plasma Exchange-based Plasma Recycling Dialysis System as an Artificial Liver Support. Takahashi K, Umehara Y, Umehara M, Nishimura A, Narumi S, Toyoki Y, Hakamada K, Yoshihara S, Sasaki M. Ther Apher Dial. 2008 Aug;12(4):264-70 2008 http://www.ncbi.nlm.nih.gov/pubmed/18789112?dopt=AbstractPlus
A bioartificial liver that combines plasma dialysis and whole liver perfusion. Umehara M, Totsuka E, Ishizawa Y, Nara M, Hakamada K, Umehara Y, Sasaki M Hepatogastroenterology. 2008; 55(85):1216-21. 2008 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=18795660&itool=pubmed_DocSum
Emerging Therapies for Extracorporeal Support. Bouchard J, Khosla N, Mehta RL Nephron Physiol. 2008;109(4):p85-p91. 2008 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=18802380&itool=pubmed_DocSum
Whither prometheus' liver? Greek myth and the science of regeneration. Power C, Rasko JE. Ann Intern Med. 2008 Sep 16;149(6):421-6 2008 http://www.ncbi.nlm.nih.gov/pubmed/18794562?dopt=AbstractPlus
Long-lasting extracorporeal albumin dialysis in a child with end-stage renal disease and severe cholestasis Javouhey E, Ranchin B, Lachaux A, Boillot O, Martin X, Floret D, Cochat P. Pediatr Transplant. 2008 13(2):235-9. 2008 http://www.ncbi.nlm.nih.gov/pubmed/18433409?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Acute liver failure: Summary of a workshop Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Hepatology. 2008 Apr;47(4):1401-15 2008 http://www.ncbi.nlm.nih.gov/pubmed/18318440?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Combined extended haemodialysis with single-pass albumin dialysis (SPAED) Rosa Diez G, Greloni G, Gadano A, Giannasi S, Crucelegui M, Trillini M, Algranati S. Nephrol Dial Transplant. 2007 Sep;22(9):2731-2 2007 http://www.ncbi.nlm.nih.gov/pubmed/17578860?ordinalpos=9&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis Pusl T, Denk GU, Parhofer KG, Beuers U. J Hepatol. 2006 Dec;45(6):887-91 2006 http://www.ncbi.nlm.nih.gov/pubmed/17046095?ordinalpos=25&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Role of plasmapheresis in the management of acute hepatic failure in children Singer AL, Olthoff KM, Kim H, Rand E, Zamir G, Shaked A. Ann Surg. 2001 Sep;234(3):418-24 2001 http://www.ncbi.nlm.nih.gov/pubmed/11524594?ordinalpos=7&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
A prognostic model for patients with end-stage liver disease. Cooper GS, Bellamy P, Dawson NV, Desbiens N, Fulkerson WJ Jr, Goldman L, Quinn LM, Speroff T, Landefeld CS. Gastroenterology. 1997 Oct;113(4):1278-88 1997 http://www.ncbi.nlm.nih.gov/pubmed/9322523?ordinalpos=11&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL. Gastroenterology.1977; 72(4 Pt 1): 573-83 1977 http://www.ncbi.nlm.nih.gov/pubmed/14049?ordinalpos=25&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Successful clinical application of the molecular adsorbent recirculating system in a patient with acute fatty liver of pregnancy Won TJ, Lin YH, Huang LW. Taiwan J Obstet Gynecol.; 2008; 47(1):113-5 2008 http://www.ncbi.nlm.nih.gov/pubmed/18400598?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
MARS dialysis in decompensated alcoholic liver disease: A single-center experience Wolff B, Machill K, Schumacher D, Schulzki I. Liver Transpl.; 2007; 13(8):1189-92 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17663393&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study Dethloff T, Tofteng F, Frederiksen HJ, Hojskov M, Hansen BA, Larsen FS. World J Gastroenterol.; 2008; 14(13):2065-71 2008 http://www.ncbi.nlm.nih.gov/pubmed/18395908?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Acute liver failure--practical management Williams R Acta Gastroenterol Belg.; 2007; 70(2):210-3 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17715636&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Pretransplant albumin dialysis in erythropoietic protoporphyria: A costly detour Wahlin S, Harper P. Liver Transpl.; 2007; 13(11):1614-5 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17969208&ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Pre-transplant optimization by Molecular Adsorbent Recirculating System in patients with severely decompensated chronic liver disease Wagholikar GD, Lee KH, Pandey D, Leong SO, Singh R, Tan KC. Indian J Gastroenterol.; 2007; 26(3):110-2 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17704575&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation Udayakumar N, Subramaniam K, Umashankar L, Verghese J, Jayanthi V. J Clin Gastroenterol.; 2007; 41(10):922-6 2007 http://www.ncbi.nlm.nih.gov/pubmed/18090162?ordinalpos=9&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL, Blei AT, Fontana RJ, McGuire BM, Rossaro L, Smith AD, Lee WM; Acute Liver Failure Study Group. Crit Care Med.; 2007; 35(11):2498-508 2007 http://www.ncbi.nlm.nih.gov/pubmed/17901832?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Acute liver failure: liver support therapies Stadlbauer V, Jalan R. Curr Opin Crit Care; 2007; 13(2):215-21 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17327745&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
A case of intractable pruritus in Turner's syndrome successfully treated with molecular adsorbent recirculating system. Silvagni E, Col“ L, Stagni B, Stefoni S, Bolondi L. Intern Emerg Med.; 2008; 3(1):65-7 2008 http://www.ncbi.nlm.nih.gov/pubmed/18273566?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Heat stroke complicated by liver failure and hyperbilirubinaemia--a case report Sein Anand J, Chodorowski Z, Korolkiewicz RP. Przegl Lek.; 2007; 64(4):344-5 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17724908&ordinalpos=13&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Indocyanine green elimination but not bilirubin indicates improvement of graft function during MARS therapy Scheingraber S, Richter S, Igna D, Girndt M, Flesch S, Kleinschmidt S, Schilling MK. Clin Transplant.; 2007; 21(6):689-95 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17988260&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Liver Support Systems Santoro A, Mancini E, Ferramosca E, Faenza S. Contrib Nephrol.; 2007; 156(0):396-404 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17464150&query_hl=14&itool=pubmed_docsum
Characterization of Pro-apoptotic Effect of Liver Failure Plasma on Primary Human Hepatocytes and Its Modulation by Molecular Adsorbent Recirculation System Therapy Saich R, Selden C, Rees M, Hodgson H. Artif Organs; 2007; 31(9):732-42 2007 http://www.ncbi.nlm.nih.gov/pubmed/17725701?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure Rose C, Ytreb¿ LM, Davies NA, Sen S, Nedredal GI, Belanger M, Revhaug A, Jalan R. Hepatology; 2007; 46(6):1883-92 2007 http://www.ncbi.nlm.nih.gov/pubmed/17705298?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Review article: clinical experience with prometheus Rifai K Ther Apher Dial.; 2006; 10(2):132-7 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16684214&query_hl=3&itool=pubmed_docsum
Single pass albumin dialysis in hepatorenal syndrome Rahman E, Al Suwaida AK, Askar A. Saudi J Kidney Dis Transpl.; 2008; 19(3):479-84 2008 http://www.ncbi.nlm.nih.gov/pubmed/18445918?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports. Pugliese F, Ruberto F, Perrella SM, Cappannoli A, Bruno K, Martelli S, Celli P, Summonti D, D'Alio A, Tosi A, Novelli G, Morabito V, Poli L, Rossi M, Berloco PB, Pietropaoli P. Transplant Proc.; 2007; 36(6):2042-4 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17692688&ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Molecular Adsorbents Recirculating System Treatment in Acute-on-Chronic Hepatitis Patients on the Transplant Waiting List Improves Model for End-Stage Liver Disease Scores. Novelli G, Rossi M, Pugliese F, Poli I, Ruberto E, Martelli S, Nudo F, Morabito V, Mennini G, Berloco PB. Transplant Proc.; 2007; 36(6):1864-67 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17692635&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Albumin dialysis and plasma filtration adsorption dialysis system. Nalesso F, Brendolan A, Crepaldi C, Cruz D, de Cal M, Bellomo R, Ronco C. Contrib Nephrol.; 2007; 156(0):411-8 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17464152&query_hl=11&itool=pubmed_docsum
Albumin dialysis: an update Mitzner SR Curr Opin Nephrol Hypertens.; 2007; 16(6):589-95 2007 http://www.ncbi.nlm.nih.gov/pubmed/18089976?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Use of extracorporeal albumin dialysis for erythropoietic protoporphyria McGuire BM, Bloomer JR. Liver Transpl.; 2007; 13(5):639-40 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17457857&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Integrating palliative care for liver transplant candidates: \"too well for transplant, too sick for life\". Larson AM JAMA; 2006; 295(18):2168-76 2006 http://www.ncbi.nlm.nih.gov/pubmed/16684988?ordinalpos=15&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Bench-to-bedside review: Current evidence for extracorporeal albumin dialysis systems in liver failure Karvellas CJ, Gibney N, Kutsogiannis D, Wendon J, Bain VG. Crit Care; 2007; 11(3):215-22 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17567927&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
MARS in acute-on-chronic liver failure Karvellas C, Wendon J. Indian J Gastroenterol.; 2007; 26(3):109 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17704574&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Cytokine profiles in acute liver failure treated with albumin dialysis Ilonen I, Koivusalo AM, Repo H, Hšckerstedt K, Isoniemi H. Artif Organs; 2008; 32(1):52-60 2008 http://www.ncbi.nlm.nih.gov/pubmed/18181803?ordinalpos=10&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT Hepatology; 2007; 46(6):1853-62 2007 http://www.ncbi.nlm.nih.gov/pubmed/17975845?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Significant decrease in dialysate albumin concentration during molecular adsorbent recirculating system (M.A.R.S.) therapy. Gong D, Ji D, Ren B, Tao J, Xu B, Ronco C, Li L. Int J Artif Organs; 2008; 31(4):333-339 2008 http://www.ncbi.nlm.nih.gov/pubmed/18432590?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
MARS and the failing liver-Any help from the outer space? Ferenci P, Kramer L. Hepatology. 2007; 2007; 46(6):1682-1684 2007 http://www.ncbi.nlm.nih.gov/pubmed/18046718?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
FRACTIONATED PLASMA SEPARATION AND ADSORPTION IN ACUTE-ON-CHRONIC LIVER FAILURE PATIENTS RESULTS IN LOSS OF PRO AND ANTICAOGULANT FACTORS Evenepoel P   2008  
The changing epidemiology of hepatitis C virus infection in Europe Esteban JI, Sauleda S, Quer J. J Hepatol; 2008; 48(1):148-162 2008 http://www.ncbi.nlm.nih.gov/pubmed/18022726?ordinalpos=7&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Erythropoietic protoporphyria and pretransplantation treatment with nonbiological liver assist devices Eefsen M, Rasmussen A, Wulf HC, Brock A, Hansen BA. Liver Transpl; 2007; 13(5):655-657 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17377916&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis Donati G, Piscaglia F, Col“ L, Silvagni E, Righini R, Donati G, Pini P, Stefoni S, Bolondi L. Aliment Pharmacol Ther; 2007; 26(5):717-726 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17697205&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Extracorporeal treatment of intoxications de Pont AC Curr Opin Crit Care; 2007; 13(6):668-673 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17975388&ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
The curative effect of ALSS on 1-month mortality in AoCLF patients after 72 to 120 hours Chen YS, Wu ZW, He JQ, Yu J, Yang SG, Zhang YM, Du WB, Cao HC, Li LJ. Int J Artif Organs; 2007; 30(10):906-914 2007 http://www.ncbi.nlm.nih.gov/pubmed/17992652?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Sorbent-based artificial liver devices: principles of operation, chemical effects and clinical results Carpentier B, Ash SR Expert Rev Med Devices 2007 Nov 4 6 839 61; 2007; 4(6):839-861 2007 http://www.ncbi.nlm.nih.gov/pubmed/18035950?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Acute renal dysfunction in liver diseases. Betrosian AP, Agarwal B, Douzinas EE. J Gastroenterol.; 2007; 13(42):5552-5559 2007 http://www.ncbi.nlm.nih.gov/pubmed/17948928?ordinalpos=8&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Plasmapheresis for hemolytic crisis and impending acute liver failure in Wilson disease Asfaha S, Almansori M, Qarni U, Gutfreund KS. J Clin Apher; 2007; 22(5):295-298 2007 http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17880018&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. Angeli P; Merkel C Journal of Hepatology; 2008; 48(0):S93-103 2008 http://www.ncbi.nlm.nih.gov/pubmed/18304678?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Acute Liver Failure due to leptospirosis sucessfully treated with MARS (Moleculars Adsorbents Recirculating System) dialysis  Gusbeth-Tatomir P; Maftei I; Covic A Int Urol Nephrol; 2007; 39(1):313-16 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17203354&query_hl=9&itool=pubmed_docsum 
Liver failure and liver transplantation: SIRS and Sepsis – Setting the stage for a molecular adsorbent recirculating system   Insert in \"Intensive Medicine\"; 2006; 11(31): 2006  
Current Strategies and Future Developments in Artificial Liver Support Rosenthal, P. US Gastroenterology Review 2006; 2006; 0(0): 2006  
MARS treatment in patients with hepatorenal syndrome in acute liver failure Novelli G.,; Rossi M.; Pretagostini R.; Poli L.; Morabito V.; Berloco P. Hemodial Int; 2007; 1(11):115 2007 Annual Dialysis Conference, Denver, CO, USA Feb. 18-20,
2007
Short-term Survival of Patients with Severe Intractable Hepatic Encephalopathy: The role of albumin dialysis Blei, T.; Gornbein, J.; McGuire, B.; Brown, R.; Tofteng, F.; Larsen, F.S.; Lynch, P.; Mehta, R.; Hassanein, T.I.; Stange, J. AASLD -  56. Annual Meeting ; 2005; 0(0): 2005  
Use of MARS in Hepatorenal Syndrome — A local Perspective Chiu, A.; Fan, S.T. Hong Kong J Nephrol; 2006; 1(8):5-9 2006  
MARS treatment in acute on chronic liver failure secondary to different liver diseases Marangoni, R.; Bellobuono, A.; Tempini, S.; Ideo, G. Int J Artif Organs; 2006; 29(5):499-551 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16856277
Development of artificial liver system: adsorbtion and hemofiltration Lim, K.M.,  Park, J.Y.,  Mun, C.H.,  Min, B.G., Shim, E.B., Jo, Y.B.,  Won, Y.S. Int J Artif Organs; 2006; 29(5):499-551 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16856277
Molecular Adsorbent Recycling System (MARS) in liver transplantation (LTx) Gaspari, R., Zileri Dal Verme, L., Avolio, A.W., Perilli, V., Proietti, R.,  Gasbarrini, A. Int J Artif Organs; 2006; 29(5):499-551 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16856277
MARS Efficiency in 38 patients with liver failure Coli, I., Donati, G., Gianciolo, G., Raimondi, C., Silvagni, E., Gozetti, F., Bolondi, L., Stefoni, Int J Artif Organs; 2006; 29(5):499-551 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16856277
Paediatric acute liver failure and transplantation: the University of Essen experience Nadalin S, Heuer M, Wallot M, Auth M, Schaffer R, Sotiropoulos GC, Ballauf A, van der Broek MA, Olde-Damink S, Hoyer PF, Broelsch CE, Malag˜ M. Transpl Int; 2007; 20(6):519-27 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17355244
Systemic and regional hemodynamics in pigs with acute liver failure and the effect of albumin dialysis Revhaug, A.; Jalan, R.; Deutz, N. E.; Williams, R.; Prinzen, F. W.; Ten Have, G. A.; Fuskevaag, O. M.; Nedredal, G. I.; Davies, N. A.; Rose, C.; Sen, S.; Ytrebo, L. M. Scand J Gastroenterol; 2006; 41(11):1350-60 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17060130
Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure Stauber, R. E.; Trauner, M.; Holzer, H.; Putz-Bankuti, C.; Jung, A.; Schneditz, D.; Haditsch, B.; Beuers, U.; Krisper, P.; Stadlbauer, V. Asaio J; 2007; 53(2):187-93 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17413559
Liver Support Systems Faenza, S.; Ferramosca, E.; Mancini, E.; Santoro, A. Contrib Nephrol; 2007; 156(0):396-404 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17464150
Albumin dialysis and plasma filtration adsorption dialysis system Ronco, C.; Bellomo, R.; de Cal, M.; Cruz, D.; Crepaldi, C.; Brendolan, A.; Nalesso, F. Contrib Nephrol; 2007; 156(0):411-8 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17464152
Comment on Camus et al.: \"Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation\" Auzinger, G.; Wendon, J.; Bernal, W.; Karvellas, C. J. Intensive Care Med; 2007; 33(6):1102-1103 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17404707
MARS: a futile tool in centres without active liver transplant support Lee, K. H.; Prahbakaran, K.; Da Costa, M.; Lee, M. K.; Quak, S. H.; Aw, M. M.; Dan, Y. Y.; Sutedja, D. S.; Lee, Y. M.; Aung, M. O.; Lim, S. G.; Wai, C. T. Liver Int; 2007; 27(1):69-75 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17241383
Extracorporeal membrane oxygenation and extracorporeal albumin dialysis in pediatric patients with sepsis and multi-organ dysfunction syndrome Peek, G. J.; Platt, V.; Balasubramanian, S. K.; Moorthy, T.; Tiruvoipati, R. Int J Artif Organs; 2007; 30(3):227-34 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17417762
The molecular basis of bilirubin encephalopathy and toxicity: report of an EASL Single Topic Conference, Trieste, Italy, 1-2 October, 2004 Ostrow, J. D.; Tiribelli, C. J Hepatol; 2005; 43(1):156-66 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15921815
Management strategies in alcoholic liver disease Day, C. P.; Tilg, H. Nat Clin Pract Gastroenterol Hepatol; 2007; 4(1):24-34 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17203086
Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system Wong, K. S.; Choong, H. L.; Lui, H. F.; Chow, P.; Yang, W. S.; Tan, H. K. Artif Organs; 2007; 31(3):193-9 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17343694
Extracorporeal liver support: a continuing challenge Kellum, J. A.; Subramanian, R. M. Crit Care; 2007; 11(1):106 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17284306
Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure Stauber, R. E.; Lackner, C.; Jung, A.; Haditsch, B.; Aigner, R.; Krisper, P.; Stadlbauer, V. Crit Care; 2006; 10(6):R169 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17156425
Cell-free artificial liver support Jalan, R.; Revhaug, A.; Butterworth, R. F.; Williams, R.; Deutz, N. E.; Hodges, S. J.; Prinzen, F. W.; Kjonno, M.; Drevland, S. S.; Nedredal, G. I.; Davies, N. A.; Ytrebo, L. M.; Rose, C.; Sen, S.; Baurmeister, U.; Sauer, I. M. Ther Apher Dial; 2006; 10(2):105-7 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16684210
A novel plasma filtration therapy for hepatic failure: preclinical studies Demetriou, A. A.; Sadahiro, T.; Trofimenko, A.; Umehara, Y.; Rozga, J. Ther Apher Dial; 2006; 10(2):138-44 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16684215
Use of molecular adsorbent recirculating system in acute liver failure attributable to dengue hemorrhagic fever Eng, P.; Tan, H. K.; Devanand, A.; Penafiel, A. J Intensive Care Med; 2006; 21(6):369-71 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17095501
Intractable pruritus in patients with hepatitis C virus Novelli G, Rossi M, Poli L, Predagostini R, Iappelli M, Morabito V, Lai Q, Novelli L, Mennini G, Corradini SG, Berloco PB. Transplant Proc; 2006; 38(4):1089-91 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16757273
Diagnosis and treatment of acute renal failure in patients with cirrhosis Lebrec, D.; Moreau, R. Best Pract Res Clin Gastroenterol; 2007; 21(1):111-23 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17223500
Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS) Montero JL, Pozo JC, Barrera P, Fraga E, Cost‡n G, Dom’nguez JL, MuntanŽ J, Rodriguez-Ariza A, Pleguezuelo M, Rufi‡n S, L—pez-Cillero P, de la Mata M. Transplant Proc; 2006; 38(8):2511-3 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17097984
Technology insight: artificial extracorporeal liver support--how does Prometheus compare with MARS? Stauber, R. E.; Krisper, P. Nat Clin Pract Nephrol; 2007; 3(5):267-76 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17457360
Treatment of severe theophylline poisoning with the molecular adsorbent recirculating system (MARS) Korsheed S, Selby NM, Fluck RJ Nephrol Dial Transplant; 2007; 22(3):969-70 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17164319
Experience of Mars therapy with and without transplantation in 101 patients with liver insufficiency Koivusalo AM, Vakkuri A, Hšckerstedt K, Isoniemi H. Transplant Proc; 2005; 37(8):3315-7 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16298584
Bilirubin kinetic modeling for quantification of extracorporeal liver support Schneditz, D.; Holzer, H.; Trauner, M.; Stauber, R. E.; Haditsch, B.; Krisper, P.; Jung, A. Blood Purif; 2006; 24(4):413-22 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16847391
Albumin dialysis has no clear effect on cytokine levels in patients with life-threatening liver insufficiency Isoniemi, H.; Hockerstedt, K.; Koivusalo, A. M.; Ilonen, I. Transplant Proc; 2006; 38(10):3540-3 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17175326
Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure Hessel, F. P. Cost Eff Resour Alloc; 2006; 4(0):16 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17022815
Liver dysfunction associated with artificial nutrition in critically ill patients Mesejo, A.; de Lorenzo, A. G.; Montejo, J. C.; Blesa, A.; Acosta, J. A.; Farre, M.; Mateo, D.; Rubio, M.; Bonet, A.; Grau, T. Crit Care; 2007; 11(1):R10 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17254321
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy Gaspari R, Avolio AW, Zileri Dal Verme L, Agnes S, Proietti R, Castagneto M, Gasbarrini A. Transplant Proc; 2006; 38(10):3544-51 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17175327
Treatment of hyperbilirubinemia with blood purification in China Duan, Z. J.; Li, L. L.; Ju, J.; Gao, Z. H.; He, G. H. World J Gastroenterol; 2006; 12(46):7467-71 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17167835
A comparison of Child-Pugh, APACHE II and APACHE III scoring systems in predicting hospital mortality of patients with liver cirrhosis Kouroumalis, E. A.; Vardas, E.; Romanos, J.; Samonakis, D.; Vlachonikolis, I. G.; Notas, G.; Roussomoustakaki, M.; Chatzicostas, C. BMC Gastroenterol; 2003; 3(0):7 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12735793
Reply to Karvellas et al. regarding \"Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation\" Thomas, R.; Jacquelinet, C.; Boudjema, K.; Camus, C. Intensive Care Med; 2007; 33(6):1104-5 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17404708
Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation Camus C, LavouŽ S, Gacouin A, Le Tulzo Y, Lorho R, BoudjŽma K, Jacquelinet C, Thomas R. Intensive Care Med; 2006; 32(11):1817-25 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16941171
The effects of continuous venovenous hemofiltration on coagulation activation de Jonge, E.; Levi, M.; Korevaar, J. C.; Wolbink, G.; Zeerleder, S.; Roem, D.; Bakhtiari, K.; Meijers, J. C.; de Pont, A. C.; Bouman, C. S. Crit Care; 2006; 10(5):R150 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17069648
Brain edema in acute liver failure: can it be prevented? Can it be treated? Blei, A. T. J Hepatol; 2007; 46(4):564-9 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17316881
Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications Renner, E. L.; Mullhaupt, B.; Stocker, R.; Maggiorini, M.; Bachli, E. B.; Schuepbach, R. A. Liver Int; 2007; 27(4):475-84 2007 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17403187
Decision for retransplantation of the liver: an experience- and cost-based analysis Azoulay, D.; Linhares, M. M.; Huguet, E.; Delvart, V.; Castaing, D.; Adam, R.; Ichai, P.; Saliba, F.; Lemoine, A.; Samuel, D.; Bismuth, H. Ann Surg; 2002; 236(6):713-21; discuss 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12454509
Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation: a pilot study Krenn, C. G.; Steltzer, H.; Sandner, S. E.; Burghuber, C.; Bacher, A.; Baker, A.; Berlakovich, G.; Faybik, P.; Hetz, H. Liver Transpl; 2006; 12(9):1357-64 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16741899
Ammonia removal as one mechanism of MARS depends strongly on the flow rate of the secondary dialysate circuit Schmidt S; Szyszkowitz T; Schmidt R 8th ISAD; 2006; 0(0):61 2006  
MARS Therapy reduces Trough Concentrations of Caspofungin - a Case Report - Wissing, H.; Bingold, T.; Kunz, T.; Klšsel, S.; Scheller, B.; Zwi§ler, B. 8th ISAD; 2006; 0(0):79 2006  
Extracorporeal liver support with MARS. The experience in our hospital Vizoso, F.; Mantinan, S.; Lange, D.; Paz, S.; Rozados, M.; Arroyo, C.; Carballas, C.; Velasco, R. 8th ISAD; 2006; 0(0):77 2006  
Extracorporeal albumin dialysis in paediatric patients with sepsis multi-organ dysfunction Tiruvoipati, R.; Moorthy, T.; Balasubramanian, S.; Platt, V.; Peek, G. 8th ISAD; 2006; 0(0):75 2006  
Octanoate-and n-acetyltryptophane free albumin exhibits higher efficacy in albumin dialysis Szyszkowitz, T.; Schmidt, S.; Mitzner, S.; Schmidt, R. 8th ISAD; 2006; 0(0):73 2006  
The International MARS Registry - Update 2006 StŸrzbecher, M.; Philipp, H. 8th ISAD; 2006; 0(0):71 2006  
Oxidized state of serum albumin in acute-on-chronic liver failure is partially reversed by extracorporeal liver support Lackner, C.; Putz-Bankuti, C.; Krisper, P.; Stadlbauer, V.; Oettl, K.; Stauber, R. 8th ISAD; 2006; 0(0):69 2006  
Octanoate-and N-acetyltryptophane free albumin (Hepalbin) as a new i.v. tool to improve patients Albumin Binding Capacity in liver failure Schmidt, R.; Mitzner, S.; Klammt, S.; Stange, J. 8th ISAD; 2006; 0(0):67 2006  
Antithrombin III loss is a useful parameter for membrane selectivity in liver support devices Schmidt, R.; Sieveking, C.; Sikole, M. 8th ISAD; 2006; 0(0):65 2006  
Contamination of commercial albumin with octanoate is a limiting factor for the efficacy of albumin dialysis in liver support Schmidt, R.; Stange, K.; Suraj, M.; Arndt, K.; Hickstein, H.; Klammt, S.; Gloger, M.; Hentschel, J.; Koball, S.; Mitzner, SR; Stange, J.; Sieveking, R. 8th ISAD; 2006; 0(0):63 2006  
A new standardized in vitro model for long term simultaneous measurement of albumin bound and unbound substance clearances in the MARS Device Schmidt, R.; Szyszkowitz, T.; Schmidt, S. 8th ISAD; 2006; 0(0):59 2006  
Liver cell based Biosensor for screening of liver functions in patients with septic shock Sauer, M.; Haubner, C.; Potschka, H.; Mencke, T.; Nšldge-Schomburg, G.; Mitzner, RS; Stange, J. 8th ISAD; 2006; 0(0):57 2006  
Hepac2: A standardized and validated long-term human hepatocyte culture system for repetitive analyses of drugs: Repeated administrations of acetaminophen reduces albumin and urea secretion Runge, D.; Berg, C.; Hengstler, J.; Ullrich, A. 8th ISAD; 2006; 0(0):55 2006  
Treatment if children with liver failure with albumin dialysis MARS-5 years experince Migda, M.; Kalici_ski, P.; Grenda, R.; Rubik, J.; Prokurat, S. 8th ISAD; 2006; 0(0):53 2006  
Observations in 3 patients with endstage-liver-disease on longterm liversupport treatment  with albumin dialysis (MARS) on an out-patient-basis Jost, U.; Mandelartz, H.; Lichtenstein, Z. 8th ISAD; 2006; 0(0):49 2006  
Diagnostic and therapeutic relevance of albumin binding capacity in liver failure Schmidt, R.; Stange, J.; Klammt, S. 8th ISAD; 2006; 0(0):47 2006  
Results of an anticoagulation protocol for MARS therapy based on patients characteristics Fernandez-ortega, FJ.; Lebron-Gallardo, M.; Seller-Perez, G.; Herrera-Gutierrez, ME. 8th ISAD; 2006; 0(0):45 2006  
Impact of MARS albumin dialysis in patients with fulminant hepatic failure who are awaiting liver transplantation at the Rennes liver transplant centre Camus, C.; Lavoue, S.; Gacouin, A.; Tulzo, Y.; Boudjema, K.; Thomas, R. 8th ISAD; 2006; 0(0):43 2006  
Mass transfer in Artificial Liver Membrane Systems Raff, M. 8th ISAD; 2006; 0(0):39 2006  
Technical innovations: News from the research lab Baurmeister, U. 8th ISAD; 2006; 0(0):37 2006  
Citrate anticoagulation under Prometheus Liver support therapy Renders, L. 8th ISAD; 2006; 0(0):35 2006  
Minimum anticoagulation and saline flushes The Helsinki approach HŠggblom, A.; Kyllšnen, P.; Koivusalo, AM. 8th ISAD; 2006; 0(0):33 2006  
Anticoagulation and bleeding complications The Zurich Experience MŸllhaupt, B. 8th ISAD; 2006; 0(0):31 2006  
MARS vs. Prometheus in Acute on Chronic Liver Failure (AoCHF) Wilmer, A. 8th ISAD; 2006; 0(0):29 2006  
Rationale of albumin regeneration Stange, J. 8th ISAD; 2006; 0(0):27 2006  
Failure of neutrophil function in decompensated alcoholic cirrhosis predicts survival Stadlbauer, V.; Mookerjee, RP.; Lidder, S.; Hodges, SJ.; Williams, R.; Jalan, R. 8th ISAD; 2006; 0(0):25 2006  
Sepsis in Liver Transplantation Saliba, F. 8th ISAD; 2006; 0(0):21 2006  
Antibiotic prophylaxis and treatment Catalina, Maria-Vega; Banares, R. 8th ISAD; 2006; 0(0):17 2006  
Treatment of spontaneous bacterial peritonitis (SBP) Arroyo, V. 8th ISAD; 2006; 0(0):15 2006  
Renal Replacement Therapies in septic patients - Lessons learned Joannidis, M. 8th ISAD; 2006; 0(0):13 2006  
Liver support in septic patients Bauer, M. 8th ISAD; 2006; 0(0):11 2006  
How can liver toxins be removed? Filtration and adsorption with the Prometheus system Christmann, H.; Vienken, J. Ther Apher Dial; 2006; 10(2):125-31 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16684213
The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation Jalan, R.; Shawcross, D. Cell Mol Life Sci; 2005; 62(19):2295-304 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16158192
TIPS for veno-occlusive disease: is the contraindication real? Burroughs, A. K.; Patch, D.; Cholongitas, E.; Senzolo, M. Hepatology; 2005; 42(1):240-1; author r 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15962296
Prometheus system: a technological support in liver failure Santoro, A.; Faenza, S.; Mancini, E.; Ferramosca, E.; Grammatico, F.; Zucchelli, A.; Facchini, M. G.; Pinna, A. D. Transplant Proc; 2006; 38(4):1078-82 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16757270
Acute Dialysis Quality Initiative (ADQI): the PASSPORT project Ronco, C. Int J Artif Organs; 2005; 28(5):438-40 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15883956
Removal selectivity of Prometheus: a new extracorporeal liver support device Rifai, K.; Ernst, T.; Kretschmer, U.; Haller, H.; Manns, M. P.; Fliser, D. World J Gastroenterol; 2006; 12(6):940-4 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16521224
Review article: clinical experience with Prometheus Manns, M. P.; Rifai, K. Ther Apher Dial; 2006; 10(2):132-7 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16684214
Blood purification in the intensive care unit Ponikvar, R. Nephrol Dial Transplant; 2003; 18(0):v63-7 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12817075
Acute liver failure Lee, W. M.; Polson, J.; Lee, D. H.; Park, J. K.; O'Grady, J. G. Postgrad Med J; 2005; 81(953):148-54 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15749789
Artificial liver support system in China: a review over the last 30 years Chen, Y. M.; Xu, X. W.; Yang, Q.; Huang, J. R.; Du, W. B.; Liu, X. L.; Zhang, Y. M.; Li, L. J. Ther Apher Dial; 2006; 10(2):160-7 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16684218
Advances in critical care management of hepatic failure and insufficiency KingHan, M; Hyzy, R. Crit Care Med; 2006; 34(9):S225-31 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16917427
Fluidized bed adsorbent systems for extracorporeal liver support Weber, V.; Posnicek, T.; Kellner, K. H.; Hartmann, J.; Brandl, M.; Falkenhagen, D. Ther Apher Dial; 2006; 10(2):154-9 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16684217
Bioartificial liver: its pros and cons van de Kerkhove, M. P.; Poyck, P. P.; Chamuleau, R. A. Ther Apher Dial; 2006; 10(2):168-74 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16684219
Therapeutic apheresis--state of the art in the year 2005 Bosch, T. Ther Apher Dial; 2005; 9(6):459-68 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16354277
Sorbent suspensions vs. sorbent columns for extracorporeal detoxification in hepatic failure Carr, D. J.; Sullivan, T. A.; Ash, S. R. Ther Apher Dial; 2006; 10(2):145-53 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16684216
Molecular Adsobent Recycling System (MARS) for Cirrhosis Porto-systemic Encephalopathy (PSE): a case report Zhao-Junyan; Li-Shiangling; Chen-Ziping; Li-Kun; Xu-Changqing 7th ISAD; 2005; 0(0):65 2005  
Caspofungin Elimination During MARS Therapy - a Case Report Zwi§ler, B; Scheller, B; Klšsel, S; Kunz, T; Bingold, T; Wissing, H 7th ISAD; 2005; 0(0):63 2005  
Clinical Therapeutic effect of Molecular Adsorbents Recirculating System on 84 patients of chronic severe hepatitis B Wen-Ya 7th ISAD; 2005; 0(0):61 2005  
MARS albumin dialysis in children with acute liver failure or with pruritus due to chronic liver disease Sturm, E; Verkade, HJ; Kok, A; Pierik, LJWM; van Dael, CML 7th ISAD; 2005; 0(0):59 2005  
Annual report of the International MARS Registry Analysis of 625 patients Philipp, H; Stuerzbecher, M 7th ISAD; 2005; 0(0):57 2005  
Use of extracorporeal albumin dialysis (MARS) in Drug overdose and intoxications Stange, J 7th ISAD; 2005; 0(0):55 2005  
Effect of two different extracorporeal liver assist devices on serum bile acids in patients with acute-on-chronic liver failure. Stauber, R; Trauner, M; Holzer, H; Krisper, P; Haditsch, B; Bankuti, C; Beuers, U; Stadlbauer, V 7th ISAD; 2005; 0(0):53 2005  
Effect of Extracorporeal liver support systems on serum cytokine levels Stauber, R; Aigner, R; Haditsch, B; Krisper, P; Stadlbauer, V 7th ISAD; 2005; 0(0):51 2005  
Extracorporeal liver support using the MARS albumin dialysis system: a rescue therapy in patients with end-stage liver-disease and renal failure Samuel, D; Castaing, D; Adam, R; Azoulay, D; Gonzales, M; Ichai, P; Saliba, F 7th ISAD; 2005; 0(0):49 2005  
Albumin dialysis for intractable pruritus in patients with liver diseases Pares, A 7th ISAD; 2005; 0(0):47 2005  
146 cases of acute liver failure treatment with MARS Novelli, G; Rossi, M; Pretagostini, M; Pugliese, F; Ruberto, F; Novelli, L; Nudo, F; Bussotti, A; Corradini, S; Martelli, S; Berloco, PB 7th ISAD; 2005; 0(0):45 2005  
Use of MARS in different etiologies of acute liver failure Berloco, PB; Martelli, S; Corradini, S; Bussotti, A; Morabito, V; Nudo, F; Novelli, L; Ruberto, F; Pugliese, F; Pretagostini, M; Rossi, M; Novelli, G 7th ISAD; 2005; 0(0):43 2005  
Mars treatment in patient affected by acute on chronic liver failure with severe pruritus refractory to pharmacological therapy Marangoni, R 7th ISAD; 2005; 0(0):41 2005  
Observations in two patients with endstage-liver-disease on longterm liversupport treatment with Albumin dialysis (MARS) on an out-patient-basis Jost, U; Mandelarzt, H; Lichtenstein, Z 7th ISAD; 2005; 0(0):37 2005  
Albumin Binding Capacity Klammt, S 7th ISAD; 2005; 0(0):35 2005  
Bilirubin Kinetics for Quantification of Extracorporeal Liver Support Schneditz, D; Holzer, H; Stauber, R; Haditsch, B; Krisper, P; Jung, A 7th ISAD; 2005; 0(0):33 2005  
Successful treatment of amitriptyline poisoning with a novel therapy: rapid decrease in lethal plasma levels induced by Molecular Adsorbents Recirculating Sysetem (MARS) Marecek, S; Lampl, C; Hubmann, R 7th ISAD; 2005; 0(0):31 2005  
SOFA scor and Ingocyanine green kinetics to monitor extracorporal albumin dialysis Hetz, H; Krenn, C; Bacher, A; Lahner, D; Faybik, P 7th ISAD; 2005; 0(0):29 2005  
The costs of acute-on-chronic liver failure - A bottom-up analysis based on individual patient data Wasem, JŸrgen; Grabein, Kristin; Mitzner, Steffen; Hessel, Franz 7th ISAD; 2005; 0(0):27 2005  
Artificial Liver Support Systems - A Medical and Health Economic HTA-Report Hessel, Franz 7th ISAD; 2005; 0(0):25 2005  
Efficacy of Albumin Dialysis (MARS) in Patients with Cirrhosis and Advanced Grades of Hepatic Encephalopthy: A Prospective, Controlled, Randomized Multicenter Trial Blei, A; Stange, J; Gornbein, J; Larsen, FS; Metha, R; Lynch, P; McGuire, BM; Brown, RS Jr.; Tofteng, F; Hassanein, T 7th ISAD; 2005; 0(0):23 2005  
Manganese impairs neuronal activity and ammonia detoxification Mitzner, S; Weiss, DG; StŸwe, S; Loock, J; Gramowski, A 7th ISAD; 2005; 0(0):21 2005  
Molecular Adsorbents Recirculating System: clinical experience in 71 patients with acute and acute on chronic liver failure Ji; Teng; Yuan; Fu; Xu; Zhong; Fang; Zou; Chen; Ding 7th ISAD; 2005; 0(0):19 2005  
Albumin dialysis in complex treatment of multiorgan failure syndrome (MOFS) in patients after heart surgery Tomarovsky, O; Heptner, R; Grigoriantz, R; Yaroustovsky, M; Bockeria, L 7th ISAD; 2005; 0(0):17 2005  
Lecture: Hemodynamic Management Catalina, Maria-Vega; Banares, Rafael 7th ISAD; 2005; 0(0):15 2005  
Octanoate- and N-Acetyltryptophane free albumin for albumin dialysis and intravenous infusion Klammt, S; Suraj, M; Arndt, K 7th ISAD; 2005; 0(0):13 2005  
The study of the correlating markers with the effect of the clinical application of Molecular Adsorbent Recycling System (MARS) treatment Hong; Yong-Jun; Xiao-Yan; Ji-Hong; Xiao-Pin; Gang 7th ISAD; 2005; 0(0):11 2005  
Kidney Dysfunction in cirrhosis Arroyo, Vicente 7th ISAD; 2005; 0(0):9 2005  
Preoperative risk factor analysis in orthotopic liver transplantation with pretransplant artificial liver support therapy Yuan, J. Z.; Ye, Q. F.; Zhao, L. L.; Ming, Y. Z.; Sun, H.; Zhu, S. H.; Huang, Z. F.; Wang, M. M. World J Gastroenterol; 2006; 12(31):5055-9 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16937506
Pharmacokinetics of liposomal amphotericin B during extracorporeal albumin dialysis Vogelsinger, H.; Joannidis, M.; Kountchev, J.; Bellmann-Weiler, R.; Wiedermann, C. J.; Bellmann, R.; Wigg, A. J.; Padbury, R. T. Artif Organs; 2006; 30(2):118-21 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16433846
Acute fulminant hepatitis B in a patient with diabetic nephropathy treated successfully with concomitant lamivudine and molecular adsorbents recirculating system Tsai, S. H.; Chang, H. M.; Hsieh, C. B.; Chao, Y. C.; Hsieh, T. Y.; Tsai, S. H.; Chang, H. M.; Hsieh, C. B.; Chao, Y. C.; Hsieh, T. Y. J Infect; 2006; 53(1):e19-23 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16269182
Bridging to transplantation in acute liver failure in a 7-month-old infant Trittenwein, G.; Boigner, H.; Mostafa, G.; Burda, G.; Muhl, A.; Amann, G.; Pollak, A. Wien Klin Wochenschr; 2006; 118(9):298-301 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16810489
Molecular adsorbent recirculating system (MARS) application in liver failure: clinical and hemodepurative results in 22 patients Stefoni, S.; Coli, L.; Bolondi, L.; Donati, G.; Ruggeri, G.; Feliciangeli, G.; Piscaglia, F.; Silvagni, E.; Sirri, M.; Baraldi, O.; Soverini, M. L.; Cianciolo, G.; Boni, P.; Patrono, D.; Ramazzotti, E.; Motta, R.; Roda, A.; Simoni, P.; Magliulo, M.; Borgn Int J Artif Organs; 2006; 29(2):207-18 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16552668
The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results Krawczyk, M.; Paczek, L.; Sanko-Resmer, J.; Giercuszkiewicz, D.; Paczkowska, A.; Grzelak, I.; Patkowski, W.; Michalowicz, B.; Zieniewicz, K.; Kotulski, M.; Nyckowski, P.; Grodzicki, M.; Skwarek, A. Transplant Proc; 2006; 38(1):209-11 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16504704
The Molecular Adsorbent Recirculating System (MARS(R)) in the intensive care unit: a rescue therapy for patients with hepatic failure Saliba, F. Crit Care; 2006; 10(1):118 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16542471
Bioartificial liver: current status Pless, G.; Sauer, I. M. Transplant Proc; 2005; 37(9):3893-5 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16386576
Slow continuous ultrafiltration with bound solute dialysis Patzer, J. F., 2nd; Safta, S. A.; Miller, R. H. Asaio J; 2006; 52(1):47-58 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16436890
Artificial liver support at present and in the future Onodera, K.; Sakata, H.; Yonekawa, M.; Kawamura, A. J Artif Organs; 2006; 9(1):17-28 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16614798
Personal view: current role of artificial liver support devices O'Grady, J. Aliment Pharmacol Ther; 2006; 23(11):1549-57 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16696802
Orthotopic liver transplantation for fulminant hepatic failure Nyckowski, P.; Skwarek, A.; Zieniewicz, K.; Patkowski, W.; Alsharabi, A.; Wroblewski, T.; Remiszewski, P.; Smoter, P.; Kotulski, M.; Korba, M.; Paczkowska, A.; Giercuszkiewicz, D.; Sanko-Resmer, J.; Paczek, L.; Krawczyk, M. Transplant Proc; 2006; 38(1):219-20 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16504707
Albumin regeneration in liver support-comparison of different methods Mitzner, S.; Klammt, S.; Stange, J.; Schmidt, R. Ther Apher Dial; 2006; 10(2):108-17 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16684211
Corticosteroids for alcoholic hepatitis--what''s next? Mathurin, P. J Hepatol; 2005; 43(3):526-33 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16026887
Successful treatment of an adult with Amanita phalloides-induced fulminant liver failure with molecular adsorbent recirculating system (MARS) Lionte, C.; Sorodoc, L.; Simionescu, V. Rom J Gastroenterol; 2005; 14(3):267-71 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16200238
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure Laleman, W.; Wilmer, A.; Evenepoel, P.; Elst, I. V.; Zeegers, M.; Zaman, Z.; Verslype, C.; Fevery, J.; Nevens, F. Crit Care; 2006; 10(4):R108 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16859530
An Australian experience with the molecular adsorbents recirculating system (Mars) Kurtovic, J.; Boyle, M.; Bihari, D.; Riordan, S. M. Ther Apher Dial; 2006; 10(1):2-6 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16556129
Molecular absorbent recirculating system for the treatment of acute liver failure in surgical patients Inderbitzin, D.; Muggli, B.; Ringger, A.; Beldi, G.; Gass, M.; Gloor, B.; Uehlinger, D.; Regli, B.; Reichen, J.; Candinas, D. J Gastrointest Surg; 2005; 9(8):1155-61 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16269387
Progress in treatment of massive ascites and hepatorenal syndrome Gerbes, A. L.; Gulberg, V. World J Gastroenterol; 2006; 12(4):516-9 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16489662
Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices Evenepoel, P.; Laleman, W.; Wilmer, A.; Claes, K.; Kuypers, D.; Bammens, B.; Nevens, F.; Vanrenterghem, Y. Artif Organs; 2006; 30(4):276-84 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16643386
Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience Doria, C.; Mandala, L.; Scott, V. L.; Gruttadauria, S.; Marino, I. R. Dig Dis Sci; 2006; 51(1):47-53 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16416211
Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience Chiu, A.; Chan, L. M.; Fan, S. T. Liver Int; 2006; 26(6):695-702 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16842326
MARS in the treatment of liver failure: controversies and evidence Chiu, A.; Fan, S. T. Int J Artif Organs; 2006; 29(7):660-7 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16874670
Functional evaluation of a new bioartificial liver system in vitro and in vitro Chen, Z.; Ding, Y. T. World J Gastroenterol; 2006; 12(8):1312-6 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16534893
Life-threatening intoxication with methylene bis(thiocyanate): clinical picture and pitfalls. A case report Braun, C.; Birck, R.; Singer, M. V.; Schnuelle, P.; van der Woude, F. J.; Lohr, M. BMC Emerg Med; 2006; 6(0):5 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16608508
Cell-free artificial liver support: design of appropriate clinical studies Bernal, W.; Wendon, J. Ther Apher Dial; 2006; 10(2):175-9 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16684220
The pruritus of cholestasis Bergasa, N. V. J Hepatol; 2005; 43(6):1078-88 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16253381
Cholestasis induced by parabolan successfully treated with the molecular adsorbent recirculating system Anand, J. S.; Chodorowski, Z.; Hajduk, A.; Waldman, W. Asaio J; 2006; 52(1):117-8 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16436902
The liver as an immunological organ REHERMANN,BARBARA; WEILER-NORMANN,CHRISTINA Journal of Gastroenterology and Hepatology; 2004; 19(0):S279-S283 2004 http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.2004.03687.x
Pathogenesis of cirrhosis WANLESS,IAN R Journal of Gastroenterology and Hepatology; 2004; 19(0):S369-S371 2004 http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.2004.03705.x
Predicting the outcome of fulminant hepatic failure Shakil, A. O. Liver Transpl; 2005; 11(9):1028-30 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16123964
Splanchnic hemodynamics: cirrhotic versus non-cirrhotic portal hypertension SCHIEDERMAIER,PETER Journal of Gastroenterology and Hepatology; 2004; 19(0):S150-S154 2004 http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.2004.03667.x
Temporary support for acute liver failure Kowdley, K. V.; Larson, A. M.; Rajvanshi, P. J Clin Gastroenterol; 2002; 35(4):335-44 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12352298
Reversible factors in portal hypertension PINZANI,MASSIMO; VIZZUTTI,FRANCESCO Journal of Gastroenterology and Hepatology; 2004; 19(0):S155-S157 2004 http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.2004.03668.x
Approach to a child with chronic liver disease VERGANI,DIEGO; MIELI-VERGANI,GIORGINA Journal of Gastroenterology and Hepatology; 2004; 19(0):S377-S378 2004 http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.2004.03638.x
Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial Kaufmann, R.; Bieber, T.; Helgesen, A. L.; Andersen, B. L.; Luger, T.; Poulin, Y.; Al-Hafidh, J.; Paul, C. Allergy; 2006; 61(3):375-81 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16436149
Acute liver failure in childhood DHAWAN,ANIL Journal of Gastroenterology and Hepatology; 2004; 19(0):S382-S385 2004 http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.2004.03707.x
Pathology of portal hypertension DENK,HELMUT Journal of Gastroenterology and Hepatology; 2004; 19(0):S346-S348 2004 http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.2004.03701.x
Therapeutic and management challenges in Wilson BAVDEKAR,ASHISH Journal of Gastroenterology and Hepatology; 2004; 19(0):S391-S395 2004 http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.2004.03709.x
Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls Bambha, K.; Kim, W. R. Eur J Gastroenterol Hepatol; 2004; 16(6):519-26 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15167152
Liver transplantation is effective, but is it cost-effective? Bambha, K.; Kim, W. R. Liver Transpl; 2003; 9(12):1308-11 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14625831
Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure Lee, K. H.; Lee, M. K.; Sutedja, D. S.; Lim, S. G. Liver Int; 2005; 25(5):973-7 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16162155
The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure Mutimer, D.; Murphy, N.; Lai, W. K.; Haydon, G. Intensive Care Med; 2005; 31(11):1544-9 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16155752
Current management of portal hypertension Wright, A. S.; Rikkers, L. F. J Gastrointest Surg; 2005; 9(7):992-1005 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16137597
Cerebral blood flow in acute liver failure: a finding in search of a mechanism Blei, A. T.; Chung, C.; Vaquero, J. Metab Brain Dis; 2004; 19(3):177-94 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15554414
Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests Mannuccio Mannucci, P.; Primignani, M.; Cazzaniga, M.; Clerici, M.; Chantarangkul, V.; Salerno, F.; Tripodi, A. Hepatology; 2005; 41(3):553-8 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15726661
Management of patients with fulminant hepatic failure and brain edema Larsen, F. S.; Toftengi, F. Metab Brain Dis; 2004; 19(3):207-14 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15554416
Natural history of hepatopulmonary syndrome: Impact of liver transplantation Krowka, M. J.; Wiesner, R. H.; Swanson, K. L. Hepatology; 2005; 41(5):1122-9 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15828054
Herbal hepatotoxicity Schuppan, D.; Patsenker, E.; Stickel, F. J Hepatol; 2005; 43(5):901-10 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16171893
Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure Nelson, D. R.; Reinhart, K.; Levi, M.; Kollef, M. J.; Macias, W. L.; Shorr, A. F.; Dhainaut, J. F. Crit Care Med; 2005; 33(2):341-8 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15699837
Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure Williams, R.; Riordan, S. M. Semin Liver Dis; 2003; 23(3):203-15 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14523674
Enterohepatic transport of bile salts and genetics of cholestasis van Gulik, T. M.; Chamuleau, R. A.; Hoekstra, R.; van de Kerkhove, M. P.; Lee, W. M.; Polson, J.; Meier, P. J.; Kullak-Ublick, G. A.; Meier, Y.; Stieger, B.; Pauli-Magnus, C. J Hepatol; 2005; 43(2):342-57 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15975683
Bioartificial liver systems: current status and future perspective Lee, D. H.; Park, J. K. J Biosci Bioeng; 2005; 99(4):311-9 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16233796
Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation Bach, F. H.; Yamashita, K.; Usheva, A.; Otterbein, L. E.; Soares, M. P.; Liloia, A.; Graca-Souza, A. V.; Csizmadia, E.; Tyagi, S.; McDaid, J.; Froio, A.; Erat, A.; Bilban, M.; Ollinger, R. Circulation; 2005; 112(7):1030-9 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16087796
Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis Berg, C. L.; Adams, R. B.; Lee, V. D.; Wanamaker, R. C.; Northup, P. G. Ann Surg; 2005; 242(2):244-51 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16041215
Oxidative stress in the pathogenesis of hepatic encephalopathy Rama Rao, K. V.; Jayakumar, A. R.; Norenberg, M. D. Metab Brain Dis; 2004; 19(3):313-29 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15554424
Artificial liver support: future aspects Naruse, K. J Artif Organs; 2005; 8(2):71-6 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16094509
Mushrooms, amatoxins and the liver Mas, A. J Hepatol; 2005; 42(2):166-9 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15664239
Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure Murphy, N.; Neuberger, J. M.; Nightingale, P.; Seyam, M. S.; Macquillan, G. C. Liver Transpl; 2005; 11(9):1073-9 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16123967
Blood ammonia levels and hepatic encephalopathy Lockwood, A. H. Metab Brain Dis; 2004; 19(3):345-9 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15554426
Comparison of plasma exchange with different membrane pore sizes in the treatment of severe viral hepatitis Yang, Q.; Huang, J. R.; Chen, Y. M.; Chen, Y.; Sheng, G. P.; Xu, X. W.; Liu, X. L.; Li, L. J. Ther Apher Dial; 2005; 9(5):396-401 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16202014
Acute liver failure: current management and future prospects Jalan, R. J Hepatol; 2005; 42(1):S115-23 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15777566
Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis Shah, V. H.; Langer, D. A. J Hepatol; 2006; 44(1):209-16 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16297493
Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients Gangl, A.; Madl, C.; Gendo, A.; Strobl, W.; Joukhadar, C.; Bauer, E.; Kramer, L. Crit Care Med; 2003; 31(10):2450-5 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14530750
Outcome of liver transplantation for hepatitis B in the United States Dickson, E. R.; Ishitani, M. B.; Kremers, W. K.; Poterucha, J. J.; Kim, W. R. Liver Transpl; 2004; 10(8):968-74 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15390321
Dispelling myths in the treatment of hepatic encephalopathy Jalan, R.; Shawcross, D. Lancet; 2005; 365(9457):431-3 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15680459
Intracranial hypertension in acute liver failure: pathophysiological basis of rational management Jalan, R. Semin Liver Dis; 2003; 23(3):271-82 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14523680
Hypothermia in acute liver failure Rose, C.; Jalan, R. Metab Brain Dis; 2004; 19(3):215-21 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15554417
The hepatoadrenal syndrome: a common yet unrecognized clinical condition Starzl, T. E.; Gayowski, T.; Marik, P. E. Crit Care Med; 2005; 33(6):1254-9 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15942340
Renal replacement therapy in patients with chronic liver disease Teitelbaum, I.; Howard, C. S. Semin Dial; 2005; 18(3):212-6 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15934968
Hepatorenal syndrome Rodes, J.; Arroyo, V.; Guevara, M.; Gines, P. Lancet; 2003; 362(9398):1819-27 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14654322
Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom Kelly, D. A.; McKiernan, P.; Lee, W. S. J Pediatr Gastroenterol Nutr; 2005; 40(5):575-81 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15861019
Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure Vanrenterghem, Y.; Nevens, F.; Bammens, B.; Kuypers, D.; Maes, B.; Claes, K.; Wilmer, A.; Laleman, W.; Evenepoel, P. Blood Purif; 2005; 23(5):349-58 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16020951
Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis D'Amico, M.; Miraglia, R.; Morabito, A.; Luca, A.; D'Amico, G. Gastroenterology; 2005; 129(4):1282-93 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16230081
Molecular neurobiology of acute liver failure Butterworth, R. F. Semin Liver Dis; 2003; 23(3):251-8 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14523678
The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension Haskal, Z. J.; Boyer, T. D. Hepatology; 2005; 41(2):386-400 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15660434
Predictive value of arterial ammonia for complications and outcome in acute liver failure Acharya, S. K.; Singh, R.; Bhatia, V. Gut; 2006; 55(1):98-104 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16024550
Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint Mieli-Vergani, G.; Cheeseman, P.; Dhawan, A.; Butterworth, R. F.; Ahboucha, S. Metab Brain Dis; 2004; 19(3):331-43 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15554425
Liver support systems: promise and reality Padbury, R. T.; Wigg, A. J. J Gastroenterol Hepatol; 2005; 20(12):1807-16 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16336437
Extracorporal liver support with molecular adsorbents recirculating system in patients with hepatitis B-associated fulminant hepatic failure Tsai MH, Chen YC, Wu CS, Ho YP, Fang JT, Lien JM, Yang C, Chu YY, Liu NJ, Lin CH, Chiu CT, Chen PC. Int J Clin Pract; 2005; 59(11):1289-94 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16236082
Liver support for fulminant hepatic failure: is it time to use the molecular adsorbents recycling system in children? Tissieres, P.; Sasbon, J. S.; Devictor, D. Pediatr Crit Care Med; 2005; 6(5):585-91 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16148822
Drain the brain: albumin dialysis for intracranial hypertension Mitzner, S. R. Crit Care Med; 2006; 34(1):254-5 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16374193
Acute hepatitis associated with lamotrigine and managed with the molecular adsorbents recirculating system (Mars) Mecarelli, O.; Pulitano, P.; Mingoia, M.; Ferretti, G.; Rossi, M.; Berloco, P. B.; Muda, A. O. Epilepsia; 2005; 46(10):1687-9 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16190944
Review article: non-biological liver support in liver failure Laleman, W.; Wilmer, A.; Evenepoel, P.; Verslype, C.; Fevery, J.; Nevens, F. Aliment Pharmacol Ther; 2006; 23(3):351-63 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16422994
Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study Faybik, P.; Bacher, A.; Kozek-Langenecker, S. A.; Steltzer, H.; Krenn, C. G.; Unger, S.; Hetz, H. Crit Care; 2006; 10(1):R24 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16469128
Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure Di Campli, C.; Santoro, M. C.; Gaspari, R.; Merra, G.; Zileri Dal Verme, L.; Zocco, M. A.; Piscaglia, A. C.; Di Gioacchino, G.; Novi, M.; Santoliquido, A.; Flore, R.; Tondi, P.; Proietti, R.; Gasbarrini, G.; Pola, P.; Gasbarrini, A. Transplant Proc; 2005; 37(6):2547-50 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16182739
The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure Di Campli, C.; Zocco, M. A.; Gaspari, R.; Novi, M.; Candelli, M.; Santoliquido, A.; Flore, R.; Tondi, P.; Proietti, R.; Gasbarrini, G.; Pola, P.; Gasbarrini, A. Transplant Proc; 2005; 37(6):2551-3 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16182740
Improvement of mitochondrial function evaluated by ketoisocaproic acid breath test in patients with HCV infection undergoing albumin dialysis Zocco, M. A.; Di Campli, C.; Gaspari, R.; Candelli, M.; Nista, E. C.; Zileri Dal Verme, L.; Di Gioacchino, G.; Santoliquido, A.; Flore, R.; Tondi, P.; Proietti, R.; Pola, P.; Gasbarrini, G.; Gasbarrini, A. Transplant Proc; 2005; 37(6):2554-6 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16182741
One hundred sixteen cases of acute liver failure treated with MARS Novelli G, Rossi M, Pretagostini M, Pugliese F, Ruberto F, Novelli L, Nudo F, Bussotti A, Corradini S, Martelli S, Berloco PB.
Transplant Proc; 2005; 37(6):2557-9 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16182742
Molecular adsorbent recirculating system treatment for acute hepatic failure in patients with hepatitis B undergoing chemotherapy for non-Hodgkin Novelli, G.; Rossi, M.; Ferretti, G.; Nudo, F.; Bussotti, A.; Mennini, G.; Novelli, L.; Ferretti, S.; Antonellis, F.; Martelli, S.; Berloco, P. B. Transplant Proc; 2005; 37(6):2560-2 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16182743
Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure Di Campli, C.; Zileri Dal Verme, L.; Andrisani, M. C.; Armuzzi, A.; Candelli, M.; Gaspari, R.; Gasbarrini, A. Curr Med Chem; 2003; 10(4):341-8 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12570706
Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study Sen, S.; Rose, C.; Ytrebo, L. M.; Davies, N. A.; Nedredal, G. I.; Drevland, S. S.; Kjonno, M.; Prinzen, F. W.; Hodges, S. J.; Deutz, N. E.; Williams, R.; Butterworth, R. F.; Revhaug, A.; Jalan, R. Crit Care Med; 2006; 34(1):158-64 2006 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16374170
A liver transplant center experience with liver dialysis in the management of patients with fulminant hepatic failure: a preliminary report Aladag M; GŸrakar A; Jahl S; Wright H; Alamian S; Rashwan S; Sebastian A; Nour B Transplant Proc; 2004; 36(1):203-5 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15013346
Therapeutic application of molecular adsorbents recirculating system in various pathigenic MODS/MOF patients Luo Hong-Tao; Guo Li-Min; Wu Min; Liu Quan-mei; Wanh Min-min Chinese Medical Journal; 2005; 118(13):1113-1117 2005 http://www.ncbi.nlm.nih.gov/pubmed/16098266
Paracetamol poisoning Day CJ; Bellamy MC Care of the Critically Ill; 2005; 21(2):51-56 2005  
Albumin dialysis for the treatment of hepatic encephalopathy Blei A. Journal of Gastroenterology and Hepatology; 2004; 19(0):S224-S228 2004  
Application of Molecular Adsorbent Recirculating System in severe viral hepatitis patients and the prognosis assessmentby MELD score Min-Min Wang; Gui-xiaYan; Ling Xu; Lin Xiao; Xiao-bo Lu; Yue-xin Sun; Li-Hua Sun; Yue-Xin Zhang 6th ISAD; 2004; 0(0):47 2004  
Effect of Albumin Dialysis on Albumin Bound Uremic Toxins in plasma of Chronic hemodialysis patients results of in-vitro experiments Nina Zeh; Steffen Mitzner; Petra Seidel; Joachim Rychly; Andrea Dillmann; Reinhard Schmidt 6th ISAD; 2004; 0(0):49 2004  
The Study of the Clinical Application of MARS Treatment in Liver Failure Patients A Yongjun; Li Li; Li Xioayan 6th ISAD; 2004; 0(0):9 2004  
Preoperation risk factor analysis in Orthotopic Liver Trans-plantation with  pretransplant artificial liver support therapy Mao-zu Zhang; Kun Wu; Shai-hongZhu; Min-Min Wang; Li-shi Zhong; Yin-zi Ming; Jin-zhong Yuan; Qi-Fa Ye 6th ISAD; 2004; 0(0):43 2004  
Therapeutic Application of Molecular AdsorbentsRecirculating System in Chronic Severe Hepatitis patientsComplicated with Multi Organ Failure HU Xiao-bing; ZHOU Ying; ZHAO Yan-qin; LIAO Ming-er; HE Min-ru 6th ISAD; 2004; 0(0):21 2004  
Effect of two different extracorporeal liver assist devices onelimination of individual bile acids R. E. Stauber1; M.Trauner; H. Holzer; C. Bankuti; U. Beuers; B. Haditsch; P. Krisper; V. Stadlbauer 6th ISAD; 2004; 0(0):33 2004  
Bound solute dialysis Patzer, J. F., 2nd; Bane, S. E. ASAIO J; 2003; 49(3):271-81 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12790375
MARS treatment  for acute hepatic failure in Hepatitis Bpatients undergoing chemotherapy P. B. Berloco; F.Antonellis; S. Ferretti; G. Mennini; A. Bussotti; F. Nudo; G. Ferretti; M. Rossi; G. Novelli 6th ISAD; 2004; 0(0):31 2004  
Experience with MARS: China results on 149 patients withliver failure based on hepatitis B HuXiao-Bin; Guo Li-Min; Zhou Xin-Min; Chen Shi-Bin; Yang Yi-Jun; Ye Qi-Fa; Wang Min-Min 6th ISAD; 2004; 0(0):35 2004  
Albumin dialysis in complex treatment of multiorgan failuresyndrome (MOFS) in patients after heart surgery O.V. Tomarovsky; R.A.Heptner; R.G.Grigoriantz; G.V.Lobacheva; M.B.Yarustovsky 6th ISAD; 2004; 0(0):41 2004  
Clinical application of MARS artificial liver support therapyin patients of serious liver dysfunction induced by hyperthy-roidism Zhang Lun-Li; Chen Shi-Bin; Shi Yu-Fei; He Jiang-Long;  Zhang Yi; Yang Xiao-Lan;  Zhang Zhi-Hua; Wang Min-Min. 6th ISAD; 2004; 0(0):45 2004  
MARS in acute liver failure P. Lamesch; S. Kreissl; U. Jost; D. Schreiter; L. Scheibner; Ch. Glien; J. Hauss 6th ISAD; 2004; 0(0):25 2004  
Quantification of Extracorporeal Liver Support:  Bilirubin Concentrations, Clearances and Reduction Ratios D Schneditz; H Holzer; R Stauber; B Haditsch; A Jung; P Krisper 6th ISAD; 2004; 0(0):23 2004  
Chronic exposure of frontal cortex network to manganese causes a reduction of electrical activity and an increase in ammonia levels Weiss D.G.; Mitzner S.; St̼we S.; B̦rner K.; Gramowski A.; Loock J. 6th ISAD; 2004; 0(0):27 2004  
The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation Hockerstedt, K.; Ilonen, I.; Repo, H.; Koivusalo, A. M.; Isoniemi, H. Transplant Proc; 2005; 37(2):1088-90 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15848631
Therapeutic Application of Molecular Adsorbents Recircu-lating System in various pathogenic SIRS/MODS patients Wu Min; Guo Li-Min; Luo Hong-Tao 6th ISAD; 2004; 0(0):29 2004  
Assessment of the toxic load of blood in severe liver failure by response of frontal cortex network activity to blood serum filtrates in vitro Dieter Weiss; Steffen Mitzner; Jan Loock; Alexandra Gramowski 6th ISAD; 2004; 0(0):19 2004  
MARS Albumin Dialysis. Mexican Initial Experience R. Mu̱oz; Carlos RodrÌ­guez; Alejandro Valdez; Laura Cisneros 6th ISAD; 2004; 0(0):17 2004  
Molecular Adsorbents Recirculating System: clinical experience in patients with acute and acute on chro-nic liver failure Jun Ji; Jie Teng; Min Yuan; Chen-sheng Fu; Shao-weiXu; Yi-hong Zhong; Yi Fang; Jian-zhou Zou; Xiao-qiang Ding; Li-ming Chen 6th ISAD; 2004; 0(0):15 2004  
Albumin dialysis (MARS system) in patients with acute liverfailure who are potential candidates for liver transplantati-on: a preliminary experience RÌ©mi Thomas; Karim BoudjÌ©ma; Richard Lorho; Yves Le Tulzo; ArnaudGacouin; Sylvain LavouÌ©; Thomas Signouret; Arnaud Person; Christophe Camus 6th ISAD; 2004; 0(0):13 2004  
MARS therapy in acute liver failure S.I Rey; E.I. Pervakova; I.V. Alexandrova 6th ISAD; 2004; 0(0):11 2004  
Therapy of intractable pruritus with MARS Acevedo Rib— M, Moreno Planas JM, Sanz Moreno C, Rubio Gonz‡lez EE, Rubio Gonz‡lez E, Boullosa Gra–a E, Sanchez-Turri—n V, Sanz Guajardo D, Cuervas-Mons V. Transplant Proc; 2005; 37(3):1480-1 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15866646
MARS-Therapy In Patients With Acute Hepatic Failure A.F.Yampolskiy; L.F. Eremeeva 6th ISAD; 2004; 0(0):39 2004  
The Prometheus Device for Extracorporeal Support of Combined Liver and Renal Failure Fliser, D.; Manns, M. P.; Haller, H.; Hafer, C.; Kretschmer, U.; Ernst, T.; Rifai, K. Blood Purif; 2005; 23(4):298-302 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15980619
Development and perspectives of perfusion treatment for liver failure Makuuchi, M.; Kokudo, N.; Sakai, Y.; Nagashima, H.; Naruse, K. Surg Today; 2005; 35(7):507-17 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15976945
In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separation Krisper, P.; Haditsch, B.; Stauber, R.; Jung, A.; Stadlbauer, V.; Trauner, M.; Holzer, H.; Schneditz, D. J Hepatol; 2005; 3(43):451-7 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16023249
The molecular adsorbent recycling system (MARS) and transmembrane transport of albumin-bound toxins Vanrenterghem, Y.; Wilmer, A.; Nevens, F.; Bammens, B.; Evenepoel, P. Liver Transpl; 2005; 11(7):853-854 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15973714
Bacteremia using the molecular adsorbent recirculating system in patients bridged to liver transplantation Marino, I. R.; Doria, C. Exp Clin Transplant; 2005; 3(1):289-92 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15989672
Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation - a pilot study Choi JY, Bae SH, Yoon SK, Cho SH, Yang JM, Han JY, Ahn BM, Chung KW, Sun HS, Kim DG. Liver Int; 2005; 25(4):740-5 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15998424
MELD and PELD: application of survival models to liver allocation. Wiesner RH; McDiarmid SV; Kamath PS; Edwards EB; Malinchoc M; Kremers WK; Krom RA; Kim WR. Liver Transpl 2001 Jul;7(7):567-80 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11460223&dopt=Abstract
Clinical application of bioartificial liver support systems van de Kerkhove, M. P.; Hoekstra, R.; Chamuleau, R. A.; van Gulik, T. M. Ann Surg; 2004; 240(2):216-30 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15273544
Binding of bilirubin and bromosulphthalein to albumin: implications for understanding the pathophysiology of liver failure and its management Steiner, C.; Sen, S.; Stange, J.; Williams, R.; Jalan, R. Liver Transpl; 2004; 10(12):1531-8 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15558653
Meta-analysis in albumin dialysis: are we really ready for it? Stange, J. Liver Transpl; 2004; 10(9):1107-8 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15350000
Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs Sen, S.; Ytrebo, L. M.; Rose, C.; Fuskevaag, O. M.; Davies, N. A.; Nedredal, G. I.; Williams, R.; Revhaug, A.; Jalan, R. Intensive Care Med; 2004; 30(3):496-501 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14735236
Emerging indications for albumin dialysis Sen, S.; Williams, R.; Jalan, R. Am J Gastroenterol; 2005; 100(2):468-75 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15667509
New liver support devices in acute liver failure: a critical evaluation Sen, S.; Williams, R. Semin Liver Dis; 2003; 23(3):283-94 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14523681
Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis Sen, S.; Mookerjee, R. P.; Cheshire, L. M.; Davies, N. A.; Williams, R.; Jalan, R. J Hepatol; 2005; 43(1):142-8 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15878216
The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure Sen S.; Jalan R. Perfusion; 2004; 19(0):S43-8 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15161063
Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study Jalan, R.; Williams, R.; Hodges, S. J.; Cheshire, L. M.; Mookerjee, R. P.; Davies, N. A.; Sen, S. Liver Transpl; 2004; 10(9):1109-19 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15350001
Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy Larsen, F. S.; Strauss, G. I.; Tofteng, F.; Schmidt, L. E. Scand J Gastroenterol; 2004; 39(10):974-80 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15513337
Benign recurrent intrahepatic cholestasis with secondary renal impairment treated with extracorporeal albumin dialysis Hodgson, H.; Standish, R.; Ala, A.; Collins, P.; Saich, R. Eur J Gastroenterol Hepatol; 2005; 17(5):585-8 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15827452
Albumin: biochemical properties and therapeutic potential Kalicinski, P.; Grenda, R.; Prokurat, S.; Drewniak, T.; Pawlowska, J.; Jozwiak, S.; Skarzynska, A.; Kaminski, A.; Pietraszek-Jezierska, E.; Rubik, J.; Evans, T. W.; Martin, G. S.; Quinlan, G. J. Hepatology; 2005; 41(6):1211-9 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15915465
AASLD position paper: the management of acute liver failure Lee, W. M.; Polson, J. Hepatology; 2005; 41(5):1179-97 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15841455
Bioartificial liver in acute liver failure: impostor or simply misunderstood? Rodes, J.; Torras, A.; Mas, A.; Caballeria, L.; Salmeron, J. M.; Cisneros, L.; Pares, A.; O'Grady, J. Hepatology; 2005; 41(2):383-5 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15578652
Liver support Wendon, J. A.; O'Beirne, J. P. Int J Artif Organs; 2005; 28(5):477-81 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15883962
Prediction of survival for patients with fulminant hepatic failure Neuberger, J. Hepatology; 2005; 41(1):19-22 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15690476
MARS--does it stand the test of time? Mullen, K. D.; Dasarathy, S. Metab Brain Dis; 2004; 19(3):223-8 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15554418
Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis Jalan, R.; Williams, R.; Hodges, S. J.; Davies, N. A.; Sen, S.; Mookerjee, R. P. Gut; 2003; 52(8):1182-7 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12865279
Acute liver failure and the Molecular Adsorbents Recirculating System: early experience in a tertiary care hospital in Mexico City Uribe, M.; Zamora-Valdes, D.; Herrera-Gomar, M.; Espinoza, B.; Chavez-Tapia, N. C.; Mendez-Sanchez, N. Ann Hepatol; 2004; 3(4):164-6 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15657560
Artificial liver support molecular adsorbents recirculating system therapy as a bridge to re-transplantation in two cases of long anhepatic duration Wang, M. M.; Shen, Z. Y.; Feng, B. L.; Sun, L. Y.; Yu, L. X.; Wang, Y.; Liu, Y. H. Hepatobiliary Pancreat Dis Int; 2004; 3(2):316-7 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15138135
Artificial and bioartificial support systems for liver failure Gluud, C.; Als-Nielsen, B.; Gluud, L. L.; Liu, J. P. Cochrane Database Syst Rev; 2004; 1:CD003628 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14974025
Effect of artificial liver support system on patients with severe viral hepatitis: a study of four hundred cases Fu, S. Z.; Chen, Y. M.; Xu, X. W.; Huang, J. R.; Yang, Q.; Li, L. J. World J Gastroenterol; 2004; 10(20):2984-8 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15378778
Value of albumin dialysis therapy in severe liver insufficiency Isoniemi, H.; Hockerstedt, K.; Vakkuri, A.; Koivusalo, A. M.; Lahdenpera, A. Transpl Int; 2005; 17(11):717-23 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15580335
Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis Farahat, K. L.; Khuroo, M. S. Liver Transpl; 2004; 10(9):1099-106 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15349999
Molecular adsorbents recirculating system dialysis for liver insufficiency and sepsis following right ventricular assist device after cardiac surgery Hein OV, Marz S, Konertz W, Kox WJ, Spies C Artif Organs; 2004; 28(8):747-50 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15270958
Continuous modalities of renal replacement therapy. Review of selected aspects Grenda, R. Rocz Akad Med Bialymst; 2004; 49:178-81 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15631338
Artificial liver support systems George, J. J Assoc Physicians India; 2004; 52:719-22 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15839451
Hybrid artificial liver support system for treatment of severe liver failure Xu, J.; Yu, H.; Zhao, W. F.; Luo, E. P.; Qin, A. L.; Zhou, X. Q.; Gan, J. H. World J Gastroenterol; 2005; 11(6):890-4 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15682488
Pathophysiology and clinical features of Wilson disease Ferenci, P. Metab Brain Dis; 2004; 19(3):229-39 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15554419
First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock El Banayosy A, Kizner L, Schueler V, Bergmeier S, Cobaugh D, Koerfer R. Asaio J; 2004; 50(4):332-7 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15307543
MELD accurately predicts mortality in patients with alcoholic hepatitis Shah, V.; Kamath, P. S.; Malinchoc, M.; Menon, K. V.; Kim, W. R.; Wiesner, R. H.; Brown, L. S.; Jamil, L. H.; Dunn, W. Hepatology; 2005; 41(2):353-8 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15660383
Molecular adsorbent recycling system in treating patients with acute liver failure: a bridge to liver transplantation Yang, Y. J.; Qiu, Y. D.; Xu, Q. X.; Ding, Y. T. Hepatobiliary Pancreat Dis Int; 2004; 3(4):508-10 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15567734
Syndromic diagnosis and management of confirmed mushroom poisonings Diaz, J. H. Crit Care Med; 2005; 33(2):427-36 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15699849
Approaches to acute liver failure in children Mieli-Vergani, G.; Cheeseman, P.; Dhawan, A. Pediatr Transplant; 2004; 8(6):584-8 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15598330
MARS liver dialysis in children with acute liver failure Da Costa M, Lee MK, Lee HL, Aw M, Lee KH, Phua KB, Prabhakaran K, Quak SH. Ann Acad Med Singapore; 2004; 33(5):S73-4 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15651219
Hepatitis E virus epidemiology in industrialized countries Girones, R.; Bofill-Mas, S.; MartIn, M.; Jardi, R.; Buti, M.; Pina, S.; Clemente-Casares, P. Emerg Infect Dis; 2003; 9(4):448-54 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12702225
Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go? Christensen, E. J Hepatol; 2004; 41(2):344-50 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15288486
MARS treatment for a patient presenting with acquired hepatic glutamine synthetase deficiency after orthotopic liver transplantation Fan, S. T.; Liu, C. L.; Chan, S. C.; Au, W. Y.; Tam, S.; Chiu, A. Liver Transpl; 2005; 11(3):353-5 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15719403
Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin Chawla, L. S.; Georgescu, F.; Abell, B.; Seneff, M. G.; Kimmel, P. L. Am J Kidney Dis; 2005; 45(3):51-6 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15754264
Hepatic tissue engineering for adjunct and temporary liver support: critical technologies Yarmush, M. L.; Toner, M.; Tilles, A. W.; Nath, B. D.; Berthiaume, F.; Chan, C. Liver Transpl; 2004; 10(11):1331-42 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15497161
The coagulopathy of cirrhosis: myth or reality? Reverter, J. C.; Bosch, J. Hepatology; 2005; 41(3):434-5 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15723321
Treatment of hepatic encephalopathy Blei, A. T. Lancet; 2005; 365(9468):1383-4 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15836876
Liver disease in pregnancy Heathcote, J.; Benjaminov, F. S. Am J Gastroenterol; 2004; 99(12):2479-88 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15571598
Treatment of intractable pruritus in drug induced cholestasis with albumin dialysis: a report of two cases Bellmann R, Feistritzer C, Zoller H, Graziadei IW, Schwaighofer H, Propst A, Wiedermann CJ, Joannidis M Asaio J; 2004; 50(4):387-91 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15307554
HELLP syndrome: the state of the art Weinstein, L.; Baxter, J. K. Obstet Gynecol Surv; 2004; 59(12):838-45 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15572962
Molecular adsorbent and re-circulating system Acharya, S. K.; Dutta, A. K.; Batra, Y. Trop Gastroenterol; 2004; 25(2):60-4 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15471317
Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children Auth MK, Kim HS, Beste M, Bonzel KE, Baumann U, Ballauff A, Wallot M, Borchers T, Vester U, Grasemann C, Hauffa B, Hoyer PF, Gerken G, Voit T. J Pediatr Gastroenterol Nutr; 2005; 40(1):54-9 2005 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15625427
Coagulation disorders in liver disease Feig, D. I.; Elenberg, E.; Chang, I. F.; Goldstein, S. L.; Askenazi, D. J.; Balzano, A.; Brancaccio, V.; Guardascione, M. A.; Amitrano, L. Semin Liver Dis; 2002; 22(1):83-96 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11928081
Experience with Molecular Adsorbents Recirculating System (MARS): China results on 149 patients with liver failure based on hepatitis B Xiao-Bin Hu; Li-Min Guo; Xin-Min Zhou; Shi-Bin Chen; Yi-Jun Yang; Qi-Fa Ye; Min-Min Wang ISICEM 2004; 2004; 0(0): 2004  
Therapeutic Application of Molecular Adsorbents Recirculating System in various pathogenic SIRS/MODS patients Min Wu; Li-Min Guo; Hong-Tao Luo ISICEM 2004; 2004; 0(0): 2004  
Treatment of Primary Liver Graft Dysfunction and Septic Liver Failure with Albumin Dialysis D. Inthorn; D. Seidel; K.-S. Boss; S. Bengsch; V. Eder 6th WCTSIS in Munich; 2004; 0(0): 2004  
Prospects for extracorporeal liver support R Williams; S Sen; R Jalan GUT; 2004; 53:890-898 2004 www.gutjnl.com
Equipment review: The molecular adsorbents recirculating Christian Steiner; Stephen Riordan; David Bihari; Jelica Kurtovic; Martin Boyle Critical Care; 2004; 4(8):280-6 2004  
Liver dialysis - an integral part of a modern intensive care medicine?   Intensive Care Medicine; 2003; 11(29):Insert 2003  
Changing clinical patterns in acute liver failure Williams, R. J Hepatol; 2003; 39(4):660-1 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12971984
Preoperative preparation of patients with advanced liver disease Wiklund, R. A. Crit Care Med; 2004; 32(4):S106-15 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15064669
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver Fattinger, K.; Meier, P. J.; Ha, H. R.; Van Montfoort, J.; Vavricka, S. R. Hepatology; 2002; 36(1):164-72 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12085361
Molecular adsorbent recirculating system (Mars) Tan, H. K. Ann Acad Med Singapore; 2004; 33(3):329-35 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15175774
Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients Meier-Hellmann, A.; Reinhart, K.; Sakka, S. G. Chest; 2002; 122(5):1715-20 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12426276
Successful treatment of a child with fulminant liver failure and coma caused by Amanita phalloides intoxication with albumin dialysis without liver transplantation Rubik, J.; Pietraszek-Jezierska, E.; Kaminski, A.; Skarzynska, A.; Jozwiak, S.; Pawlowska, J.; Drewniak, T.; Prokurat, S.; Grenda, R.; Kalicinski, P. Pediatr Transplant; 2004; 8(3):295-300 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15176968
Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial La Greca, G.; Piccinni, P.; Dan, M.; Brendolan, A.; Homel, P.; Bellomo, R.; Ronco, C. Lancet; 2000; 356(9223):26-30 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10892761
Use of the molecular adsorbent recycling system in the treatment of postoperative hepatic failure and septic multiple organ dysfunction--preliminary results Rittler P, Ketscher C, Inthorn D, Jauch KW, Hartl WH. Liver Int; 2004; 24(2):136-41 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15078478
Prometheus--a new extracorporeal system for the treatment of liver failure Fliser, D.; Manns, M. P.; Haller, H.; Hafer, C.; Schneider, A.; Bahr, M. J.; Kretschmer, U.; Ernst, T.; Rifai, K. J Hepatol; 2003; 39(6):984-90 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14642616
Coagulation disorders in patients with cirrhosis and severe sepsis Moreau, R.; Valla, D. C.; Lebrec, D.; Chauvelot-Moachon, L.; Bezeaud, A.; Francque, S.; Durand, F.; Francoz, C.; Pessione, F.; Consigny, Y.; Denninger, M. H.; Plessier, A. Liver Int; 2003; 23(6):440-8 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15002397
Independent risk factors and natural history of renal dysfunction in liver transplant recipients Thuluvath, P. J.; Fine, D. M.; Pawarode, A. Liver Transpl; 2003; 9(7):741-7 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12827563
Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis ParŽs A, Cisneros L, Salmer—n JM, Caballer’a L, Mas A, Torras A, RodŽs J. Am J Gastroenterol; 2004; 99(6):1105-10 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15180733
Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure Oliven, A.; Srugo, I.; Sabo, E.; Odeh, M. Liver Int; 2004; 24(2):110-6 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15078474
Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients Tajimi, K.; Asanuma, Y.; Nakae, H. Ther Apher; 2002; 6(6):419-24 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12460404
Effectiveness of combining plasma exchange and continuous hemodiafiltration (combined modality therapy in a parallel circuit) in the treatment of patients with acute hepatic failure Nakae H; Yonekawa C; Wada H; Asanuma Y; Sato T; Tanaka H Ther Apher 2001 Dec;5(6):471-5 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11800083&dopt=Abstract
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a Burlina, A. B.; Giron, G.; Meroni, M.; Feltracco, P.; Granato, A.; Vilei, M. T.; Neri, D.; Gerunda, G.; Muraca, M. Lancet; 2002; 359(9303):317-8 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11830200
Evaluation of abnormal liver function tests Hyde, G. M.; Limdi, J. K. Postgrad Med J; 2003; 79(932):307-12 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12840117
Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus) Mallek, R.; Vigl, M.; Steininger, R.; Schenk, P.; Bauer, E.; Kramer, L. Wien Klin Wochenschr; 2003; 115(15):599-603 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14531175
Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure Kanematsu, T.; Furui, J.; Kawashita, Y.; Eguchi, S.; Fujioka, H.; Kamohara, Y. Artif Organs; 2000; 24(4):265-70 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10816199
Economic evaluation and 1-year survival analysis of MARS in patients with alcoholic liver disease Wasem, J.; Steiner, S.; Guellstorff, B.; Rief, J.; Mitzner, S. R.; Hessel, F. P. Liver Int; 2003; 23:66-72 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12950964
Hepatic encephalopathy: An update of pathophysiologic mechanisms Butterworth, R. F.; Hazell, A. S. Proc Soc Exp Biol Med; 1999; 222(2):99-112 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10564534
Hepatic dysfunction increases length of stay and risk of death after injury Peitzman, A. B.; Clancy, K. D.; Townsend, R. N.; McMichael, J.; Doyle, H. R.; Zenati, M. S.; Harbrecht, B. G. J Trauma; 2002; 53(3):517-23 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12352490
Liver micro-organs transcribe albumin and clotting factors and increase survival of 92% hepatectomized rats Mitrani, E.; Ilan, Y.; Shouval, D.; Shemesh, R.; Kotok, T.; Lev, H.; Fuchs, A. G.; Grad-Itach, E. J Hepatol; 2003; 39(4):552-8 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12971965
Review article: albumin for circulatory support in patients with cirrhosis Arroyo, V.; De Las Heras, D.; Guevara, M.; Gines, P. Aliment Pharmacol Ther; 2002; 16:24-31 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12423450
Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey Moss, M.; Mannino, D. M.; Foreman, M. G. Chest; 2003; 124(3):1016-20 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12970032
Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system Marino, I. R.; Magnone, M.; Gruttadauria, S.; Scott, V. L.; Caruana, G.; Smith, J. D.; Mandala, L.; Doria, C. Clin Transplant; 2004; 18(4):365-71 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15233811
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure Demetriou, A. A.; Brown, R. S., Jr.; Busuttil, R. W.; Fair, J.; McGuire, B. M.; Rosenthal, P.; Am Esch, J. S., 2nd; Lerut, J.; Nyberg, S. L.; Salizzoni, M.; Fagan, E. A.; de Hemptinne, B.; Broelsch, C. E.; Muraca, M.; Salmeron, J. M.; Rabkin, J. M.; Metse Ann Surg; 2004; 239(5):660-7 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15082970
Bioartificial liver support devices: historical perspectives Maddern, G. J.; Dennison, A. R.; Wemyss-Holden, S. A.; Court, F. G. ANZ J Surg; 2003; 73(9):739-48 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12956791
Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure Catalina, M. V.; Barrio, J.; Anaya, F.; Salcedo, M.; Rincon, D.; Clemente, G.; Banares, R. Liver International; 2003; 0(23):39-43 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12950960
Living donor liver transplantation Rogiers, X.; Sterneck, M.; Broering, D. C. J Hepatol; 2003; 38:S119-35 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12591190
Liver transplantation in adults with acute liver failure Wendon, J.; Bernal, W. J Hepatol; 2004; 40(2):192-7 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14739087
Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis Bellmann R, Graziadei IW, Feistritzer C, Schwaighofer H, Stellaard F, Sturm E, Wiedermann CJ, Joannidis M. Liver Transpl; 2004; 10(1):107-14 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14755786
Management of a severe carbamazepine overdose using albumin-enhanced continuous venovenous hemodialysis Askenazi DJ, Goldstein SL, Chang IF, Elenberg E, Feig DI Pediatrics; 2004; 113(2):406-9 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14754959
Study of plasma exchange for liver failure: beneficial and harmful effects Abe T, Kobata H, Hanba Y, Kitabata Y, Narukawa N, Hasegawa H, Abe T, Fukagawa M. Ther Apher; 2004; 8(3):180-4 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15154867
Extracorporeal albumin dialysis Abe T, Shono M, Kodama T, Kita Y, Fukagawa M, Akizawa T. Ther Apher; 2004; 8(3):217-22 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15154874
Liver replacement therapy: an effective new option Steiner C, Bšhm SH, Reske A. International Journal of Intensive Care, Spring 2004; 11:43-48 2004  
Intensive Care Management of Liver Failure using the Albumin Dialysis MARS Mitzner S; Nšldge-Schomburg G; Schmidt R Jahrbuch Intensivmedizin 2004 2004  
In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD) Sauer, I. M.; Goetz, M.; Steffen, I.; Walter, G.; Kehr, D. C.; Schwartlander, R.; Hwang, Y. J.; Pascher, A.; Gerlach, J. C.; Neuhaus, P. Hepatology; 2004; 39(5):1408-14 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15122770
A 3-year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion Novelli G, Rossi M, Pretagostini R, Novelli L, Poli L, Ferretti G, Iappelli M, Berloco P, Cortesini R. Liver Int; 2003; 23:10-5 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12950955
MARS¨ treatment improves renal function independent of systemic haemodynamics in acute liver failure: A randomized controlled study in a pig model Lars M. Ytreb¿; Sambit Sen; Christopher Rose; Geir I. Nedredal; Nathan A. Davies; Roger Williams; Arthur Revhaug; Rajiv Jalan 5th ISAD; 2003; 0(0):75 2003  
Improvement of Multiple Organ Functions in chronic severe viral hepatitis B with the Molecular Adsorbent Recirculating System and itÕs prognosis assessment by MELD score Yi-Jun Yang; Li-Rong Wang; Nin Zhang; Ping-Huang; Yun-Wei Chen; Gui-Xia Meng; Xiao-Dong Gai; Min-Min Wang 5th ISAD; 2003; 0(0):71 2003  
Artificial liver support MARS therapy as a bridge to re-transplantation in two cases on long anhepatic duration Min-Min Wang; Zhong-Yang Shen; Bao-Lan Feng; Li-Ying Sun; Li-Xin Yu; Yu Wang; Yi-He Liu 5th ISAD; 2003 2003  
Clinical investigation of using Molecular Adsorbent Recirculaing System(MARS¨) in perioperative period with liver transplantation Ye Qifa; Yuan Jinzhong; Ming Yinzhi; Wu Kun; Zhu Saihong; Sha Bo; Huang Zufa 5th ISAD; 2003; 0(0):53 2003  
First experience with the use of MARS therapy in a 4-months old infant after radical correction of FallotÕs tetralogy. Mike B Yarustovsky; Rachik G Grigoriantz; Roman A Heptner; Oleg V Tomarovsky; Marina.V.Abramian; Andrew.V.Kharkin 5th ISAD; 2003; 0(0):73 2003  
Clinical experience with Molecular Adsorbent Recirculating System(MARS¨) in fourteen patients with drug induced liver failure Xin-Min Zhou; Ji-Yan Miao; Yan Yang; Ling Zhao; Xin Wang; Li Xu; Jie Ding; Kai-CHun Wu; Dai-Ming Fan; Min-Min Wang 5th ISAD; 2003; 0(0):77 2003  
Successful clinical application of MARS¨ in maternal Amanita poisoning during the second pregnancy trimester: a case report Bang-Fu Wu; Min-Min Wang 5th ISAD; 2003; 0(0):69 2003  
Catholic university experience with mars depurative system in patients with severe liver failure A Gasbarrini; G Gasbarrini; R Proietti; F Gargano; M C Santoro; R Gaspari; L Zileri Dal Verme 5th ISAD; 2003; 0(0):79 2003  
Chronic ammonia exposure decreases neuronal network activity in primary frontal cortex cultures Dieter Weiss; Jan Loock; Alexandra Gramowski; Katrin Bšrner; Simone StŸwe 5th ISAD; 2003; 0(0):67 2003  
Albumin dialysis reduces brain water and intracranial pressure in acute liver failure: A randomised controlled study in a pig model Sambit Sen; Christopher Rose; Lars M.Ytrebo; Nathan A.Davies; Geir I.Nedredal; Synnove S. Drevland; Marianne Kj¿nn¿; Roger Williams; Roger Butterworth; Arthur Revhaug; Rajiv Jalan 5th ISAD; 2003; 0(0):65 2003  
Pathophysiological basis of extracorporeal albumin dialysis with MARS¨ in acute-on-chronic liver failure due to alcohol Sambit Sen; Nathan A. Davies; Rajeshwar P. Mookerjee; Lisa M. Cheshire; Stephen J. Hodges; Roger Williams; Rajiv Jalan 5th ISAD; 2003; 0(0):63 2003  
Detoxifying Capacity of MARS¨: membrane transport and adsorption columms are effective over entire intermittent treatment period Tilo Schneider; Sebastian Klammt; Steffen Mitzner 5th ISAD; 2003; 0(0):61 2003  
Improvement in cerebral lactate, glutamate and energy metabolism with albumin dialysis in a large animal model of  acute liver failure: a microdialysis study. Christopher Rose; Sambit Sen; Lars M Ytrebo; Nathan A Davies; Geir I Nedredal; Roger Williams; Roger Butterworth; Arthur Revhaug; Rajiv Jalan 5th ISAD; 2003; 0(0):59 2003  
Markers of lymphocyte activation in patients with liver failure and albumin-dialysis (MARS¨) Thomas Rath; Bernhard Thiele; Franz Werner Albert 5th ISAD; 2003; 0(0):57 2003  
MARS¨-therapy: Legal and Practical Strategies for Patients Elke Rampfl-Platte 5th ISAD; 2003; 0(0):55 2003  
Extracorporeal therapy in transplant patients: Molecular Adsorbent Reciculating System (MARS¨) procedure in acute liver failure requiring urgent transplantation S.Prokurat; J.Rubik; P.Kalicinski; R.Grenda; A. Kaminski; M. Markiewicz; J. Socha 5th ISAD; 2003; 0(0):51 2003  
MARS¨ may decrease intracranial pressure in patients with severe hepatic encephalopathy when other therapies have failed. Werner Pothmann; Axel Nierhaus; Kamayni Agarwal; Dieter C Bršring; Jochen Schulte am Esch 5th ISAD; 2003; 0(0):49 2003  
MARS¨ in Cirrhosis with Superimposed Acute Liver Decompensation and Renal Failure as Bridge to Liver Transplantation. Report of the First Application on Acute-on-Chronic Liver Failure in Latin-AmŽrica. Rosa Mar’a PŽrez; Patricio Downey; Patricio Iba–ez; Helmut Goecke; Aquiles Jara; Mireya Ortiz; Elisa Espinoza; Edelmira Castro; Jorge Mart’nez; Robinson Gonzalez; Marco Arrese. 5th ISAD; 2003; 0(0):47 2003  
Albumin dialysis decreases aromatic amino acids and improves hepatic encephalopathy in patients with severe liver dysfunction. Albert ParŽs; Ram—n Deulofeu; Laura Cisneros; Angels Escorsell; Joan Manuel Salmer—n; Joan Caballer’a; Antoni Mas and Juan RodŽs 5th ISAD; 2003; 0(0):43 2003  
Utility of albumin dialysis in the treatment of cholestatic pruritus. Albert ParŽs 5th ISAD; 2003; 0(0):45 2003  
Extracorporeal liver support with MARS¨ in severe alcoholic hepatitis. Albert ParŽs 5th ISAD; 2003; 0(0):41 2003  
Classification of hepatic encephalopathy grades by responses of in vitro frontal cortex network activity to blood serum filtrates Jan Loock; Alexandra Gramowski; Katrin Bšrner; Steffen Mitzner; Dieter Weiss 5th ISAD; 2003; 0(0):37 2003  
Application of Molecular Adsorbents Recirculating System in patients with severe chronic viral hepatitis B in middle and end stages La-Yang Liu; Hong Deng; Xiao-Juan Sun; Jie Zhao; Xiao-Yan Li; Min-Min Wang 5th ISAD; 2003; 0(0):33 2003  
Non-invasive monitoring of indocyanine green plasma disappearance rate in the treatment of primary graft dysfunction by MARS¨ Kortgen A; Pistorius G; Fischinger J; Kuhlmann M; Becker C; Bauer M 5th ISAD; 2003; 0(0):31 2003  
Albumin dialysis as a therapeutic option in drug overdose and intoxication B. Drewelow; S. Mitzner; P. Peszynski; J. Majcher-Peszynska; S .Klammt 5th ISAD; 2003; 0(0):29 2003  
Perioperative application of artificial liver support system in orthotopic liver transplantation HUANG Jianrong; LI Lanjuan; CHEN Yuemei 5th ISAD; 2003; 0(0):27 2003  
MARS¨ treatment in acute liver failure Krister Hšckerstedt; Anna-Maria Koivusalo; Anne Vakkuri; Leena Lindgren; Marika Blomster and Helena Isoniemi 5th ISAD; 2003; 0(0):25 2003  
Serum Markers for Hepatocyte Regeneration and Apoptosis in Patients with Liver Failure undergoing Extracorporal Albumin Dialysis H Hetz; P Faybik; J Ankersmith; C Krenn 5th ISAD; 2003; 0(0):23 2003  
Economic evaluation and one year survival analysis of MARS¨ in patients with alcoholic liver disease Franz P. Hessel; Steffen R. Mitzner; Jana Rief; JŸrgen Wasem 5th ISAD; 2003; 0(0):21 2003  
Management of the hypophosphataemia and hypokalemia due to extracorporeal liver support with MARS¨ Montero Garc’a A*; Erdozain Sosa JC; Pajares Villarroya R; Mance–ido Marcos N; Castillo Grau P; Olveira Martin A; Olea Tejero T*; Gonz‡lez Sanz-Agero P; Segura Cabral JM 5th ISAD; 2003; 0(0):39 2003  
MARS¨ in primary graft dysfunction after liver transplantation (LTx) V Eder; S Bengsch; K-S Boos; D Seidel; D Inthorn 5th ISAD; 2003; 0(0):19 2003  
Molecular Adsorbents Recirculating Systems (MARS¨): A model for removing midazolam, fentanyl and possibly other protein-bound drugs Nathan A Davies; Sambit Sen; Christopher Rose; Lars M Ytrebo; Ole M Fuskevaag; Geir I Nedredal; Arthur Revhaug; Roger Williams; Rajiv Jalan 5th ISAD; 2003; 0(0):17 2003  
MARS¨ therapy improves grade IV hepatic encephalophaty in acute liver failure prior to liver transplantation. The first case experience in Chile. Jorge Contreras; Jaime Poniachik; Danny Oksenberg; Jose M Valera; Alejandro Cotera; Alejandro Pacheco; Erico Segovia; Maria E. Sanhueza; Jorge Rojas; Carla Mancilla; Julia Guerrero; Christian Toledo; Sandra Mena; Juan Carlos Diaz. 5th ISAD; 2003; 0(0):15 2003  
Need for dosage adjustment of immunosuppressive drugs during MARS¨. R. Ba–ares.; G. Clemente; M. Salcedo; D. Rincon; O. Nu–ez; G. de la Cruz; C. Ripoll; MV. Catalina 5th ISAD; 2003; 0(0):13 2003  
Chronic manganese exposure decreases neuronal network activity in primary frontal cortex cultures Katrin Bšrner1; Alexandra Gramowski; Jan Loock; Steffen Mitzner; Dieter Weiss 5th ISAD; 2003; 0(0):11 2003  
Hepatocyte growth factor (hgf) and hcv viral load variations along hemodialysis session. A comparison with MARS¨ therapy G Barril; J BartolomŽ*; MP Ruiz; P Sanz; JA Traver; R Selgas; V Carre–o* 5th ISAD; 2003; 0(0):9 2003  
The effect of extracorporeal albumin dialysis on plasma phospholipid fatty acids in patients with end-stage liver disease. Zeh N; Rossi SS; Hofmann AF; Steinbach JH; Hagey LR; Oliver D; Stange J; Hassanein T. Liver International; 2003; 0(23):34-38 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12950959
MARS therapy in critically ill patients with advanced malignancy: a clinical and technical report. Tan HK, Lim JS, Tan CK, Ng HS, Chow P, Lui HF, Wong GC, Tan PH, Raghuram J, Ng HN, Choong LH, Wong KS, Woo KT. Liver international; 2003; 0(23):52-60 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12950962
Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs Sen S, Ytreb¿ LM, Rose C, Fuskevaag OM, Davies NA, Nedredal GI, Williams R, Revhaug A, Jalan R. Intensive Care Med; 2004; 0(30):496-501 2004 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14735236
Pathophysiology and therapy of pruritus in cholestatic liver diseases [Article in German] Schmidt H.; Schachschal G Z Gastroenterol; 2003; 0(41):627 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12806549
Extracorporeal liver support based on primary human liver cells and albumin dialysis--treatment of a patient with primary graft non-function. Gerlach JC.; Neuhaus P; Goetz M; Pascher A; Theruvath T; Kardassis D; Pless G; Zeilinger K; Sauer IM Journal of Hepatology; 2003; 0(39):649-653 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12971979
Cirrhosis and bleeding: the need for very early management. Beauchant M.; Silvain C; Paupard T; Bianchi A; Martin T; Pilette C; Masliah C; Berthelemy P; Ragot S; Nidegger D Journal of Hepatology; 2003; 0(39):509-514 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12971959
Case report of the first Severe Acute Respiratory Syndrome patient in China: successful application of extracorporeal liver support MARS therapy in multiorgan failure possibly induced by Severe Acute Respiratory Syndrome. Wang MM.; Wu M; Luo HT Artif Organs. 2003 Sep;27(9):847-9. 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12940908
Experience with albumin dialysis in five patients with severe overdoses of paracetamol. Koivusalo AM, Yildirim Y, Vakkuri A, Lindgren L, Hšckerstedt K, Isoniemi H. Acta Anaesthesiol Scand; 2003;47(9):1145-1150 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12969110
Hypoglycemia in nondiabetic patients undergoing albumin dialysis by molecular adsorbent recirculating system. Lee KH.; Lim GK; Tham LS; Khoo AL Liver Transplantation; 2003; 0(9):949-953 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12942456
MARS treatment in posthepatectomy liver failure. van de Kerkhove MP, de Jong KP, Rijken AM, de Pont AC, van Gulik TM. Liver International; 2003; 0(23):44-51 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12950961
Liver support in acute liver failure. Hughes RD. Wien Klin Wochenschr; 2003; 15(115):547-548 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14531165
Albumin dialysis in cirrhosis with superimposed acute liver injury: possible impact of albumin dialysis on hospitalization costs. Steiner C.; Stange J; Oliver D; Hassanein T Liver International; 2003; 0(23):61-65 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12950963
Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome Wang MM.; He ZP; Yao Y; Zhang JP; Liu XD; Zhang HY; Sun FX; Guo X; Lu LH; Zhang WY; Wang LH; Han H; Li BS; Xu DZ; Liu JY; Guo LM Liver International; 2003; 0(23):16-20 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12950956
Liver support in fulminant liver failure after hemorrhagic shock Steltzer H.; Steininger R; Berlakovich G; Germann P; Baker A; Krenn CG; Hetz H; Faybik P Wien Klien Wochenschr; 2003; 15(115):595-598 2003  
Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning Faybik P, Hetz H, Baker A, Bittermann C, Berlakovich G, Werba A, Krenn CG, Steltzer H Liver International; 2003; 0(23):28-33 2003 http://www.ncbi.nlm.nih.gov/pubmed/12950958?ordinalpos=11&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Use of molecular adsorbent recirculating system for treatment of refractory pruritus De Simone P, Van Nuffelen M, Donckier V. Liver Transplantation; 2003; 9(9):997-1002 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12942466
Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Volovat C, Dimitriu AG, Cristogel F, Bizo A. Liver international; 2003; 0(23):21-27 2003 http://www.ncbi.nlm.nih.gov/pubmed/12950957?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Bioartificial liver support devices: historical perspectives. Court FG; Wemyss-Holden SA; Dennison AR; Maddern GJ. ANZ J Surg; 73(9):739-48 2003  
Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices Butterworth RF. Liver International; 2003; 0(23):S5-S9 2003  
Intensive care support therapy Bernal W. Liver International; 2003; 0(9):S15-S17 2003  
Extracorporeal liver support: waiting for the deciding vote Adham M. ASAIO Journal; 2003; 0(49):621-632 2003  
A Vasopressin Receptor Antagonist (VPA-985) Improves Serum Sodium Concentration in Patients With Hyponatremia: A Multicenter, Randomized, Placebo-Controlled Trial Paul J. Thuluvath; Laurence M. Blendis; Andres T. Blei; Florence Wong HEPATOLOGY, Vol. 37, No. 1, 2003 2003  
Vascular Mediators in the Injured Liver Don C. Rockey HEPATOLOGY, Vol. 37, No. 1, 2003 2003  
Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past - issues for the future ReneŽ EugŽnie Poupon Journal of Hepatology 2000; 32: 685–688 2000  
Primary biliary cirrhosis Keith D Lindor; Jayant A Talwalkar Lancet 2003; 362: 53–61 2003  
Predictive Models of Short- and Long-Term Survival in Patients With Nonbiliary Cirrhosis Myriam Delhaye; Philippe Thiry; Pierre Vereerstraeten; Ge«rald Longheval Liver Transplantation, Vol 9, No 3 (March), 2003: pp 260-267 2003  
Subclinical Hepatic Encephalopathy Impairs Daily Functioning IENEKE J. C. HARTMANN; ILONE DE BRUIJN; 1 JUAN C. QUERO; MICHAEL GROENEWEG HEPATOLOGY 1998;28:45-49 1998  
The molecular pathogenesis of hepatic encephalopathy Nathan Davies; Debbie Shawcross; Rajiv Jalan The International Journal of Biochemistry & Cell Biology 35 (2003) 1175–1181 2003 www.elsevier.com/locate/ijbcb
Is the Change in MELD Score a Better Indicator of Mortality Than Baseline MELD Score? Patrick S. Kamath and W. Ray Kim Liver Transplantation, Vol 9, No 1 ( January), 2003: pp 19-21 2003  
Current management of portal hypertension Jaime Bosch; Juan G. Abraldes; Roberto Groszmann Journal of Hepatology 38 (2003) S54–S68 2003 www.elsevier.com/locate/jhep
Clinical Profile of Autosomal Dominant Polycystic Liver Disease Patrick S. Kamath; Bernard F. King; Airong Li; Qi Qian HEPATOLOGY 2003;37:164-171 2003  
Current management of primary biliary cirrhosis and primary sclerosing cholangitis Keith D. Lindor; Cynthia Levy Journal of Hepatology 38 (2003) S24–S37 2003 www.elsevier.com/locate/jhep
NAFLD May Be a Common Underlying Liver Disease in Patients With Hepatocellular Carcinoma in the United States Anna S. Lok; Dawn M. Emick; Hari S. Conjeevaram; Grace L. Su; Robert J. Fontana; Jorge A. Marrero HEPATOLOGY 2002;36:1349-1354 2003  
Review article: pruritus in cholestatic and other liver diseases A. MANCUSO & A. K. BURROUGHS; M. MELA Aliment Pharmacol Ther 2003; 17: 857–870. 2003  
Recent Advances in Liver Transplantation MD;; MD; MICHAEL B. ISHITANI; MD; JORGE RAKELA; RUSSELL H. WIESNER Mayo Clin Proc. 2003;78:197-210 2003 www.mayo.edu
Extrahepatic Manifestations of Hepatitis C Among United States Male Veterans Linda Rabeneck; Christine Yeh; 1-3 Howard Hampel; Hashem B. El-Serag HEPATOLOGY 2002;36:1439-1445 2002  
Optimal Timing of Liver Transplantation for Primary Biliary Cirrhosis ; 1 TERRY M. THERNEAU; 1 RUSSELL H. WIESNER; W. RAY KIM HEPATOLOGY 1998;28:33-38 1998  
Increased Lipopolysaccharide Binding Protein in Cirrhotic Patients With Marked Immune and Hemodynamic Derangement Jose-Luis Moya; M« onica Gonz«alez; Antonio de la Hera; Agustý«n Albillos HEPATOLOGY, Vol. 37, No. 1, 2003 2003  
Liver fibrosis ? from bench to bedside Scott L. Friedman Journal of Hepatology 38 (2003) S38–S53 2003 www.elsevier.com/locate/jhep
Living donor liver transplantation Xavier Rogiers; Martina Sterneck; Dieter C. Broering Journal of Hepatology 38 (2003) S119–S135 2003 www.elsevier.com/locate/jhep
Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis Rajiv Jalan; Sambit Sen; Christian Steiner; Dharmesh Kapoor; Akeel Alisa; Roger Williams Journal of Hepatology 38 (2003) 24–31 2003 http://www.ncbi.nlm.nih.gov/pubmed/12480556
Extracorporeal liver support with MARS in liver failure: has it a role in the treatment of severe alcoholic hepatitis? Didier Samuel; Philippe Ichai Journal of Hepatology 38 (2003) 104–106 2003 www.elsevier.com/locate/jhep
Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model D.W.Y. Ho Gut 2002;50;869-876 2002  
Hepatitis E Virus Epidemiology in Industrialized Countries Pilar Clemente-Casares Emerging Infectious Diseases ¥ Vol. 9, No. 4, April 2003 2003 www.cdc.gov/eid
Management of hepatitis C Luisa Benvegnu`; Alfredo Alberti Journal of Hepatology 38 (2003) S104–S118 2003 www.elsevier.com/locate/jhep
Management of chronic hepatitis B Hari S. Conjeevaram; Anna Suk-Fong Lok Journal of Hepatology 38 (2003) S90–S103 2003 www.elsevier.com/locate/jhep
Markers of disease activity in chronic hepatitis B virus infection Kendal Yalcin Clin Invest Med 2003;26(1):27-34 2003  
Hereditary hemochromatosis: update for 2003 Bruce R. Bacon; Stephen A. Harrison Journal of Hepatology 38 (2003) S14–S23 2003 www.elsevier.com/locate/jhep
Hepatocellular carcinoma: present status and future prospects Michel Beaugrand; Josep M. Llovet Journal of Hepatology 38 (2003) S136–S149 2003 www.elsevier.com/locate/jhep
Prospective Evaluation of Outcomes and Predictors of Mortality in Patients With Hepatopulmonary Syndrome Undergoing Liver Transplantation Michael B. Fallon; Michael J. Krowka; Gary A. Abrams; Miguel R. Arguedas HEPATOLOGY 2003;37:192-197 2003  
Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial H J de Silva; J K Aronson; D G Lalloo; C D Ranasinha; S B Gunatilake; G A Ratnatilake; D G S Alahakone; A Pathmeswaran; M M D Fonseka; H A de Silva Lancet 2003; 361: 1935–38 2003 www.thelancet.com
Liver failure: basis of benefit of therapy with the molecular adsorbents recirculating system Sen S; Jalan R; Williams R. Int J Biochem Cell Biol. 2003 Sep;35(9):1306-11. 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12798344&dopt=Abstract
A comparison of Child-Pugh, APACHE II and APACHE III scoring systems inA comparison of Child-Pugh, APACHE II and APACHE III scoring systems inpredicting hospital mortality of patients with liver cirrhosis Constantinos Chatzicostas BioMed Central, 2003 2003 http://www.biomedcentral.com/1471-230X/3/7
Cerebral Microdialysis in Patients With Fulminant Hepatic Failure Fin Stolze Larsen; Jens Kondrup; Peter Ott; Bent Adel Hansen; Linda Jorgensen; Flemming Tofteng HEPATOLOGY 2002;36:1333-1340 2002  
Ascites and hepatorenal syndrome in cirrhosis Jordi Colmenero; Vicente Arroyo Journal of Hepatology 38 (2003) S69–S89 2003 www.elsevier.com/locate/jhep
The Acute Liver Failure Study Group     2003 www3.utsouthwestern.edu/liver
The management of alcoholic liver disease Stephen F. Stewart; Christopher P. Day Journal of Hepatology 38 (2003) S2–S13 2003 www.elsevier.com/locate/jhep
Reversal of severe cholestasis caused by chronic graft-versus-host disease with the MARS liver-support device. Sen S; Jalan R; Morris EC; Steiner C; Mackinnon S; Williams R. Transplantation. 2003 May 27;75(10):1766-7. 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12777879&dopt=Abstract
Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial. Schmidt LE; Wang LP; Hansen BA; Larsen FS. Liver Transpl. 2003 Mar;9(3):290-7. 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12619027&dopt=Abstract
Successful use of the Molecular Adsorbent Recirculating System (MARS) in a patient with primary biliary cirrhosis (PBC) and treatment refractory pruritus. Mullhaupt B; Kullak-Ublick GA; Ambuhl PM; Stocker R; Renner EL. Hepatol Res. 2003 Apr;25(4):442-446. 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12699855&dopt=Abstract
Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Sen S; Ratnaraj N; Davies NA; Mookerjee RP; Cooper CE; Patsalos PN; Williams R; Jalan R. Epilepsia. 2003 Feb;44(2):265-7. 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12558586&dopt=Abstract
Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis. Macia M; Aviles J; Navarro J; Morales S; Garcia J. Am J Med. 2003 Jan;114(1):62-4. 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12543292&dopt=Abstract
Liver support - a task for nephrologists? Extracorporeal treatment of a patient with fulminant Wilson crisis. Manz T; Ochs A; Bisse E; Strey C; Grotz W. Blood Purif. 2003;21(3):232-6. 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12784049&dopt=Abstract
Detoxifying capacity and kinetics of the molecular adsorbent recycling system. Contribution of the different inbuilt filters. Evenepoel P; Maes B; Wilmer A; Nevens F; Fevery J; Kuypers D; Bammens B; Vanrenterghem Y. Blood Purif. 2003;21(3):244-52. 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12784051&dopt=Abstrac
Recent developments in the treatment of alcoholic hepatitis. Madhotra R; Gilmore IT. QJM. 2003 Jun;96(6):391-400. 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12788957&dopt=Abstract
Treatment with the molecular adsorbent recirculating system in patients with acute liver failure. Felldin M; Friman S; Backman L; Siewert-Delle A; Henriksson BA; Larsson B; Olausson M. Transplant Proc. 2003 Mar;35(2):822-3. 2003 http://www.ncbi.nlm.nih.gov/pubmed/12644154
Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus Doria C; Mandala L; Smith J; Vitale CH; Lauro A; Gruttadauria S; Marino IR; Foglieni CS; Magnone M; Scott VL. Liver Transpl. 2003 Apr;9(4):437-43 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12682899&dopt=Abstract
Extracorporeal Support for Patients with Hepatic Failure Andrew Davenport Hemodial Int. 2003; 7(3):256–263. 2003  
Successful MARS treatment in severe cholestatic patients with acute on chronic liver failure Campli CD; Gaspari R; Mignani V; Stifano G; Santoliquido A; Verme LZ; Proietti R; Pola P; Silveri NG; Gasbarrini G; Gasbarrini A. Artif Organs. 2003 Jun;27(6):565-9 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12780511&dopt=Abstract
Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Moreau R; Lebrec D Hepatology. 2003 Feb;37(2):233-43 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12540770&dopt=Abstract
Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure. Sadahiro T; Hirasawa H; Oda S; Shiga H; Nakanishi K; Kitamura N; Hirano T. Crit Care Med 2001 Jul;29(7):1386-92 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11445692&dopt=Abstract
Long-term survivors with artificial liver support in fulminant hepatic failure. Nitta M; Hirasawa H; Oda S; Shiga H; Nakanishi K; Matsuda K; Nakamura M; Yokohari K; Hirano T; Hirayama Y; Moriguchi T; Watanabe E. Ther Apher 2002 Jun;6(3):208-12 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12109945&dopt=Abstract
Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. Sheth M; Riggs M; Patel T. BMC Gastroenterol 2002;2(1):2 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11835693&dopt=Abstract
Current topics on cytokine removal technologies. Matsuda K; Hirasawa H; Oda S; Shiga H; Nakanishi K. Ther Apher 2001 Aug;5(4):306-14 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11724517&dopt=Abstract
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Arroyo V; Gines P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Scholmerich J. Hepatology 1996 Jan;23(1):164-76 1996 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8550036&dopt=Abstract
Clinical investigation of a single treatment using Molecular Adsorbents Recirculation System (MARS) in patients with acute-on-chronic liver failure Zhou X; Wang X; Yang Y; Zhao L; Miao J; Ding J; Fan. 4th ISAD 2002 - abstract 2002  
Effect of extracorporeal albumin dialysis (ECAD) using the MARS device on plasma phospholipid fatty acids and bile acid Zeh N; Rossi SS; Hagey LR; Hofmann AF; Steinbach JH; Oliver D; Hassanein T. 4th ISAD 2002 - abstract 2002  
The first cases of MARS therapy in Russia Tretyakov BV 4th ISAD 2002 - abstract 2002  
International MARS Registry: Analysis of 287 patients from 51 submitting centres Steiner C 4th ISAD 2002 - abstract 2002  
Pathophysiological basis of clinical changes in acute-on-chronic liver failure following treatment with MARS: A randomized evaluation Sen S; Davies NA; Mookerjee RP; Cheshire L; Williams R; Jalan R. 4th ISAD 2002 - abstract 2002  
Treatment of phenytoin toxicity by the Molecular Adsorbents Recirculating System (MARS) Sen S; Ratnaraj N; Davies NA; Mookerjee RP; Patsalos PN; Williams R; Jalan R. 4th ISAD 2002 - abstract 2002  
Systemic hemodynamic effects of treatment with the Molecular Adsorbents Recirculating System versus mild hypothermia in patients with hyperacute liver failure: Results of a prospective, controlled trial Schmidt LE; Wang LP; Hansen BA; LarsenFS. 4th ISAD 2002 - abstract 2002  
Successful application of MARS therapy in a 7 year-old patient with hepatic chronic rejection and severe cholestatic syndrome Rusu E; Ioanitescu S; Micu D; Mihaila M; Micu L; Voiculescu M. 4th ISAD 2002 - abstract 2002  
Clearance of immunosuppressive drugs FK and MMF by MARS treatment. Polo B; Sanchis R; Donat E; Ribes-Koninckx C. 4th ISAD 2002 - abstract 2002  
The effect of MARS treatment on cytokine levels: Preliminary results in pediatric patients. Polo B; Sanchis R; Donat E; Ribes-Koninckx C. 4th ISAD 2002 - abstract 2002  
Effects of the Molecular Adsorbents Recirculating System (MARS) on vasoactive agents and systemic hemodynamics in patients with severe alcoholic hepatitis. ParŽs A; Escorsell A; Cisneros L; Salmeron JM; Mas A; Jimenez W; Torras A; Caballer’a J; Rodes J. 4th ISAD 2002 - abstract 2002  
MARS: 3 years experience Novelli G; Rossi M; Poli L; Pretagostini R; Ferretti G; Berloco P; Novelli L; Iappelli M; Nudo F; Cortesini R 4th ISAD 2002 - abstract 2002  
Elimination of fluoroquinolones during extracorporeal albumin dialysis (MARS) Majcher-Peszynska J; Schneider T; MŸller S; Peszynski P; Mundkowski R; Berg A; Klammt S; Drewelow B. 4th ISAD 2002 - abstract 2002  
The preliminary clinical results of treatment of chronic liver failure combined with MARS and conventional internal therapy Li Y; Yang H; Gao J; Li M; Jiang H; Liu Z; Zhao L. 4th ISAD 2002 - abstract 2002  
Pharmacokinetics of Amikacin in patients undergoing liver dialysis by Molecular Adsorbents Recirculating System (MARS) Khoo AL; Tham LS; Lee KH; Lim GK. 4th ISAD 2002 - abstract 2002  
Current indications for the albumin dialysis: Intractable pruritus Joannidis M; Bellmann R; Graziadei I; Vogel W; Wiedermann CJ. 4th ISAD 2002 - abstract 2002  
Current indications for albumin dialysis: Acute hepatic failure Isoniemi H. 4th ISAD 2002 - abstract 2002  
Improvement of multiple organ functions in chronic severe hepatitis with the Molecular Adsorbents Recirculating System and its prognosis assessment by MELD score Hu X; Yang Z; Tang X; Wang M; Zhou Y; Li S. 4th ISAD 2002 - abstract 2002  
Liver monitoring by indocyanine green kinetics during albumin dialysis in liver failure Hetz H; Faybik P; Baker A; Kopp A; Berlakovich G; Krenn CG; Steltzer H. 4th ISAD 2002 - abstract 2002  
Use of Molecular Adsorbents Recirculating System (MARS) in patients with end stage liver disease and progressive hyperbilirubinemia as a bridge to liver transplantation Hassanein T; Selim K; Oliver D; Hall K; Wahlstrom E; Hart M; Mehta R. 4th ISAD 2002 - abstract 2002  
Effect of blood plasma ultrafiltrates and extracts from patients in hepatic encephalopathy on neuronal network activity in vitro Gramowski A; Loock J; Bšrner K; Mitzner S; Weiss DG. 4th ISAD 2002 - abstract 2002  
Liver support in liver failure after hemorrhagic shock Faybik P; Hetz H; ; Krenn CG; Berlakovich G; Baker A; Steltzer H 4th ISAD 2002 - abstract 2002  
Effect of MARS on haemostasis in patients with liver failure. Faybik P; Hetz H; Baker A; Krenn CG; Berlakovich G; Unger S; Varady S; Steltzer H 4th ISAD 2002 - abstract 2002  
Molecular adsorbent recirculating system (MARS) used in course of untreatable pruritus in patients with liver cirrhosis liver monitoring by indocyanine green kinetics during albumin dialysis in liver failure Doria C; Arcadipane A; Marino IR; Mandala L.Carlo Scotti-Foglieni2; Victor L Scott 4th ISAD 2002 - abstract 2002  
Use of MARS in the treatment of liver failure patients with hepatic encephalopathy Chen S; Shi Y; Zhang L; Yang X; Wang Z; Wang M. 4th ISAD 2002 - abstract 2002  
Hepatic and systemic hemodynamics changes after MARS in patients with acute on chronic liver failure Catalina MV; Ba–ares R; Anaya F; Barrio J. 4th ISAD 2002 - abstract 2002  
MARS for the treatment of primary dysfunction post liver transplantation Berlakovich GA; Hetz H; Faybik P; Baker A; Steininger R; Steltzer H; Muehlbacher F. 4th ISAD 2002 - abstract 2002  
Evaluation of MARS technique on patients suffering from hypoxic liver failure following cardiogenic shock El-Banayosy; L. Kizner; M. Noto; D. Cobaugh; V. Schueler; S. Bergmeier; R. Koerfer. 4th ISAD 2002 - abstract 2002  
High levels of Transforming Growth Factor Beta (TGF-beta) in acute liver failure inhibit hepatic regeneration and recovery -The Role of MARS Therapy. Awad SS 4th ISAD 2002 - abstract 2002  
Artificial and Bioartificial Support Systems for Acute and Acute-on-Chronic Liver Failure:  A Systematic Review. Kjaergard LL; Liu J; Als-Nielsen B; Gluud C. JAMA 2003 Jan 8;289(2):217-22. 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12517233&dopt=Abstract
Extracorporeal liver support with MARS in liver failure: has it a role in the treatment of severe alcoholic hepatitis? Ichai P; Samuel D. J Hepatol 2003 Jan;38(1):104-106. 2003 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12480567&dopt=Abstract
Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS: A Review of clinical, biochemical, and electrophysiological data. Mitzner S; Loock J; Peszynski P; Klammt S; Majcher-Peszynska J; Gramowski A; Stange J; Schmidt R. Metabol Brain Dis 2002;17(4):463-75. 2002 http://www.ncbi.nlm.nih.gov/pubmed/12602522
Molecular adsorbent recirculating system: Albumin dialysis-based extracorporeal liver assist device. Kapoor D. J Gastroenterol Hepatol 2002 Dec;17 Suppl 3:S280-S286. 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12472950&dopt=Abstract
Characterization of treatment dose delivered by albumin dialysis in the treatment of acute renal failure associated with severe hepatic dysfunction. McIntyre CW; Fluck RJ; Freeman JG; Lambie SH. Clin Nephrol 2002 Nov;58(5):376-83. 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12425489&dopt=Abstract
Review article: the Molecular Adsorbents Recirculating System (MARS) in liver failure. Sen S; Mookerjee RP; Davies NA; Williams R; Jalan R. Aliment Pharmacol Ther 2002 Dec;16 Suppl 5:32-8. 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12423451&dopt=Abstract
Review article: albumin in the treatment of liver diseases-new features of a classical treatment. Arroyo V. Aliment Pharmacol Ther 2002 Dec;16 Suppl 5:1-5. 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12423447&dopt=Abstract
Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Heemann U; Treichel U; Loock J; Philipp T; Gerken G; Malago M; Klammt S; Loehr M; Liebe S; Mitzner S; Schmidt R; Stange J. Hepatology 2002;36:949-58. 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12297843
Extracorporeal albumin dialysis in acute-on-chronic liver failure: Will it stand the test of time? Sen S; Jalan R; Williams R. Hepatology 2002;36:1014-17. 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12297853
Is there life in MARS ? - Editorial Kamath PS. Hepatology 2002;36:1017-19. 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12297854&dopt=Abstract
Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson Sen S; Felldin M; Steiner C; Larsson B; Gillett GT; Olausson M; Williams R; Jalan R. Liver Transpl 2002 Oct;8(10):962-7 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12360442&dopt=Abstract
Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child. Hommann M; Kasakow LB; Geoghegan J; Kornberg A; Schotte U; Fuchs D; Hermann J; Zintl F; Scheele J. Pediatr Transplant 2002 Sep;6(4):340-3 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12234277&dopt=Abstract
Rofecoxib-induced cholestatic hepatitis: treatment with molecular adsorbent recycling system (MARS). Huster D; Schubert C; Berr F; Mossner J; Caca K. J Hepatol 2002 Sep;37(3):413 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12175641&dopt=Abstract
MARS: optimistic therapy method in fulminant hepatic secondary to cytotoxic mushroom poisoning - a case report Shi Y; He J; Chen S; Zhang L; Yang X; Wang Z; Wang M. Liver 2002:22(Suppl.2):78-80 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220312&dopt=Abstract
MARS procedure as a bridge to combined liver-kidney transplantation in severe chromium-copper acute intoxication: a paediatric case report Prokurat S; Grenda R; Lipowski D; Kalicinski P; Migdal M. Liver 2002:22(Suppl.2):76-77 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220311&dopt=Abstract
Extracorporeal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC) Sturm E; Franssen CFM; Gouw A; Staels B; Boverhof R; de Knegt RJ Liver 2002:22(Suppl.2):72-75 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220310&dopt=Abstract
Modular extracorporeal life support for multiorgan failure patients Peek GJ; Killer HM; Sosnowski MA; Firmin RK. Liver 2002:22(Suppl.2):69-71 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220309&dopt=Abstract
Emerging indications for MARS dialysis Schachschal G; Morgera S; KŸpferling S; Neumayer HH; Lochs H; Schmidt HH-J. Liver 2002:22(Suppl.2):63-68 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220308&dopt=Abstract
First clinical experience with Molecular Adsorbent Recirculating System (MARS) in six patients with severe acute on chronic liver failure Mullhaupt B; Kullak-Ublick GA; AmbŸhl P; Maggiorini M; Stocker R; Kadry Z; Clavien PA; Renner EL. Liver 2002:22(Suppl.2):59-62 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220307&dopt=Abstract
Application of Molecular Adsorbent Recirculating System in patients with severe liver failure after hepatic resection or transplantation: initial single-centre experiences Kellersmann R; Gassel H-J; BŸhler C; Thiede A; Timmermann W. Liver 2002:22(Suppl.2):56-58 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220306&dopt=Abstract
The Molecular Adsorbent Recirculating System in patients with severe liver failure: clinical results at the K.U.Leuven Wilmer A; Nevens F; Evenpoel P; Hermans G; Fevery J. Liver 2002:22(Suppl.2):52-55 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220305&dopt=Abstract
Molecular Adsorbent Recirculating System: clinical experience in patients with liver failure based on hepatitis B in China Chen S; Zhang L; Shi Y; Yang X; Wang M. Liver 2002:22(Suppl.2):48-51 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220304&dopt=Abstract
MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure Novelli G; Rossi M; Pretagostini R; Poli L; Novelli L; Berlococ P; Ferretti G; Iappelli M; Cortesini . Liver 2002:22(Suppl.2):43-47 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220303&dopt=Abstract
Albumin dialysis:single pass vs. Recirculation (MARS) Peszynski P; Klammt S; Peters E; Mitzner S; Stange J; Schmidt R. Liver 2002:22(Suppl.2):40-42 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220302&dopt=Abstract
Economic evaluation of MARS-preliminary results on survival and quality of life Hessel FP; Mitzner SR; Rief J; Gre§ S; Guellstorff B; Wasem J. Liver 2002:22(Suppl.2):26-29 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220299&dopt=Abstract
Experiences with MARS liver support therapy in liver failure: analysis of 176 Patients of the International MARS Registry Steiner C; Mitzner S. Liver 2002:22(Suppl.2):20-25 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220298&dopt=Abstract
Cholestatic liver disease: pathophysiology and therapeutic options Hofmann AF. Liver 2002:22(Suppl.2):14-19 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220297&dopt=Abstract
The pathophysiological basis of acute-on-chronic liver failure Sen S; Williams R; Jalan R. Liver 2002:22(Suppl.2):5-13 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12220296&dopt=Abstract
Successful application of MARS therapy in a 7 year-old patient with hepatic chronic rejection and severe cholestatic syndrome Voiculescu M; Ioanitescu S; Rusu E; Micu D; Mihaila M; Micu L. Rom J Gastroenterol 2002 Jun;11(2):135-40 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12145670&dopt=Abstract
Clinical research of patients with acute or chronic hepatic failure treated with molecular adsorbent recirculating system Zhou XM; Wang X; Yang Y; Zhao L; Miao JY; Ding J; Fan DM Zhonghua Gan Zang Bing Za Zhi 2002 Jun 20;10 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12113683&dopt=Abstract
Role of transport proteins in bioartificial liver assist systems. Mitzner S; Stange J; Freytag J; Lindemann S; Schmidt R. Int J Artif Organs 1996 Jan;19(1):49-52 1996 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8641819&dopt=Abstract
Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems Wehler M; Kokoska J; Reulbach U; Hahn EG; Strauss R. Hepatology 2001;34:255-261. 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11481609&dopt=Abstract
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Malinchoc M; Kamath PS; Gordon FD; Peine CJ; Rank J; ter Borg PCJ Hepatology 2000;31:864-871. 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10733541&dopt=Abstract
Predicting the prognosis of chronic liver disease: An evolution from CHILD to MELD Forman LM; Lucey MR Hepatology 2001;33:473-475 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11172352&dopt=Abstract
A model to predict survival in patients with end stage liver disease Kamath PS; Wiesner RH; Malinchoc M; Kremers W; Therneau TM; Kosberg C; D Hepatology 2001;33:464-470. 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11172350&dopt=Abstract
Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice Sass G; Koerber K; Bang R; Guehring H; Tiegs G J Clin Invest 2001 Feb;107(4):439-47 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11181643&dopt=Abstract
Nitric Oxideas a Mediator of hemodynamic Abnormalities and Sodium and Water Retention in Cirrhosis Martin P-Y; Gines P; Schrier RW The New England Journal of Medicine 1998 Volume 339 Number 8 : 533-541 1998 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9709047&dopt=Abstract
Give me iNOS or give me death Kim PK; Billiar TR Hepatology 2001 Aug;34(2):436-7 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11481632&dopt=Abstract
Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients Jimenez W; Ros J; Morales-Ruiz M; Navasa M; Sole M; Colmenero J; Sort P; Rivera F; Arroyo V; Rodes J Hepatology 1999 Sep;30(3):670-6 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10462373&dopt=Abstract
Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS Hori M; Kita M; Torihashi S; Miyamoto S; Won KJ; Sato K; Ozaki H; Karaki H Am J Physiol Gastrointest Liver Physiol 2001 May;280(5):G930-8 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11292602&dopt=Abstract
Mechanism of hepatocellular uptake of albumin-bound Bilirubin Zucker SD; Goessling W Biochim Biophys Acta 2000 Feb 15;1463(2):197-208 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10675499&dopt=Abstract
Kinetic model of protein-mediated ligand transport: influence of soluble binding proteins on the intermembrane diffusion of a fluorescent fatty acid Zucker SD Biochemistry 2001 Jan 30;40(4):977-86 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11170419&dopt=Abstract
Thermodynamics of fatty acid transfer Zakim D J Membr Biol 2000 Jul 15;176(2):101-9 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10926675&dopt=Abstract
Liver and intestinal fatty acid-binding proteins obtain fatty acids from phospholipid membranes by different mechanisms Thumser AE; Storch J J Lipid Res 2000 Apr;41(4):647-56 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10744786&dopt=Abstract
The peroxisomal proliferator clofibrate enhances the hepatic cytoplasmic movement of fatty acids in rats Milliano MT; Luxon BA Hepatology 2001 Feb;33(2):413-8 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11172343&dopt=Abstract
Cytoplasmic transport of fatty acids in rat enterocytes:role of binding to fatty acid-binding protein Luxon B; Milliano MT Am J Physiol G 1999 361-G 366 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10444450&dopt=Abstract
Oatp2 Mediates Bidirectional Organic Solute Transport: A Role for Intracellular Glutathione Li L; Meier PJ; Ballatori N MOL 2000;58:335-340 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10908301&dopt=Abstract
Fatty acid transfer from liver and intestinal fatty acid-binding proteins to membranes occurs by different mechanisms Hsu KT; Storch J J Biol Chem 1996 Jun 7;271(23):13317-23 1996 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8662836&dopt=Abstract
Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6 Cui Y; Konig J; Leier I; Buchholz U; Keppler D J Biol Chem 2001 Mar 30;276(13):9626-30 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11134001&dopt=Abstract
The helical domain of intestinal fatty acid binding protein is critical for collisional transfer of fatty acids to phospholipid membranes Corsico B; Cistola DP; Frieden C; Storch J Proc Natl Acad Sci U S A 1998 Oct 13;95(21):12174-8 1998 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9770459&dopt=Abstract
Endotoxin Downregulates Rat Hepatic ntcp Gene Expression via Decreased Activity of Critical Transcription Factors Trauner M; Arrese M; Lee H; Boyer JL; Karpen SJ J Clin Invest 1998 May 15;101(10):2092-100 1998  
Hepatic transport systems Ferenci P; Zollner G; Trauner M J Gastroenterol Hepatol 2002 Feb;17 Suppl 1:105-112 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12000597&dopt=Abstract
Endotoxin-induced reduction in biliary indocyanine green excretion rate in a chronically catheterized rat model Beno DW; Uhing MR; Goto M; Chen Y; Jiyamapa-Serna VA; Kimura RE Am J Physiol Gastrointest Liver Physiol 2001 May;280(5):G858-65 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11292593&dopt=Abstract
Bilirubin directly disrupts membrane lipid polarity and fluidity, protein order, and redox status in rat mitochondria Rodrigues CM; Sola S; Brito MA; Brites D; Moura JJ J Hepatol 2002 Mar;36(3):335-41 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11867176&dopt=Abstract
Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons Rodrigues CM; Sola S; Brites D Hepatology 2002 May;35(5):1186-95 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11981769&dopt=Abstract
By indirections find directions out Reuben A Hepatology 2002 May;35(5):1287-90 2002  
Mechanisms of Bilirubin Neurotoxicity Ostrow JD; Pascolo L; Tiribelli C Hepatology 2002 May;35(5):1277-80 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11981780&dopt=Abstract
Effect of Stabilisers on the Binding Capacity of Albumin Binding Sites and Effectivity of Albumin Dialysis (MARS) - in vitro and in-vivo experiments Peszynski P; Stange J; Mitzner S; Klammt S; Schmidt R ASAIO 45(2), 1999 1999  
Albumin Binding Capacity ( ABiC) is reduced in commercially available Human Serum Albumin preparations with stabilizers Klammt S; Brinkmann B; Mitzner S; Munzert E; Loock J; Stange J; Emmerich; Liebe S;  Z Gastroenterol 2001; 39: 24-27 2001  
Assesment of Albumin Binding Capacity (ABiC) for Characterization of Albumin Transport Function by a new Method Klammt S; Brinkmann B; Mitzner SR; Stange J; Loock J; Peters E; Emmerich; Liebe S; Munzert E J Hepatol 2001 Abstract 2001  
Role of albumin for transport and distribution of protein bound substances between compartments Steiner C; Stange J; Mitzner S; Schmidt R 2nd ISAD 2000 abstract 2000  
Properties And Functions of Human Albumin and Its Use In Liver Disease Salit M 3rd ISAD 2001 abstract 2001  
Is there still a need for albumin infusions to treat patients with liver disease? Gines P; Arroyo V Gut 2000;46:588-590. 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10764695&dopt=Abstract
Unique features of albumin: a brief review Emerson TE Jr Crit Care Med 1989 Jul;17(7):690-4 1989 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2661149&dopt=Abstract
Human albumin administration in critically ill patients: systematic review of randomised controlled trials No authors listed BMJ 1998 Jul 25;317(7153):235-40 1998 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9677209&dopt=Abstract
Ligand-dependent conformational equilibria of serum albumin revealed by tryptophan fluorescence quenching Chadborn N; Bryant J; Bain AJ; O Biophys J 1999 Apr;76(4):2198-207 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10096914&dopt=Abstract
Selection of donors and recipients for living donor liver transplantation Trotter JF Liver Transpl 2000 Nov;6(6 Suppl 2):S52-8 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11084086&dopt=Abstract
Living donor liver transplantation in adults: outcome in Japan Todo S; Furukawa H; Jin MB; Shimamura T Liver Transpl 2000 Nov;6(6 Suppl 2):S66-72 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11084089&dopt=Abstract
Long-term complications of living donor liver transplantation Renz JF; Roberts JP Liver Transpl 2000 Nov;6(6 Suppl 2):S73-6 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11084090&dopt=Abstract
Assessment of potential donors for living related liver transplantation Baker A; Dhawan A; Devlin J; Mieli-Vergani G; O Br J Surg 1999 Feb;86(2):200-5 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10100787&dopt=Abstract
Liver stem cells and model systems for liver repopulation Shafritz DA; Dabeva MD J Hepatol 2002 Apr;36(4):552-64 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11943430&dopt=Abstract
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a Muraca M; Gerunda G; Neri D; Vilei MT; Granato A; Feltracco P; Meroni M; Giron G; Burlina AB THE LANCET 2002 Vol 359 (26) 317-18 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11830200&dopt=Abstract
Predictors of the cost of liver transplantation Brown RS Jr; Lake JR; Ascher NL; Emond JC; Roberts JP Liver Transpl Surg 1998 Mar;4(2):170-6 1998 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9516571&dopt=Abstract
A comparison of the costs and effects of liver transplantation for acute and for chronic liver failure van Agthoven M; Metselaar HJ; Tilanus HW; de Man RA; Ijzermans JNM; van Ineveld BM Transp Int (2001) 14: 87-94 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11370172&dopt=Abstract
Retransplantation for hepatitis C: implications of different policies Rosen HR Liver Transpl 2000 Nov;6(6 Suppl 2):S41-6 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11084084&dopt=Abstract
Posttransplantation prevention and treatment of recurrent hepatitis B Rizzetto M; Marzano A Liver Transpl 2000 Nov;6(6 Suppl 2):S47-51 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11084085&dopt=Abstract
Effect of race on outcome of orthotopic liver transplantation: a cohort study Nair S; Eustace J; Thuluvath PJ Lancet 2002 Jan 26;359(9303):287-93 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11830194&dopt=Abstract
Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation Nair S; Verma S; Thuluvath PJ Hepatology 2002 May;35(5):1179-85 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11981768&dopt=Abstract
Posttransplantation prevention and treatment of recurrent hepatitis C Burroughs AK Liver Transpl 2000 Nov;6(6 Suppl 2):S35-40 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11084083&dopt=Abstract
Therapeutic plasma exchange in the intensive care setting Samtleben W; Mistry-Burchardi N; Hartmann B; Lennertz A; Bosch T Ther Apher 2001 Oct;5(5):351-7 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11778919&dopt=Abstract
Hepatic blood flow and splanchnic oxygen consumption in patients with liver failure. Effect of high-volume plasmapheresis Clemmesen JO; Gerbes AL; Gulberg V; Hansen BA; Larsen FS; Skak C; Tygstrup N; Ott P Hepatology 1999 Feb;29(2):347-55 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9918909&dopt=Abstract
Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin boundsubstances. Falkenhagen D; Strobl W; Vogt G; Schrefl A; Linsberger I; Gerner FJ; Schoenhofen M Artif Organs 1999 Jan;23(1):81-6 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9950184&dopt=Abstract
Assessment of an extracorporeal liver assist device in anhepatic dogs Kelly JH; Koussayer T; He D; Chong MG; Shang TA; Whisennand HH; Sussman NL Artif Organs 1992 Aug;16(4):418-22 1992 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10078286&dopt=Abstract
Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure Ellis AJ; Hughes RD; Wendon JA; Dunne J; Langley PG; Kelly JH; Gislason GT; Sussman NL; Williams R Hepatology 1996 Dec;24(6):1446-51 1996 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8938179&dopt=Abstract
Powdered Sorbent Liver Dialysis and Pheresis in treatment of Hepatic Failure Ash SR Ther Apher 2001 5(5): 404-416 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11778927&dopt=Abstract
Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation Samuel D; Ichai P; Feray C; Saliba F; Azoulay D; Arulnaden JL; Debat P; Gigou M; Adam R; Bismuth A; Castaing D; Bismuth H Transplantation 2002 Jan 27;73(2):257-64 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11821741&dopt=Abstract
Assessment of the AMC-bioartificial liver in the anhepatic pig Sosef MN; Abrahamse LS; van de Kerkhove MP; Hartman R; Chamuleau RA; van Gulik TM Transplantation 2002 Jan 27;73(2):204-9 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11821731&dopt=Abstract
Long-term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis Seige M; Kreymann B; Jeschke B; Schweigart U; Kopp KF; Classen M Transplant Proc 1999 Feb-Mar;31(1-2):1371-5 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10083608&dopt=Abstract
Albumin dialysis: single pass vs. Recirculation Peszynski P; Klammt S; Peters E; Mitzner S; Stange J; Schmidt R 3rd ISAD 2001 abstract 2001  
Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation:a new possibility for the elimination of protein-bound toxins Kreymann B; Seige M; Schweigart U; Kopp KF; Classen M Journal of Hepatology 1999; 31: 1080-1085 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10604583&dopt=Abstract
An Albumin-Peritoneal Dialysis Treatment for Detoxification Albumin-bound Toxines in Rats Happich S; Schildberg FM; Koebe HG; Stickel M 3rd ISAD 2001 abstract; 2001; 0(0): 2001  
Distribution of protein bound substances Steiner C; Stange J; Mitzner S; Williams R; Jalan R 3rd ISAD 2001 abstract 2001  
A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver Stange J; Mitzner S Int J  Art Organs 1996;19(11):677-691 1996 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8970836&dopt=Abstract
Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support Stange J; Mitzner SR; Risler T; Erley CM; Lauchart W; Goehl H; Klammt S; Peszynski P; Freytag J; Hickstein H; Lohr M; Liebe S; Schareck W; Hopt UT; Schmidt R Artif Organs 1999 Apr;23(4):319-30 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10226696&dopt=Abstract
Dialysis against a Recycled Albumin Solution Enables the Removal of Albumin-Bound Toxins Stange J; Ramlow W; Mitzner S; Schmidt R; Klinkmann H Artificial Organs 1993;17(9):809-813 1993 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8240075&dopt=Abstract
What determines elimination of albumin bound toxins during clinical treatment preliminary results Schneider T; Peters E; Hickstein H; Klammt S 3rd ISAD 2001 abstract 2001  
Albumin dialysis: single pass vs. Recirculation Peszynski P; Klammt S; Peters E; Mitzner S; Stange J; Schmidt P 3rd ISAD 2001 abstract 2001  
Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin Lee KH; Wendon J; Lee M; Da Costa M; Lim SG; Tan KC Liver Transpl 2002 Jul;8(7):591-3 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12089711&dopt=Abstract
Blood purification in excretory liver insufficiency by albumin dialysis: Impact of the dialysis membrane Klammt S; Stange J; Mitzner S; Peszynski P; Freytag J; Steiner C; Schmidt R; Pertschy A; Adam U; Hopt U Hepatology 2000; 32:167A [19] 2000  
Can the clearance of tumor necrosis factor alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system? Awad SS; Sawada S; Soldes OS; Rich PB; Klein R; Alarcon WH; Wang SC; Bartlett RH ASAIO J 1999 Jan-Feb;45(1):47-9 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9952006&dopt=Abstract
The In Vivo Clearance of TGF-BETA and interleukinn-6 using Albumin Dialysis as a non-cell based extrcorporeal Hepatic Support Device Awad SS; Alacron WH; Swaniker F; Wang SC; Bartlett RH 3rd ISAD 2001 abstract 2001  
The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers Stange J; Hassanein TI; Mehta R; Mitzner SR; Bartlett RH Artif Organs 2002 Feb;26(2):103-10 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11879237&dopt=Abstract
Extracorporeal Detoxification Using the Molecular Adsorbent Recirculating System for Critically Ill Patients with Liver Failure Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Noldge-Schomburg G J Am Soc Nephrol 2001 Feb;12 Suppl 17:S75-82 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11251037&dopt=Abstract
Albumin dialysis using the molecular adsorbent recirculating system Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R Curr Opin Nephrol Hypertens 2001 Nov;10(6):777-83 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11706305&dopt=Abstract
Molecular Adsorbant Recirculating System in Patients With Liver Failure Lamesch P; Jost U; Schreiter D; Scheibner L; Beier O; Fangmann J; Hauss J Transplant Proc 2001 Nov-Dec;33(7-8):3480-2 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11750489&dopt=Abstract
Aktueller Stand der extrakorporalen Albumin-Dialyse (MARS) bei Patienten mit akutem Leberversagen -Indikationen, Vorgehen, Kosten Jost U; Schreiter D; Scheibner L; Glien C; Lamesch P; Hauss J GASL 2002 abstract 2002  
MARS Treatment in Patients affected by acute Liver Failure or acute on chronic Liver Failure: The Catholic University Experience Di Campli C; Gaspari R; Mensi S; Zocco MA; Piscaglia AC; Stifano G; Dal Verme LZ; Lupascu A; Nista AC; Gentiloni N; Proietti R; Gasbarrini G; Gasbarrini A EASL 2002 abstract 2002  
Use of extracorporeal liver assist device (MARS) in a patient with acute on chronic liver failure caused by transplant rejection in chronic Hepatis C Lenz K; Hubmann R; Fritsch N; Pixner N; Kapral C; Wewalka F 3rd ISAD 2001 abstract 2001  
MARS improves indocyanine green Kinetics in primary Dysfunction after OLT Hetz H; Faybik P; Baker A; Kopp AM; Neumayer C; Steltzer H 3rd ISAD 2001 abstract 2001  
PDF Post Liver Transplant treated by MARS: Case Report and general Consideration Ambrosino G; Cillo U; Varotto S; Basso S; Naso A; Konthotanassis D; Montin U; Bettiol M; Carraro P; Turioni B; Feltracco P; Boccagni P; Brolese A; Zanus G; Fagiuoli S; Plebani M; DÕAmico D 3rd ISAD 2001 abstract 2001  
Molecular Adsorbent Recirculating System: Clinical experience in a pediatric patient Ribes-Koninckx C; Polo B; Sanchis R; Donat E 3rd ISAD 2001 abstract 2001  
MARS Procedure as a bridge to combined Liver-Kidney-Transplantation in acute severe chromium-copper Intoxication-a pedriatic Case Report Prokurat S; Lipowski D; Grenda R; Kaliciski P; Migda M 3rd ISAD 2001 abstract 2001  
Extracorporeal Hepatic Support Device (MARS) with Albumin Dialysis in a 9 month-old Boy with Hepatic Graft Dysfunction Javouhey E; Delafosse B; Stamm D; Boucaud C; Floret D; Lachaux A; ; Boillot O 3rd ISAD 2001 abstract 2001  
Modular Extra-corporeal Life Support for Multi-Organ Failure Patients Peek GJ; Killer HM; Sosnowski MA; Sosnowski AW; Firmin RK 3rd ISAD 2001 abstract 2001  
Case Report : Early MARS-Treatment for Liver Dysfunction following complicated Hemihepatectomy Hetz H; Faybik P; Baker A; Gruenberger T; Neumayer C; Steltzer H ISAD 2001 abstract 2001  
Therapie der benignen intrahepatischen Cholestase (BRIC) mit MARS Sturm E; Franssen CFM; Boverhof R; de Knegt RJ; Kuipers F; Stellaard F; Bijleveld CMA GASL 2002 poster 2002  
Einsatz des Molecular Adsorbents Recirculating System (MARS) bei einem Patienten mit benigner rekurrierender intrahepatischer Cholestase (BRIC) Schiefke I; Huster D; Schubert C; Jost U; Achenbach H; Hauss J; Berr F GASL 2001 abstract 2001  
MARS dialysis in the state of chronic rejection in a liver transplant recipient Schachschal G; Morgera S; Kupferling S; Schmidt HH; Lochs H Am J Gastroenterol 2002 Apr;97(4):1059-60 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12003389&dopt=Abstract
Molecular Adsorbent Recirculating System: Clinical experience in a pediatric patient Ribes-Koninckx; Polo B; Sanchis R; Donat R 3rd ISAD 2001:abstract 2001  
Molecular adsorbent recirculating system: A new procedure for relieving intractable pruritus in patients with primary biliary cirrhosis ParŽs A; Cisneros L; Salmeron JM; Caballer’a  L; Mas A; Torras A; Rodes J EASL 2002 Poster 2002  
Molecular adsorbent recirculating system: A new procedure for relieving intractable pruritus in patients with primary biliary cirrhosis ParŽs A; Cisneros L; Salmeron JM; Caballeria L; Mas A; Torras A; Rodes J EASL 2002 abstract 2002  
Successful clinical application of extracorporeal albumin dialysis in a patient with Benign Reccurent Intrahepatic Cholestasis Huster D; Schubert C; Achenbach H; Caca K; Mšssner J; Berr F Z Gastroenterol 2001;39:13-14 2001  
Treatment of steroid-induced cholestasis with albumin dialysis (Case Report) Bellmann R; Zoller H; Schwaighofer G; Vogel G; Wiedermann CJ; Joannidis M. Poster Genf 2001 2001  
Treatment of Hepatorenal Syndrome: Lessons from the MARS Trials Mullen K Hepatology 2002 : 492-3 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11826426&dopt=Abstract
Improvement of Hepatorenal Syndrome With Extracorporeal Albumin Dialysis MARS: Results of a Prospective, Randomized, Controlled Clinical Trial Mitzner SR; Stange J; Klammt S; Risler T; Erley CM; Bader BD; Berger ED; Lauchart W; Peszynski P; Freytag J; Hickstein H; Loock J; Lohr JM; Liebe S; Emmrich J; Korten G; Schmidt R Liver Transpl 2000 May;6(3):277-86 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10827226&dopt=Abstract
MARS: A new treatment for  hepatorenal failure Kapoor D; Jalan R; Williams R Gastroenterol December 2000 : Selected Summaries 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11113107&dopt=Abstract
New treatments for hepatorenal syndrome Arroyo V Liver Transpl 2000 May;6(3):287-9 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10827227&dopt=Abstract
New extracorporeal liver support for chronic liver disease complicated by cholestasis results of a prospective controlled randomized two-center trial (abstract) Stange J; Mitzner S; Klammt S; Loock J; Treichel U; Gerken G; Schmidt R; Liebe S J Hepatology 2001; 34 S1: 45 A1289 2001  
Are only Bilirubin and bile Acids removed by Albumin Dialysis? Observations of a randomized two Center clinical Trial Loock J; Heemann U; Mitzner SM; Treichel U; Stange J; Peszynski P; Liebe S; Klammt S EASL 2002 abstract 2002  
The Molecular Adsorbent Recirculating System improves systemic hemodynamics and hepatic encephalopathy in patients with severe alcoholic hepatitis ParŽs A; Cisneros L; Salmer—n J; Mas A; Torras A; Caballer’a J EASL 2002 abstract 2002  
MARS (Molecular Adsorbent Recycling System) als neues Verfahren zum Ersatz der Leberentgiftungsfunktion bis zur orthotopne Lebertransplantation Ullerich H; Avenhaus W; Menzel J; Dietl KH; Domschke W; Lerch MM Z Gastroenterol 2001;39:1023-26 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11753787&dopt=Abstract
Liver support by extracorporeal blood purification: a clinical observation Stange J; Mitzner SR; Klammt S; Freytag J; Peszynski P; Loock J; Hickstein H; Korten G; Schmidt R; Hentschel J; Schulz M; Lohr M; Liebe S; Schareck W; Hopt UT Liver Transpl 2000 Sep;6(5):603-13 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10980060&dopt=Abstract
Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure Sorkine P; Ben Abraham R; Szold O; Biderman P; Kidron A; Merchav H; Brill S; Oren R Crit Care Med 2001 Jul;29(7):1332-6 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11445681&dopt=Abstract
Case report of fulminant liver failure with raised intra-cranial pressure treated with MARS dialysis. Southern PB 3rd ISAD 2001 abstract 2001  
Progressive intrahepatic cholestasis is a recognized component of chronic graft-versus-host disease (GVHD). Sen S; Steiner C; Jalan R; Williams R 3rd ISAD 2001 abstract 2001  
Treatment of Wilson Disease Crisis by Albumin Dialysis - Case Report Rzadkiewicz E; Dbowska M; Lipowski D; Przyjakowski W; Cianciara J 3rd ISAD 2001 abstract 2001  
Use of MARS in the treatment of acute liver failure: preliminar monocentric experience Novelli G; Rossi M; Pretagostini R; Poli L; Peritore D; Berloco P; Di Nicuolo A; Iappelli M; Cortesini R Transplant Proc 2001 Feb-Mar;33(1-2):1942-4 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11267580&dopt=Abstract
Use  of albumin dialysis in the treatment of hepatic and renal dysfunction due to paracetamol intoxication McIntyre CW; Fluck RJ; Freeman JG; Lambie SH Nephrol Dial Transplant 2002:17:316-17 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11812892&dopt=Abstract
Artificial liver support as a bridge to orthotopic liver transplantation in a case of acute liver dysfunction on Non-Alcoholic Steato Hepatitis (NASH) Gaspari R; Pennisi MA; Mignani V; Gasbarrini A; Mercurio G; Di Campli C; Conti G; Gentiloni Silveri N; Proietti R Z Gastroenterol Suppl 2001;39:15-17 2001  
Results of a phase I trial evaluating a liver support device utilizing albumin dialysis Awad SS; Swaniker F; Magee J; Punch J; Bartlett RH Surgery 2001 Aug;130(2):354-62 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11490371&dopt=Abstract
Reduction of plasma hepatotoxicity in cholestatic patients by extrcorporeal liver support Stange J; Mitzner S; Klammt S; Peszynski P; Freytag J; Loock J; Schmidt R J Hepatol 2000 abstract 2000  
Impact of albumin dialysis on toxicokinetic of bile acids in severe intrahepatic cholestasis Stange J; Mitzner S; Klammt S; Peszynski P; Freytag J; Schmidt R ASAIO 45(2), 1999 1999  
Removal of Albumin bound Toxins with the MARS-Systems shows protective effects on hepatocytes Koball S; Peszynski P; Freytag J; Stange J; Mitzner S; Korten G; Schmidt R;  ASAIO 46(2), 2000:239 2000  
Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system Mitzner SR; Klammt S; Peszynski P; Hickstein H; Korten G; Stange J; Schmidt R Ther Apher 2001 Oct;5(5):417-22 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11778928&dopt=Abstract
Cerebral Blood Flow Velocity Increases During a Single Treatment With the Molecular Adsorbents Recirculating System in Patients With Acute on Chronic Liver Failure Schmidt L; Svendsen L; S¿rensen VS; Hansen BA; Larsen FS Liver Transpl 2001 Aug;7(8):709-12 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11510016&dopt=Abstract
Removal of Benzodiazepine-like Substances as a Cause of Improvement of Hepatic Encephalopathy during Albumin Dialysis Peszynski P; Stange J; Mitzner S; Klammt S; Majcher-Peszynska J; Wacke R; Drewelow B; Schmidt R Z Gastoenterol Suppl 2000;39:53 2000  
Influence of Albumin dialysis (MARS) on neuronal network activity in vitro - early results Loock J; Stange J; Mitzner S; Schmidt R; Gramowski A; Schiffmann D; Weiss D; Keefer EW; Gross GW Z Gastroenterol Suppl 2001;39:28-32 2001 http://www.ncbi.nlm.nih.gov/pubmed/16215892?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS) but not by non-recirculating albumin dialysis and renal replacement therapy Loock J; Peters E; Heemann U; Klammt S; Schmidt R; Mitzner SR; Stange J 3rd ISAD 2001 abstract 2001  
Improvement in Cerebral Perfusion After MARS Therapy: Further Clues About the Pathogenesis of Hepatic Encephalopathy? Jalan R; Williams R Liver Transpl 2001 Aug;7(8):713-5 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11510017&dopt=Abstract
The Effect of Albumin Dialysis (MARS) on Neuronal Network Activity evaluated in vitro Loock J; Stange J; Mitzner S; Schmidt R; Schiffmann D; Weiss D; Keefer E; Gross G Hepatology vol.30(4)1999 1999  
Reduction of Nitric Oxide Displacing Albumin bound Toxins by Extracorporal Liver Support - New therapy for Hyperdynamic Circulation ?
Stange J; Mitzner S; Klammt S; Peszynski P; Freytag J; Hentschel J; Schulz M; Loock J; Schmidt R J Hepatol 2000 2000  
Inhibition of NO synthase by arginine removal by liver support (MARS) seems to be only a cofactor for reversal of hypotension in decompensated liver cirrhosis that seems to be linked more to removal of protein bound toxins Stange J; Mitzner S; Klammt S; Freytag J; Peszynski P; Hickstein H; Hentschel J; Schulz M; Schmidt R; Loock J; Heemann U; Treichel U; Gerken G Hepatology 2000; 32:612A [1812 ] 2000  
Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure Schmidt LE; Sorensen VR; Svendsen LB; Hansen BA; Larsen FS Liver Transpl 2001 Dec;7(12):1034-9 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11753905&dopt=Abstract
The Molecular Adsorbent Recirculating System (MARS) increases Systemic Vascular Resistance in Patients with Acute Liver Failure Schmidt L; Wang L; Hansen B; Larsen F J Hepatol 2002 Abstract: 685 2002  
Kinetics of drugs during MARS-treatment Peszynski P; Majcher-Peszynska J; Stange J; Mitzner S; Klammt S; Drewelow B; Schmidt R Hepatology 2000; 32:484A [1299] 2000  
Drugs in Liver Disease and during albumin dialysis-MARS Majcher- Peszynska J; Klammt S; Hehl E; Wacke P; Peszynski P; Stange J; Mitzner S; Schmidt R; Drewelow B Z Gastroenterol Supplement 2001; 39: 33-35 2001 http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&db=pubmed&cmd=Search&term=2001%5Bpdat%5D%20AND%20Majcher-%20Peszynska%20J%5Bauthor%5D
Removal of Albumin Bound Drugs in Albumin Dialysis (MARS) - a New Liver Support System Majcher- Peszynska J; Klammt S; Hehl E; Wacke P; Peszynski P; Stange J; Mitzner S; Schmidt R; Drewelow B J Hepatol 2000; 32 (Suppl2): 60 2000  
Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients Abraham RB; Szold O; Merhav H; Biderman P; Kidron A; Nakache R; Oren R; Sorkine P Transplant Proc 2001 Sep;33(6):2897-9 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11543780&dopt=Abstract
Improvement of Albumin Binding Capacity (ABiC) by Albumin dialysis: Clinical results Liebe S; Peters E; Peszynski P; Munzert E; Brinkmann B; Loock J; Mitzner S; Klammt S 3rd ISAD 2001 abstract; 2001; 0(0): 2001  
Primary or established liver cells for a hybrid liver? Comparison of metabolic features Stange J; Mitzner S; Strauss M; Fischer U; Lindemann S; Peters E; Holtz M; Drewelow B; Schmidt R ASAIO J 1995 Jul-Sep;41(3):M310-5 1995 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8573814&dopt=Abstract
Artificial liver support devices for fulminant liver failure. Sechser A; Osorio J; Freise C; Osorio RW. Clin Liver Dis 2001 May;5(2):415-30. 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11385970&dopt=Abstract
Extracorporeal support of the failing liver Rozga J Med Sci Monit,2001;7(Suppl.1):78-90 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12211756&dopt=Abstract
Extracorporeal support of the failing liver. Mitzner S; Stange J; Peszynski P; Klammt S. Curr Opin Crit Care 2002;8:171-177. 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12386520&dopt=Abstract
Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure Kamohara Y; Fujioka H; Eguchi S; Kawashita Y; Furui J; Kanematsu T Artif Organs 2000 Apr;24(4):265-70 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10816199&dopt=Abstract
What progress with artificial livers? Hayes PC; Lee A Lancet 2001 Oct 20;358(9290):1286-7 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11684205&dopt=Abstract
Treatment of acute liver failure: hybrid liver support. A critical overview Busse B; Smith MD; Gerlach JC Langenbecks Arch Surg 1999 Dec;384(6):588-99 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10654275&dopt=Abstract
Advances in bioartificial liver devices Allen JW; Hassanein T; Bhatia SN Hepatology 2001 Sep;34(3):447-55 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11526528&dopt=Abstract
Methods of Extrcorporeal Liver Support For Treatment of Liver Cell Failure Adham M Z Gastroenterol 2001 Supplement 1 : 1-5 2001  
Spontaneous bacterial peritonitis--in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998 Thuluvath PJ; Morss S; Thompson R Am J Gastroenterol 2001 Apr;96(4):1232-6 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11316175&dopt=Abstract
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document Rimola A; Garcia-Tsao G; Navasa M; Piddock LJ; Planas R; Bernard B; Inadomi JM J Hepatol 2000 Jan;32(1):142-53 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10673079&dopt=Abstract
Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality Navasa M; Follo A; Filella X; Jimenez W; Francitorra A; Planas R; Rimola A; Arroyo V; Rodes J Hepatology 1998 May;27(5):1227-32 1998 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9581675&dopt=Abstract
Intravenous albumin reduces mortality in patients with spontaneous bacterial peritonitis Mogyorosi A; Schubert ML Gastroenterology 2000 Jan;118(1):231-3 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10611175&dopt=Abstract
New challenge of hepatorenal syndrome: prevention and treatment Wong F; Blendis L Hepatology 2001 Dec;34(6):1242-51 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11732014&dopt=Abstract
Increased plasma levels of neuropeptide Y in hepatorenal syndrome Uriz J; Gines P; Ortega R; Jimenez W; Cardenas A; Calahorra B; Sort P; Fernandez J; Bataller R; Arroyo V; Rivera F; Rodes J J Hepatol 2002 Mar;36(3):349-55 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11867178&dopt=Abstract
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study Duvoux C; Zanditenas D; Hezode C; Chauvat A; Monin JL; Roudot-Thoraval F; Mallat A; Dhumeaux D Hepatology 2002 Aug;36(2):374-80 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12143045&dopt=Abstract
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study Moreau R; Durand F; Poynard T; Duhamel C; Cervoni JP; Ichai P; Abergel A; Halimi C; Pauwels M; Bronowicki JP; Giostra E; Fleurot C; Gurnot D; Nouel O; Renard P; Rivoal M; Blanc P; Coumaros D; Ducloux S; Levy S; Pariente A; Perarnau JM; Roche J; Scribe-Out Gastroenterology 2002 Apr;122(4):923-30 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11910344&dopt=Abstract
The hepatorenal syndrome Dagher L; Moore K Gut 2001;49:729-737 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11600480&dopt=Abstract
Renal Failure After Upper Gastrointestinal Bleeding in Cirrhosis: Incidence, Clinical Course, Predictive Factors, and Short-Term Prognosis Cardenas A; Gines P; Uriz J; Bessa X; Salmeron JM; Mas A; Ortega R; Calahorra B; De Las Heras D; Bosch J; Arroyo V; Rodes J Hepatology 2001 Oct;34(4 Pt 1):671-6 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11584362&dopt=Abstract
Intravenous albumin with diuretics: protean lessons to be learnt? Blendis L; Wong F J Hepatol 1999 Apr;30(4):727-30 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10207818&dopt=Abstract
Hepatorenal syndrome in cirrhosis: pathogenesis and treatment Arroyo V; Guevara M; Gines P Gastroenterology 2002 May;122(6):1658-76 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12016430&dopt=Abstract
Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide Angeli P; Volpin R; Gerunda G; Craighero R; Roner P; Merenda R; Amodio P; Sticca A; Caregaro L; Maffei-Faccioli A; Gatta A Hepatology 1999 Jun;29(6):1690-7 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10347109&dopt=Abstract
Pulmonary dysfunction in chronic liver disease Fallon MB; Abrams GA Hepatology 2000 Oct;32(4 Pt 1):859-65 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11003635&dopt=Abstract
Hepatopulmonary Syndrome in Inferior Vena Cava Obstruction Responding to Cavoplasty De Binay K; Sen S; Biswas PK; Sany AL R; Majumdar J; Biswas J Gastroenterology 2000;118:192-196 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10611168&dopt=Abstract
Hepatic Encephalopathy Blei AT, Cordoba J Am J Gastroenterol 2001 Jul;96(7):1968-76 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11467622&dopt=Abstract
Vascular hyporesponsiveness in cirrhosis - many facets of a common problem! Kapoor D; Jalan R European Journal of Clinical Investigation (2001) 31, 95-97 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11168444&dopt=Abstract
Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis del Olmo JA; Pena A; Serra MA; Wassel AH; Benages A; Rodrigo JM J Hepatol 2000 Jan;32(1):19-24 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10673062&dopt=Abstract
UK guidelines on the management of variceal haemorrhage in cirrhotic patients Jalan R; Hayes PC Gut 2000;46(Suppl III):iii1-iii15 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10862604&dopt=Abstract
Endotoxin Downregulates Rat Hepatic ntcp Gene Expression via Decreased Activity of Critical Transcription Factors Trauner M; Arrese M; Lee H; Boyer JL; Karpen SJ J Clin Invest 1998 May 15;101(10):2092-100 1998 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9593765&dopt=Abstract
Indomethacin Prevents the Development of Experimental Ammonia-Induced Brain Edema in Rats After Portacaval Anastomosis Chung C; Gottstein J; Blei AT Hepatology 2001 Aug;34(2):249-54 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11481608&dopt=Abstract
Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal Lee WJ; Hawkins RA; Vina JR; Peterson DR Am J Physiol 1998 Apr;274(4 Pt 1):C1101-7 1998 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9580550&dopt=Abstract
Mild Hypothermia Modifies Ammonia-Induced Brain Edema in Rats After Portacaval Anastomosis Cordoba J; Crespin J; Gottstein J; Blei AT Gastroenterology 1999 Mar;116(3):686-93 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10029628&dopt=Abstract
Is cerebral edema a component of the syndrome of hepatic encephalopathy? Jones EA; Lavini C Hepatology 2002 May;35(5):1270-3 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11981778&dopt=Abstract
Medical Therapy of Brain Edema in Fulminant Hepatic Failure Blei AT Hepatology 2000 Sep;32(3):666-9 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10960467&dopt=Abstract
Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis Salo J; Gines A; Gines P; Piera C; Jimenez W; Guevara M; Fernandez-Esparrach G; Sort P; Bataller R; Arroyo V; Rodes J. J Hepatol 1997 Oct;27(4):645-53 1997 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9365040&dopt=Abstract
MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt Salerno F; Merli M; Cazzaniga M; Valeriano V; Rossi P; Lovaria A; Meregaglia D; Nicolini A; Lubatti L; Riggio O. J Hepatol 2002 Apr;36(4):494-500 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11943420&dopt=Abstract
Prognostic evaluation of patients with parenchymal cirrhosis Adler M; Verset D; Bouhdid H; Bourgeois N; Gulbis B; Le Moine O; Van de Stadt J; Gelin M; Thiry P J Hepatol 1997 Mar;26(3):642-9 1997 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9075673&dopt=Abstract
Non-alcoholic fatty liver disease Angulo P; Lindor KD J Gastroenterol Hepatol 2002 Feb;17 Suppl 1:186-190 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12000605&dopt=Abstract
Hereditary hemochromatosis and iron overload diseases Powell LW J Gastroenterol Hepatol 2002 Feb;17 Suppl 1:191-195 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12000606&dopt=Abstract
Molecular aspects of iron absorption: Insights into the role of HFE in hemochromatosis Philpott CC Hepatology 2002 May;35(5):993-1001 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11981749&dopt=Abstract
Cost effectiveness of combination therapy for hepatitis C: a decision analytic model Stein K; Rosenberg W; Wong J Gut 2002 Feb;50(2):253-8 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11788569&dopt=Abstract
Management of viral hepatitis C Leung NW J Gastroenterol Hepatol 2002 Feb;17 Suppl 1:146-154 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12000600&dopt=Abstract
Outcome of Hospital Care of Liver Disease Associated With Hepatitis C in the United States Kim R; Gross J jr.; Potechursa J; Locke R III.; Dickson R J Hepatol 2001 201-206 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11124837&dopt=Abstract
Clinical guidelines on the management of hepatitis C. Booth JC; O Gut 2001 Jul;49 Suppl 1:1-21 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11413125&dopt=Abstract
Management of viral hepatitis B. Pramoolsinsup C J Gastroenterol Hepatol 2002 Feb;17 Suppl :126-146 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12000599&dopt=Abstract
Chronic Hepatitis B Lok AS; McMahon BJ; Practice Guidelines Committee; American Association for the Study of Liver Diseases. Hepatology 2001 Dec;34(6):1225-41 2001 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11732013&dopt=Abstract
Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis Kapoor D; Guptan RC; Wakil SM; Kazim SN; Kaul R; Agarwal SR; Raisuddin S; Hasnain SE; Sarin SK. J Hepatol 2000(33):308-312 2000 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10952249&dopt=Abstract
Epidemiology and prophylaxis of viral hepatitis: A global perspective. Poovorawan Y; Chatchatee P; Chongsrisawat V. J Gastroenterol Hepatol 2002 Feb;17 Suppl 1:155-166 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12000601&dopt=Abstract
Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum van Ooteghem N; Klomp L; van Berge-Henegouwen G; Houwen R J Hepatol 2002(36):439-443 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11867191&dopt=Abstract
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of in severe AH Mathurin P; Mendenhall C; Carithers Jr. L; Ramond M-J; Maddrey W; Garstide P; Rueff B; Naveau S; Chaput J-C; Poynard T J Hepatol 2002(36):480-487 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11943418
Apoptosis in alcoholic hepatitis - Letter Farinati F; Cardin R; Fiorentino M J Hepatology 2002(36):570-573 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11943433&dopt=Abstract
Alcoholic hepatitis: glucocorticosteriods or not? - Editorial Christensen E J Hepatol 2002(36):547-548 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11943428&dopt=Abstract
Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality. Singh N; Gayowski T; Wagener MM; Marino IR. J Gastroenterol 1998 Feb;33(1):73-9 1998 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9497225&dopt=Abstract
Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options Jalan R; Williams R Blood Purif 2002;20:252-261 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11867872&dopt=Abstract
Prognostic significance of hepatic encephalopathy in patients with cirrhosis Bustamante J; Rimola A; Ventura P; Navasa M; Cirera I; Reggiardo V; Rodes J J Hepatol 1999 May;30(5):890-5 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10365817&dopt=Abstract
Advances, challenges, and controversies in poisoning Jones AL; Dargan PI Emerg Med J 2002 May;19(3):190-2 2002 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11971821&dopt=Abstract
Indications for referral and assessment in adult liver transplantation: a clinical guideline Devlin J; OÕGrady J Gut 1999;45(Suppl VI):VI1-VI22 1999 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10561164&dopt=Abstract